<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/2021.07.09.451828</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.07.09.451828v4</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;2021.07.09.451828</article-id><article-id pub-id-type="other" hwp:sub-type="slug">2021.07.09.451828</article-id><article-id pub-id-type="other" hwp:sub-type="atom-slug">2021.07.09.451828</article-id><article-id pub-id-type="other" hwp:sub-type="tag">2021.07.09.451828</article-id><article-version>1.4</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Biochemistry" hwp:journal="biorxiv"><subject>Biochemistry</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">Inhibitory proteins block substrate access by occupying the active site cleft of <italic toggle="yes">Bacillus subtilis</italic> intramembrane protease SpoIVFB</article-title></title-group><author-notes hwp:id="author-notes-1"><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1"><label>1</label>To whom correspondence should be addressed. Email: <email hwp:id="email-1">kroos@msu.edu</email></corresp></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" hwp:id="contrib-1"><name name-style="western" hwp:sortable="Olenic Sandra"><surname>Olenic</surname><given-names>Sandra</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">a</xref></contrib><contrib contrib-type="author" hwp:id="contrib-2"><name name-style="western" hwp:sortable="Heo Lim"><surname>Heo</surname><given-names>Lim</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">a</xref></contrib><contrib contrib-type="author" hwp:id="contrib-3"><name name-style="western" hwp:sortable="Feig Michael"><surname>Feig</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-3" hwp:rel-id="aff-1">a</xref></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-4"><name name-style="western" hwp:sortable="Kroos Lee"><surname>Kroos</surname><given-names>Lee</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-4" hwp:rel-id="aff-1">a</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">1</xref></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2 xref-aff-1-3 xref-aff-1-4"><label>a</label><institution hwp:id="institution-1">Department of Biochemistry and Molecular Biology, Michigan State University</institution>, East Lansing, MI 48824</aff></contrib-group><pub-date pub-type="epub-original" date-type="pub" publication-format="electronic" hwp:start="2021"><year>2021</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2021-07-10T16:33:20-07:00">
    <day>10</day><month>7</month><year>2021</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2021-10-26T14:33:13-07:00">
    <day>26</day><month>10</month><year>2021</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2021-07-10T16:37:36-07:00">
    <day>10</day><month>7</month><year>2021</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2021-10-26T14:41:03-07:00">
    <day>26</day><month>10</month><year>2021</year>
  </pub-date><elocation-id>2021.07.09.451828</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2021-07-09"><day>09</day><month>7</month><year>2021</year></date>
<date date-type="rev-recd" hwp:start="2021-10-26"><day>26</day><month>10</month><year>2021</year></date>
<date date-type="accepted" hwp:start="2021-10-26"><day>26</day><month>10</month><year>2021</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">Â© 2021, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2021</copyright-year><license hwp:id="license-1"><p hwp:id="p-1">The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.</p></license></permissions><self-uri xlink:href="451828.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/change-list" xlink:role="change-list" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2021/pdf/2021.07.09.451828v4.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="451828.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2021/abstracts/2021.07.09.451828v4/2021.07.09.451828v4.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2021/fulltext/2021.07.09.451828v4/2021.07.09.451828v4.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">Abstract</title><p hwp:id="p-2">Intramembrane proteases function in numerous signaling pathways that impact health, but knowledge about regulation of intramembrane proteolysis is limited. We examined inhibition of intramembrane metalloprotease SpoIVFB by proteins BofA and SpoIVFA. We found that BofA residues in and near a predicted transmembrane segment are required for SpoIVFB inhibition, and cross-linking experiments indicated that this transmembrane segment occupies the SpoIVFB active site cleft. SpoIVFA is also required for SpoIVFB inhibition. The inhibitory proteins block access of the substrate N-terminal Proregion to the membrane-embedded SpoIVFB active site, based on additional cross-linking experiments; however, the inhibitory proteins did not prevent interaction between the substrate C-terminal region and the SpoIVFB soluble domain. A structural model was built of SpoIVFB in complex with BofA and parts of SpoIVFA and substrate, using partial homology and constraints from cross-linking and co-evolutionary analyses. The model predicts that conserved BofA residues interact to stabilize a transmembrane segment and a membrane-embedded C-terminal region. SpoIVFA is predicted to bridge the BofA C-terminal region and SpoIVFB, forming a membrane-embedded inhibition complex. Our results reveal a novel mechanism of intramembrane protease inhibition with clear implications for relief from inhibition <italic toggle="yes">in vivo</italic> and design of inhibitors as potential therapeutics.</p></abstract><counts><page-count count="62"/></counts><custom-meta-wrap><custom-meta hwp:id="custom-meta-1"><meta-name>special-property</meta-name><meta-value>contains-inline-supplementary-material</meta-value></custom-meta></custom-meta-wrap><custom-meta-wrap>
    <custom-meta hwp:id="custom-meta-2">
      <meta-name>has-earlier-version</meta-name>
      <meta-value>yes</meta-value>
    </custom-meta>
  </custom-meta-wrap></article-meta><notes hwp:id="notes-1"><notes notes-type="competing-interest-statement" hwp:id="notes-2"><title hwp:id="title-2">Competing Interest Statement</title><p hwp:id="p-3">The authors have declared no competing interest.</p></notes><fn-group content-type="summary-of-updates" hwp:id="fn-group-1"><title hwp:id="title-3">Summary of Updates:</title><fn fn-type="update" hwp:id="fn-1"><p hwp:id="p-4">Figure S22 is now Figure 8.  Figures S1-S21 were renamed as Figure X-figure supplement X. The supplementary Results, Discussion, Materials and Methods, and Tables S1-S4 were renamed as Supplementary Files 1-4, respectively.  Datasets 1-4 were renamed as Supplementary Files 5-8, respectively. </p></fn></fn-group></notes></front><body><sec id="s1" hwp:id="sec-1"><title hwp:id="title-4">Introduction</title><p hwp:id="p-5">Intramembrane proteases (IPs) are membrane proteins containing a membrane-embedded active site. IPs cleave membrane-associated substrates within a transmembrane segment (TMS) or near the membrane surface in a process referred to as regulated intramembrane proteolysis (RIP) (<xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">1</xref>). Released substrate fragments impact diverse signaling pathways in a wide variety of organisms (<xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-1" hwp:rel-id="ref-2">2</xref>). IPs also profoundly impact protein degradation (<xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">3</xref>). There are four known IP families: metallo IPs like SpoIVFB, aspartyl IPs like Î³-secretase, serine IPs (rhomboids), and the glutamyl IP Rce1 (<xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-2" hwp:rel-id="ref-2">2</xref>, <xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">4</xref>). Crystal structures have been solved for one or more IP in each family (<xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-2" hwp:rel-id="ref-4">4</xref>â<xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">9</xref>), revealing that TMSs arrange to form a channel that delivers water to the active site for hydrolysis of a substrate peptide bond. Structures have also been solved for rhomboidÂ·peptide (inhibitor and substrate) complexes (<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-1" hwp:rel-id="ref-10">10</xref>â<xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-1" hwp:rel-id="ref-12">12</xref>) and for Î³-secretaseÂ·substrate complexes (<xref ref-type="bibr" rid="c13" hwp:id="xref-ref-13-1" hwp:rel-id="ref-13">13</xref>, <xref ref-type="bibr" rid="c14" hwp:id="xref-ref-14-1" hwp:rel-id="ref-14">14</xref>), which may guide the design of IP modulators as therapeutics.</p><p hwp:id="p-6">Metallo IPs activate transcription factors via RIP in all three domains of life (<xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-2" hwp:rel-id="ref-1">1</xref>, <xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-3" hwp:rel-id="ref-2">2</xref>). In mammals, S2P is involved in regulation of cholesterol homeostasis and responses to endoplasmic reticulum stress and viral infection (<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-1" hwp:rel-id="ref-15">15</xref>, <xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-1" hwp:rel-id="ref-16">16</xref>). S2P homologs in plants and in the pathogenic fungus <italic toggle="yes">Cryptococcus neoformans</italic> play important roles in chloroplast development and virulence, respectively (<xref ref-type="bibr" rid="c17" hwp:id="xref-ref-17-1" hwp:rel-id="ref-17">17</xref>, <xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-1" hwp:rel-id="ref-18">18</xref>). In bacteria, metallo IPs enhance pathogenicity, control stress responses and polar morphogenesis, produce mating signals, and clear signal peptides from the membrane (<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19">19</xref>â<xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21">21</xref>). In bacilli and most clostridia that form spores, SpoIVFB cleaves inactive Pro-Ï<sup>K</sup> to Ï<sup>K</sup>, which directs RNA polymerase to transcribe genes necessary for endospore formation (<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-1" hwp:rel-id="ref-22">22</xref>â<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-1" hwp:rel-id="ref-25">25</xref>). Endospores are dormant and are able to survive harsh environmental conditions (<xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-1" hwp:rel-id="ref-26">26</xref>), enhancing the persistence of pathogenic species (<xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-1" hwp:rel-id="ref-27">27</xref>â<xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-1" hwp:rel-id="ref-29">29</xref>). Understanding regulation of SpoIVFB could lead to new strategies to manipulate endosporulation and other processes involving IPs in bacteria and eukaryotes.</p><p hwp:id="p-7">During endospore formation, <italic toggle="yes">B. subtilis</italic> forms a polar septum that divides the mother cell (MC) and forespore (FS) compartments (<xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-1" hwp:rel-id="ref-30">30</xref>) (Figure 1-figure supplement 1). The MC engulfs the FS, surrounding it with a second membrane and pinching it off within the MC. Regulation of SpoIVFB involves inhibition by BofA and SpoIVFA (<xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-1" hwp:rel-id="ref-31">31</xref>â<xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-1" hwp:rel-id="ref-33">33</xref>). The three proteins form a complex in the outer FS membrane during engulfment (<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-1" hwp:rel-id="ref-34">34</xref>â<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-1" hwp:rel-id="ref-36">36</xref>). BofA was implicated as the direct inhibitor of SpoIVFB (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-1" hwp:rel-id="ref-37">37</xref>), while SpoIVFA appeared to localize and stabilize the inhibition complex (<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-2" hwp:rel-id="ref-36">36</xref>, <xref ref-type="bibr" rid="c38" hwp:id="xref-ref-38-1" hwp:rel-id="ref-38">38</xref>). Signaling from the FS relieves inhibition of SpoIVFB (Figure 1-figure supplement 1). Two proteases, SpoIVB and CtpB, are exported into the space between the two membranes surrounding the FS (<xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-1" hwp:rel-id="ref-39">39</xref>, <xref ref-type="bibr" rid="c40" hwp:id="xref-ref-40-1" hwp:rel-id="ref-40">40</xref>). SpoIVB cleaves the C-terminal end of SpoIVFA (<xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-1" hwp:rel-id="ref-41">41</xref>â<xref ref-type="bibr" rid="c44" hwp:id="xref-ref-44-1" hwp:rel-id="ref-44">44</xref>) and CtpB can cleave the C-terminal ends of both SpoIVFA and BofA (<xref ref-type="bibr" rid="c42" hwp:id="xref-ref-42-1" hwp:rel-id="ref-42">42</xref>, <xref ref-type="bibr" rid="c43" hwp:id="xref-ref-43-1" hwp:rel-id="ref-43">43</xref>, <xref ref-type="bibr" rid="c45" hwp:id="xref-ref-45-1" hwp:rel-id="ref-45">45</xref>). Once inhibition is removed, SpoIVFB cleaves the N-terminal 21-residue Proregion from Pro-Ï<sup>K</sup>, releasing Ï<sup>K</sup> into the MC (<xref ref-type="bibr" rid="c46" hwp:id="xref-ref-46-1" hwp:rel-id="ref-46">46</xref>â<xref ref-type="bibr" rid="c48" hwp:id="xref-ref-48-1" hwp:rel-id="ref-48">48</xref>). Ï<sup>K</sup> directs RNA polymerase to transcribe genes whose products form the spore coat and lyse the MC, releasing a mature spore (<xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-1" hwp:rel-id="ref-49">49</xref>, <xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-1" hwp:rel-id="ref-50">50</xref>).</p><p hwp:id="p-8">Regulation of SpoIVFB by direct interaction with the inhibitory proteins BofA and SpoIVFA differs from known regulation of other IPs. Rather, in eukaryotic cells some IP substrates initially localize to a different organelle than their cognate IP, and regulation involves membrane trafficking to deliver the substrate to the enzyme (<xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-2" hwp:rel-id="ref-3">3</xref>, <xref ref-type="bibr" rid="c51" hwp:id="xref-ref-51-1" hwp:rel-id="ref-51">51</xref>). In bacteria as well as eukaryotes, many IP substrates require an initial extramembrane cleavage by another protease prior to the intramembrane cleavage, and the initial cleavage is typically the regulated step (<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-2" hwp:rel-id="ref-19">19</xref>-<xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-2" hwp:rel-id="ref-21">21</xref>, <xref ref-type="bibr" rid="c52" hwp:id="xref-ref-52-1" hwp:rel-id="ref-52">52</xref>, <xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-1" hwp:rel-id="ref-53">53</xref>). In contrast, Pro-Ï<sup>K</sup> is cleaved only once, by SpoIVFB. Cleavage of SpoIVFA and BofA by SpoIVB and CtpB is regulated (Figure 1-figure supplement 1), but how this relieves inhibition of SpoIVFB has been unknown. Understanding the mechanism of inhibition could have broad implications since the catalytic core of metallo IPs includes three conserved TMSs (<xref ref-type="bibr" rid="c54" hwp:id="xref-ref-54-1" hwp:rel-id="ref-54">54</xref>) and general principles may emerge that inform potential inhibition strategies for other IP types.</p><p hwp:id="p-9">Cleavage of Pro-Ï<sup>K</sup> by SpoIVFB can be reproduced by expressing these proteins in <italic toggle="yes">Escherichia coli</italic> (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-2" hwp:rel-id="ref-37">37</xref>) (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-1" hwp:rel-id="F1">Figure 1A</xref>). Cleavage could be inhibited by additionally producing GFPÎ27BofA (a functional fusion protein lacking predicted TMS1 of BofA) and SpoIVFA (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-3" hwp:rel-id="ref-37">37</xref>, <xref ref-type="bibr" rid="c45" hwp:id="xref-ref-45-2" hwp:rel-id="ref-45">45</xref>). However, we found that the extent of cleavage inhibition was incomplete and variable.</p><fig id="fig1" position="float" orientation="portrait" fig-type="figure" hwp:id="F1" hwp:rev-id="xref-fig-1-1 xref-fig-1-2 xref-fig-1-3 xref-fig-1-4 xref-fig-1-5 xref-fig-1-6 xref-fig-1-7 xref-fig-1-8 xref-fig-1-9 xref-fig-1-10 xref-fig-1-11 xref-fig-1-12 xref-fig-1-13 xref-fig-1-14 xref-fig-1-15 xref-fig-1-16 xref-fig-1-17 xref-fig-1-18 xref-fig-1-19 xref-fig-1-20 xref-fig-1-21 xref-fig-1-22 xref-fig-1-23"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.07.09.451828v4/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>Figure 1</label><caption hwp:id="caption-1"><title hwp:id="title-5">Inhibition of Pro-Ï<sup>K</sup> cleavage.</title><p hwp:id="p-10">(<bold>A</bold>) Diagram of SpoIVFB inhibition during <italic toggle="yes">B. subtilis</italic> endosporulation and upon heterologous expression in <italic toggle="yes">E. coli</italic>. During endosporulation (<italic toggle="yes">Left</italic>), SpoIVFB and its inhibitory proteins BofA and SpoIVFA are produced in the mother cell (MC) and localize to the outer forespore (FS) membrane (OFM). Pro-Ï<sup>K</sup> is also produced in the MC and associates with membranes. When these proteins are synthesized in <italic toggle="yes">E. coli</italic> (<italic toggle="yes">Right</italic>), they localize to the inner membrane (IM). The expanded view of the membranes (<italic toggle="yes">Center</italic>) shows a SpoIVFB variant with an extra N-terminal transmembrane segment (cytTM), and highlights several residues (E44, V70, P135) at or near the active site in the membrane domain, which is connected to the CBS domain by an interdomain linker. When produced in <italic toggle="yes">E. coli</italic>, cytTM-SpoIVFB cleaves Pro-Ï<sup>K</sup>(1â127), removing its N- terminal Proregion [Note: Pro-Ï<sup>K</sup>(1â126) was renamed Pro-Ï<sup>K</sup>(1â127) as explained in (<xref ref-type="bibr" rid="c56" hwp:id="xref-ref-56-1" hwp:rel-id="ref-56">56</xref>)]. Co- production of SpoIVFA and either full-length BofA or GFPÎ27BofA (lacking predicted TMS1) inhibits Pro-Ï<sup>K</sup>(1â127) cleavage. The dashed double-headed arrows indicate that SpoIVFB, BofA or GFPÎ27BofA, and SpoIVFA form a complex of unknown structure. (<bold>B</bold>) Cleavage assays comparing inhibition by SpoIVFA and either GFPÎ27BofA or full-length BofA in <italic toggle="yes">E. coli</italic>. Pro-Ï<sup>K</sup>(1â127) and cytTM-SpoIVFB were produced alone (lane 1, pYZ2) or in combination with GFPÎ27BofA and SpoIVFA (lane 2, pYZ46) or full-length BofA and SpoIVFA (lane 3, pSO212). Alternatively, âpET Quartetâ plasmids were used to produce Pro-Ï<sup>K</sup>(1â127), cytTM- SpoIVFB, SpoIVFA, and either GFPÎ27BofA (lane 4, pSO40) or full-length BofA (lane 5, pSO213). Samples collected after 2 h of IPTG induction were subjected to immunoblot analysis with SpoIVFA (<italic toggle="yes">Top</italic>), GFP (<italic toggle="yes">Middle</italic>), or penta-His antibodies (<italic toggle="yes">Bottom</italic>, 2 and 30 s exposures). The single star (*) indicates cross-reacting proteins below SpoIVFA and the double star (**) indicates breakdown species of GFPÎ27BofA. A breakdown species below SpoIVFA (not indicated) is observed in some experiments. The graph shows quantification of the cleavage ratio (cleavage product/[Pro-Ï<sup>K</sup>(1-127) + cleavage product]) for three biological replicates. Error bars, 1 standard deviation. (<bold>C</bold>) Cleavage assays comparing inhibition by either GFPÎ27BofA or SpoIVFA. pET Triplet plasmids were used to produce Pro-Ï<sup>K</sup>(1-127), cytTM-SpoIVFB, and either GFPÎ27BofA (lane 2, pSO64) or SpoIVFA (lane 3, pSO65). Samples were subjected to immunoblot analysis and quantification as in (<bold>B</bold>).</p><p hwp:id="p-11"><bold>Figure 1-source data 1</bold></p><p hwp:id="p-12"><bold>Immunoblot images (raw and annotated) and quantification of cleavage assays (</bold><xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-2" hwp:rel-id="F1">Figure 1</xref> <bold>B and C).</bold></p></caption><graphic xlink:href="451828v4_fig1" position="float" orientation="portrait" hwp:id="graphic-1"/></fig><p hwp:id="p-13">Here, we describe an improved cleavage inhibition assay. Using the assay and bioinformatics, we identified three conserved residues of BofA important for inhibition of SpoIVFB in <italic toggle="yes">E. coli</italic> and in sporulating <italic toggle="yes">B. subtilis.</italic> One of the residues is near the middle of predicted TMS2 of BofA, close to the sole Cys residue of BofA, C46. We exploited C46 for disulfide cross-linking experiments that showed BofA TMS2 can occupy the SpoIVFB active site cleft. Additional experiments in <italic toggle="yes">E. coli</italic> indicate that BofA and SpoIVFA block access of the N-terminal Proregion of Pro-Ï<sup>K</sup> to the membrane-embedded SpoIVFB active site, yet the C-terminal soluble regions of Pro-Ï<sup>K</sup> and SpoIVFB can interact. These results reveal a novel mechanism of IP inhibition and were used in combination with prior cross-linking studies (<xref ref-type="bibr" rid="c55" hwp:id="xref-ref-55-1" hwp:rel-id="ref-55">55</xref>, <xref ref-type="bibr" rid="c56" hwp:id="xref-ref-56-2" hwp:rel-id="ref-56">56</xref>), partial homology, and evolutionary co-variation of amino acid residues, to constrain a structural model of SpoIVFB in complex with BofA and parts of SpoIVFA and Pro-Ï<sup>K</sup>. The model predicts that conserved residues in TMS2 and the C-terminal region of BofA interact, and that SpoIVFA bridges the BofA C-terminal region and SpoIVFB to form an inhibition complex. The predicted inhibition complex has implications for activation of SpoIVFB and its orthologs in other endospore formers, as well as for translational efforts to design therapeutic IP inhibitors.</p></sec><sec id="s2" hwp:id="sec-2"><title hwp:id="title-6">Results</title><sec id="s2a" hwp:id="sec-3"><title hwp:id="title-7">Both BofA and SpoIVFA Are Required to Inhibit SpoIVFB in <italic toggle="yes">E. coli</italic></title><p hwp:id="p-14">To study RIP of Pro- Ï<sup>K</sup>, <italic toggle="yes">E</italic>. <italic toggle="yes">coli</italic> was engineered to synthesize variants of SpoIVFB and Pro-Ï<sup>K</sup>, and the inhibitory proteins BofA and SpoIVFA, in various combinations. The SpoIVFB variant contains the extra TMS cytTM (<xref ref-type="bibr" rid="c57" hwp:id="xref-ref-57-1" hwp:rel-id="ref-57">57</xref>) (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-3" hwp:rel-id="F1">Figure 1A</xref>), which improves accumulation (<xref ref-type="bibr" rid="c48" hwp:id="xref-ref-48-2" hwp:rel-id="ref-48">48</xref>). The substrate variant Pro- Ï<sup>K</sup>(1â127) lacks the C-terminal half of Pro-Ï<sup>K</sup>, but is accurately cleaved by SpoIVFB and the cleavage product is easily separated from Pro-Ï<sup>K</sup>(1â127) by SDS-PAGE (<xref ref-type="bibr" rid="c58" hwp:id="xref-ref-58-1" hwp:rel-id="ref-58">58</xref>). When Pro-Ï<sup>K</sup>(1â127) and cytTM-SpoIVFB were produced from the same plasmid, about 80% of the substrate was cleaved (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-4" hwp:rel-id="F1">Figure 1B</xref>). The additional production of GFPÎ27BofA and SpoIVFA from a second plasmid reduced cleavage to about 30%. A similar result was seen when full-length BofA (for which no antibody has been described) and SpoIVFA were produced from a second plasmid.</p><p hwp:id="p-15">Since the two plasmids had the same replication origin, their copy number may be unequal in some cells, despite using different selection markers. Unequal copy numbers could result in Pro-Ï<sup>K</sup>(1â127) cleavage in cells producing too little of the inhibitory proteins.</p><p hwp:id="p-16">Therefore, we designed single âpET Quartetâ plasmids to synthesize all four proteins. When pET Quartets produced either GFPÎ27BofA or BofA, very little Pro-Ï<sup>K</sup>(1â127) was cleaved (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-5" hwp:rel-id="F1">Figure 1B</xref>). A longer exposure of the immunoblot revealed a faint cleavage product with pET Quartet GFPÎ27BofA, but not with pET Quartet BofA, indicating that full-length BofA inhibits cleavage slightly better than GFPÎ27BofA.</p><p hwp:id="p-17">We tested whether both inhibitory proteins are required for cleavage inhibition by engineering âpET Tripletâ plasmids to synthesize Pro-Ï<sup>K</sup>(1â127), cytTM-SpoIVFB, and either GFPÎ27BofA, full-length BofA, or SpoIVFA. With pET Triplets containing GFPÎ27BofA (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-6" hwp:rel-id="F1">Figure 1C</xref>) or BofA (Figure 1-figure supplement 2A), cleavage inhibition was lost and accumulation of cytTM-SpoIVFB, Pro-Ï<sup>K</sup>(1â127), and cleavage product was greatly diminished, suggesting that BofA inhibits synthesis and/or enhances degradation of the other proteins when SpoIVFA is absent. With pET Triplet SpoIVFA, cleavage inhibition was also nearly lost (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-7" hwp:rel-id="F1">Figure 1C</xref>). We conclude that both inhibitory proteins are necessary to prevent Pro-Ï<sup>K</sup>(1â127) cleavage by cytTM-SpoIVB in <italic toggle="yes">E. coli</italic>. Both inhibitory proteins are also required to prevent cleavage of full-length Pro-Ï<sup>K</sup> in <italic toggle="yes">E. coli</italic> (Figure 1-figure supplement 2B and Supplementary File 1). The heterologous system mimics the endogenous pathway of <italic toggle="yes">B. subtilis</italic>, since both inhibitory proteins are necessary to prevent cleavage of Pro-Ï<sup>K</sup> by SpoIVFB during sporulation (<xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-2" hwp:rel-id="ref-31">31</xref>, <xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-3" hwp:rel-id="ref-36">36</xref>, <xref ref-type="bibr" rid="c59" hwp:id="xref-ref-59-1" hwp:rel-id="ref-59">59</xref>).</p><p hwp:id="p-18">We also showed that the <italic toggle="yes">E. coli</italic> system mimics the endogenous pathway with respect to partial relief from inhibition by SpoIVB (<xref ref-type="bibr" rid="c40" hwp:id="xref-ref-40-2" hwp:rel-id="ref-40">40</xref>, <xref ref-type="bibr" rid="c42" hwp:id="xref-ref-42-2" hwp:rel-id="ref-42">42</xref>, <xref ref-type="bibr" rid="c43" hwp:id="xref-ref-43-2" hwp:rel-id="ref-43">43</xref>, <xref ref-type="bibr" rid="c45" hwp:id="xref-ref-45-3" hwp:rel-id="ref-45">45</xref>) (Figure 1-figure supplement 3 and Supplementary File 1) or an F66A substitution in SpoIVFB (<xref ref-type="bibr" rid="c59" hwp:id="xref-ref-59-2" hwp:rel-id="ref-59">59</xref>) (Figure 1-figure supplement 4 and Supplementary File 1). We reasoned that the strong cleavage inhibition observed with pET Quartet plasmids in <italic toggle="yes">E. coli</italic> (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-8" hwp:rel-id="F1">Figure 1B</xref>) could be used to test the effects of Ala substitutions in the inhibitory proteins. Since most endospore formers encode BofA, but about half lack a recognizable gene for SpoIVFA (<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-2" hwp:rel-id="ref-22">22</xref>, <xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-1" hwp:rel-id="ref-23">23</xref>), we focused first on identifying residues of BofA important for inhibition of SpoIVFB.</p></sec><sec id="s2b" hwp:id="sec-4"><title hwp:id="title-8">Three Conserved Residues of BofA Are Important for Inhibition of SpoIVFB in <italic toggle="yes">E. coli</italic></title><p hwp:id="p-19">To identify residues of BofA that may play a role in SpoIVFB inhibition, an alignment of 70 BofA orthologs was analyzed (Figure 2-figure supplement 1A). Thirteen highly conserved residues reside in predicted TMS2 and the C-terminal region. The lack of highly conserved residues in TMS1 may explain why GFPÎ27BofA (lacking predicted TMS1) is a functional inhibitor (<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-4" hwp:rel-id="ref-36">36</xref>, <xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-4" hwp:rel-id="ref-37">37</xref>) (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-9" hwp:rel-id="F1">Figure 1B</xref>). An alignment of just the 31 BofA orthologs from species with a recognizable gene for SpoIVFA revealed an additional four conserved residues that we deemed of interest for Ala substitutions (Figure 2-figure supplement 1B). We also substituted Ala for F85 and I87 (as well as for I86, which is conserved), since deletion of three residues from the C-terminal end of BofA caused a loss of function or stability in <italic toggle="yes">B. subtilis</italic> (<xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-2" hwp:rel-id="ref-33">33</xref>, <xref ref-type="bibr" rid="c60" hwp:id="xref-ref-60-1" hwp:rel-id="ref-60">60</xref>).</p><p hwp:id="p-20">The Ala substitutions were made in GFPÎ27BofA and co-produced with Pro-Ï<sup>K</sup>(1â127), cytTM-SpoIVFB, and SpoIVFA from pET Quartet plasmids in <italic toggle="yes">E. coli</italic>. Three GFPÎ27BofA variants, N48A, N61A, and T64A led to 40-60% cleavage of Pro-Ï<sup>K</sup>(1â127), indicating that these substitutions strongly impaired inhibition of cytTM-SpoIVFB (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-1" hwp:rel-id="F2">Figure 2</xref>). Less of the N61A and T64A variants was observed than most of the other GFPÎ27BofA variants, and for all three variants, less SpoIVFA and cytTM-SpoIVFB was observed, perhaps indicative of reduced complex formation leading to protein instability, as inferred from studies in <italic toggle="yes">B. subtilis</italic> (<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-5" hwp:rel-id="ref-36">36</xref>, <xref ref-type="bibr" rid="c61" hwp:id="xref-ref-61-1" hwp:rel-id="ref-61">61</xref>). We also examined the effects of the GFPÎ27BofA N48A, N61A, and T64A variants during <italic toggle="yes">B. subtilis</italic> sporulation (see the next section).</p><fig id="fig2" position="float" orientation="portrait" fig-type="figure" hwp:id="F2" hwp:rev-id="xref-fig-2-1 xref-fig-2-2 xref-fig-2-3 xref-fig-2-4"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.07.09.451828v4/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>Figure 2</label><caption hwp:id="caption-2"><title hwp:id="title-9">Effects of alanine substitutions in GFPÎ27BofA on inhibition of Pro-Ï<sup>K</sup>(1-127) cleavage in <italic toggle="yes">E. coli</italic>.</title><p hwp:id="p-21">pET Quartet plasmids were used to produce Pro-Ï<sup>K</sup>(1-127), cytTM-SpoIVFB, SpoIVFA, and GFPÎ27BofA (lane 1, pSO40) or Ala-substituted GFPÎ27BofA (lanes 2-20, pSO44-pSO58 and pSO60-pSO63). Samples collected after 2 h of IPTG induction were subjected to immunoblot analysis with SpoIVFA, GFP, and penta-His antibodies. Single (*) and double (**) stars are explained in the <xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-10" hwp:rel-id="F1">Figure 1B</xref> legend, as is the graph.</p><p hwp:id="p-22"><bold>Figure 2-source data 1</bold></p><p hwp:id="p-23"><bold>Immunoblot images (raw and annotated) and quantification of cleavage assays.</bold></p></caption><graphic xlink:href="451828v4_fig2" position="float" orientation="portrait" hwp:id="graphic-2"/></fig><p hwp:id="p-24">The other GFPÎ27BofA variants had less effect on Pro-Ï<sup>K</sup>(1â127) cleavage, indicating less effect on cytTM-SpoIVFB inhibition in <italic toggle="yes">E. coli</italic> (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-2" hwp:rel-id="F2">Figure 2</xref>). Although the F85A, I86A, and I87A variants had little effect, both a triple-Ala variant and a variant lacking residues 85-87 strongly impaired inhibition of cytTM-SpoIVFB (Figure 2-figure supplement 2A and Supplementary File 1); the latter mimicking the results in <italic toggle="yes">B. subtilis</italic> (<xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-3" hwp:rel-id="ref-33">33</xref>, <xref ref-type="bibr" rid="c60" hwp:id="xref-ref-60-2" hwp:rel-id="ref-60">60</xref>). We also used pET Quartet plasmids in <italic toggle="yes">E. coli</italic> to show for the first time that the nine residues preceding predicted TMS2 of GFPÎ27BofA contribute to its inhibitory function, perhaps by moving the GFP tag away from the membrane (Figure 2-figure supplement 2B and Supplementary File 1).</p></sec><sec id="s2c" hwp:id="sec-5"><title hwp:id="title-10">The Conserved Residues of BofA Are Important for SpoIVFB Inhibition during <italic toggle="yes">B. subtilis</italic> Sporulation</title><p hwp:id="p-25">To test the effects of the three GFPÎ27BofA variants (N48A, N61A, and T64A) during sporulation, each was produced ectopically under control of the MC-specific <italic toggle="yes">bofA</italic> promoter in a <italic toggle="yes">spoIVB165 bofA::erm</italic> double mutant. The <italic toggle="yes">spoIVB165</italic> null mutation alone would block Pro-Ï<sup>K</sup> cleavage, but the <italic toggle="yes">bofA::erm</italic> null mutation allows unregulated cleavage in the double mutant, providing a genetic background in which ectopic production of GFPÎ27BofA under control of a MC-specific promoter leads to inhibition of SpoIVFB and loss of Pro-Ï<sup>K</sup> cleavage (<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-6" hwp:rel-id="ref-36">36</xref>, <xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-5" hwp:rel-id="ref-37">37</xref>). As anticipated, Pro-Ï<sup>K</sup> was cleaved primarily between 4 and 5 h poststarvation (PS) in wild type, very little cleavage was observed in the <italic toggle="yes">spoIVB165</italic> single mutant, and cleavage occurred prematurely at 4 h in the <italic toggle="yes">spoIVB165 bofA::erm</italic> double mutant (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-1" hwp:rel-id="F3">Figure 3A</xref>). Very little SpoIVFA and SpoIVFB was detected in the double mutant, consistent with the need for BofA to stabilize these proteins (<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-7" hwp:rel-id="ref-36">36</xref>). Also as expected, ectopic production of GFPÎ27BofA in the double mutant inhibited SpoIVFB so that little Pro-Ï<sup>K</sup> cleavage was observed (lanes 7 &amp; 8). GFPÎ27BofA allowed slightly more Pro-Ï<sup>K</sup> cleavage at 5 h (lane 8) than BofA in the <italic toggle="yes">spoIVB165</italic> single mutant (lane 4), suggesting that full-length BofA is a slightly better inhibitor of SpoIVFB during <italic toggle="yes">B. subtilis</italic> sporulation, as observed in <italic toggle="yes">E. coli</italic> (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-11" hwp:rel-id="F1">Figure 1B</xref>, longer exposure).</p><fig id="fig3" position="float" orientation="portrait" fig-type="figure" hwp:id="F3" hwp:rev-id="xref-fig-3-1 xref-fig-3-2 xref-fig-3-3 xref-fig-3-4 xref-fig-3-5 xref-fig-3-6 xref-fig-3-7 xref-fig-3-8 xref-fig-3-9 xref-fig-3-10 xref-fig-3-11 xref-fig-3-12 xref-fig-3-13 xref-fig-3-14 xref-fig-3-15 xref-fig-3-16 xref-fig-3-17 xref-fig-3-18"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.07.09.451828v4/FIG3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F3</object-id><object-id pub-id-type="publisher-id">fig3</object-id><label>Figure 3</label><caption hwp:id="caption-3"><title hwp:id="title-11">Effects of alanine substitutions in GFPÎ27BofA during <italic toggle="yes">B. subtilis</italic> sporulation.</title><p hwp:id="p-26">(<bold>A</bold>) Effects of GFPÎ27BofA variants (N48A, N61A, and T64A) on Pro-Ï<sup>K</sup> cleavage. Wild-type strain PY79, a <italic toggle="yes">spoIVB165</italic> null mutant, a <italic toggle="yes">spoIVB165 bofA::erm</italic> double mutant, and the double mutant with P<italic toggle="yes"><sub>bofA</sub></italic>-<italic toggle="yes">gfpÎ27bofA</italic> integrated ectopically at <italic toggle="yes">amyE</italic> to express GFPÎ27BofA with no substitution (none) or the indicated Ala substitution, were starved to induce sporulation. Samples collected at 4 and 5 h poststarvation (PS) were subjected to immunoblot analysis with antibodies against SpoIVFA, GFP, SpoIVFB, and Pro-Ï<sup>K</sup>. The graph shows quantification of the cleavage ratio [Ï<sup>K</sup>/(Pro-Ï<sup>K</sup> + Ï<sup>K</sup>)] for three biological replicates. Error bars, 1 standard deviation. Studentâs two-tailed <italic toggle="yes">t</italic> tests were performed to compare certain cleavage ratios (<italic toggle="yes">p</italic> values). (<bold>B</bold>) Localization of GFPÎ27BofA and the three variants. Samples collected at 3 h PS were treated with FM 4-64 to stain membranes. Confocal microscopy images of fluorescence from GFPÎ27BofA, membranes, and merged images are shown for representative sporangia with discrete (no substitution in GFPÎ27BofA, designated ânoneâ), partial (N48A and T64A), or no forespore (FS) localization (N61A). Scale bar, 1 Î¼m. The percentage of sporangia (44-93 counted; non-sporulating cells were not counted) with each localization pattern is shown.</p><p hwp:id="p-27"><bold>Figure 3-source data 1</bold></p><p hwp:id="p-28"><bold>Immunoblot images (annotated) and quantification of cleavage assays (</bold><xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-2" hwp:rel-id="F3">Figure 3A</xref><bold>), and confocal microscopy images (see the readme file) and a table of the numbers of sporangia in which FS localization of GFPÎ27BofA and the three variants was counted (</bold><xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-3" hwp:rel-id="F3">Figure 3B</xref>).</p><p hwp:id="p-29"><bold>Figure 3-source data 2</bold></p><p hwp:id="p-30"><bold>Immunoblot images (raw) (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-4" hwp:rel-id="F3">Figure 3A</xref>).</bold></p></caption><graphic xlink:href="451828v4_fig3" position="float" orientation="portrait" hwp:id="graphic-3"/></fig><p hwp:id="p-31">Strikingly, ectopic production of the GFPÎ27BofA N48A or N61A variant in the double mutant did not inhibit SpoIVFB, as Pro-Ï<sup>K</sup> was cleaved prematurely at 4 h (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-5" hwp:rel-id="F3">Figure 3A</xref>, lanes 9 &amp; 11). The level of the N48A variant was comparable with GFPÎ27BofA, but less of the N61A variant was observed, especially at 5 h (lane 12). In comparison with the strain that produced GFPÎ27BofA, the SpoIVFA level was normal in the strain that produced the N48A variant, but less SpoIVFB was observed, and less of both SpoIVFA and SpoIVFB was observed in the strain producing the N61A variant. The reduced levels of SpoIVFB and SpoIVFA may reflect protein instability due to less complex formation with the GFPÎ27BofA variants, as inferred from reduced SpoIVFB and SpoIVFA levels in the absence of BofA during <italic toggle="yes">B. subtilis</italic> sporulation (<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-8" hwp:rel-id="ref-36">36</xref>).</p><p hwp:id="p-32">Production of the T64A variant in the double mutant (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-6" hwp:rel-id="F3">Figure 3A</xref>, lanes 13 &amp; 14) showed a pattern similar to wild type; Pro-Ï<sup>K</sup> cleavage increased between 4 and 5 h, and the levels of SpoIVFA and SpoIVFB decreased. The levels of all three proteins were slightly lower in the strain producing the T64A variant than in wild type. The level of the T64A variant was similar to the N48A and N61A variants at 4 h, yet a lower percentage of the Pro-Ï<sup>K</sup> was cleaved in the T64A variant (lanes 9, 11 &amp; 13), suggesting that the T64A variant inhibits SpoIVFB, although not as well as GFPÎ27BofA (lane 7). We conclude that the three conserved residues of BofA are important for SpoIVFB inhibition during sporulation.</p><p hwp:id="p-33">Since GFPÎ27BofA co-localizes with SpoIVFA and SpoIVFB to the outer FS membrane during sporulation (<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-2" hwp:rel-id="ref-34">34</xref>â<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-9" hwp:rel-id="ref-36">36</xref>), we examined the ability of the GFPÎ27BofA variants to localize to the FS. As a control, GFPÎ27BofA produced in the <italic toggle="yes">spoIVB165 bofA::erm</italic> double mutant localized discretely to the FS at 3 h PS (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-7" hwp:rel-id="F3">Figure 3B</xref>). The N48A and T64A variants localized partially to the FS, but GFP fluorescence was also observed in the MC cytoplasm, suggesting partial mislocalization. The N61A variant appeared to be dispersed evenly throughout the MC cytoplasm. The fusion proteins were intact, demonstrating that the cytoplasmic GFP fluorescence was not attributable to breakdown (Figure 3-figure supplement 1). Inability of the N61A variant to localize to the FS may explain the loss of SpoIVFB inhibition and the abundant cleavage of Pro-Ï<sup>K</sup> at 4 h (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-8" hwp:rel-id="F3">Figure 3A</xref>, lane 11). Importantly, the similar ability of the N48A and T64A variants to localize to the FS (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-9" hwp:rel-id="F3">Figure 3B</xref>) does not account for their differential effects on the level of SpoIVFB and its ability to cleave Pro-Ï<sup>K</sup> (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-10" hwp:rel-id="F3">Figure 3A</xref>). The strain producing GFPÎ27BofA N48A exhibited less SpoIVFB yet more Pro-Ï<sup>K</sup> cleavage at 4 h (lane 9) than the strain producing GFPÎ27BofA T64A (lane 13), so the N48A substitution more severely impairs the ability of GFPÎ27BofA to inhibit SpoIVFB.</p></sec><sec id="s2d" hwp:id="sec-6"><title hwp:id="title-12">BofA TMS2 Occupies the SpoIVFB Active Site Cleft</title><p hwp:id="p-34">A common mechanism of metalloprotease inhibition involves a protein residue side chain coordinating the catalytic metal ion in place of a water molecule necessary for substrate peptide bond hydrolysis (<xref ref-type="bibr" rid="c62" hwp:id="xref-ref-62-1" hwp:rel-id="ref-62">62</xref>, <xref ref-type="bibr" rid="c63" hwp:id="xref-ref-63-1" hwp:rel-id="ref-63">63</xref>). Early work suggested that BofA H57 might inhibit SpoIVFB by coordinating zinc (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-6" hwp:rel-id="ref-37">37</xref>). Although His is highly conserved at the corresponding position of BofA orthologs (Figure 2-figure supplement 1) and GFPÎ27BofA H57A allowed about 20% cleavage of Pro-Ï<sup>K</sup>(1â127) in <italic toggle="yes">E. coli</italic> (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-3" hwp:rel-id="F2">Figure 2</xref>), H57 is near the predicted C-terminal end of BofA TMS2 (Figure 2-figure supplement 1) and therefore presumably near the membrane surface, whereas a zinc ion at the SpoIVFB active site is predicted to be near the middle of the lipid bilayer (<xref ref-type="bibr" rid="c56" hwp:id="xref-ref-56-3" hwp:rel-id="ref-56">56</xref>). The sole Cys of <italic toggle="yes">B. subtilis</italic> BofA, C46, is a potential zinc ligand located near the center of TMS2, but Cys is not conserved at the corresponding position in BofA orthologs (Figure 2-figure supplement 1). However, nearby N48 is highly conserved among BofA orthologs and is also a potential zinc ligand. For example, the latent form of <italic toggle="yes">Staphylococcus aureus</italic> LytM has a prosegment with an Asn residue as a zinc ligand (<xref ref-type="bibr" rid="c64" hwp:id="xref-ref-64-1" hwp:rel-id="ref-64">64</xref>). We hypothesized that BofA N48 is a zinc ligand and that BofA TMS2 occupies the SpoIVFB active site cleft in the inhibition complex.</p><p hwp:id="p-35">To begin testing our hypothesis, we devised a strategy based on a model of the SpoIVFB membrane domain derived from the crystal structure of an archaeal homolog (<xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7">7</xref>). The model is supported by cross-linking studies of catalytically-inactive SpoIVFB E44Q in complex with Pro- Ï<sup>K</sup>(1â127), whose Proregion appears to occupy the SpoIVFB active site cleft (<xref ref-type="bibr" rid="c55" hwp:id="xref-ref-55-2" hwp:rel-id="ref-55">55</xref>, <xref ref-type="bibr" rid="c56" hwp:id="xref-ref-56-4" hwp:rel-id="ref-56">56</xref>, <xref ref-type="bibr" rid="c65" hwp:id="xref-ref-65-1" hwp:rel-id="ref-65">65</xref>). A cleft between TMS1 and TMS6 of SpoIVFB is proposed to gate substrate access to the active site (<xref ref-type="bibr" rid="c59" hwp:id="xref-ref-59-3" hwp:rel-id="ref-59">59</xref>), which mutational evidence supports is formed by a zinc ion near E44 of the HELGH metalloprotease motif within SpoIVFB TMS2 (<xref ref-type="bibr" rid="c46" hwp:id="xref-ref-46-2" hwp:rel-id="ref-46">46</xref>, <xref ref-type="bibr" rid="c47" hwp:id="xref-ref-47-1" hwp:rel-id="ref-47">47</xref>) (Figure 4-figure supplement 1A). If BofA N48 is a zinc ligand and BofA TMS2 occupies the SpoIVFB active site cleft in the inhibition complex, we reasoned that BofA C46 may be near SpoIVFB E44 (Figure 4-figure supplement 1B) and we used a disulfide cross-linking approach to test this possibility.</p><p hwp:id="p-36">We tested whether BofA C46 could be cross-linked to SpoIVFB E44C in the inhibition complex formed with pET Quartet plasmids in <italic toggle="yes">E. coli</italic> as in <xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-12" hwp:rel-id="F1">Figure 1B</xref>, but with appropriate variants of the four proteins. Single-Cys E44C cytTM-SpoIVFB (which is catalytically-inactive) and Cys-less Pro-Ï<sup>K</sup>(1â127) (which can be cleaved by active SpoIVFB) were described previously (<xref ref-type="bibr" rid="c55" hwp:id="xref-ref-55-3" hwp:rel-id="ref-55">55</xref>). We created functional variants of Cys-less SpoIVFA and single-Cys MBPÎ27BofA (GFP has Cys residues but MBP lacks them, leaving BofA C46 as the sole Cys residue) (Figure 4-figure supplement 2). As a negative control, we replaced C46 with Ser to obtain functional Cys-less MBPÎ27BofA. <italic toggle="yes">E. coli</italic> induced to co-produce combinations of four proteins were treated with the oxidant Cu<sup>2+</sup>(phenanthroline)<sub>3</sub> to promote disulfide bond formation. For MBPÎ27BofA C46 (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-1" hwp:rel-id="F4">Figure 4A</xref>, lane 2), but not the Cys-less C46S negative control (lane 5), treatment with oxidant caused formation of a species of the expected size for a cross-linked complex with single-Cys E44C cytTM-SpoIVFB, which was detected by immunoblotting with anti-FLAG antibodies. Treatment with the reducing agent DTT greatly diminished the abundance of the apparent complex, consistent with cross-link reversal (lane 3). A species of the expected size for a cross-linked dimer of single-Cys E44C cytTM-SpoIVFB was also observed. Formation of the apparent dimer varies, as reported previously (<xref ref-type="bibr" rid="c55" hwp:id="xref-ref-55-4" hwp:rel-id="ref-55">55</xref>). As expected, anti-MBP antibodies detected the presumptive cross-linked complex of MBPÎ27BofA C46 with single-Cys E44C cytTM-SpoIVFB, albeit weakly, and the negative control with E44Q rather than E44C failed to form the complex (Figure 4-figure supplement 3, lanes 2 &amp; 5). Since the signal for the complex was stronger with anti-FLAG antibodies (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-2" hwp:rel-id="F4">Figure 4A</xref>), we used those antibodies in the cross-linking experiments reported below.</p><fig id="fig4" position="float" orientation="portrait" fig-type="figure" hwp:id="F4" hwp:rev-id="xref-fig-4-1 xref-fig-4-2 xref-fig-4-3 xref-fig-4-4"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.07.09.451828v4/FIG4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F4</object-id><object-id pub-id-type="publisher-id">fig4</object-id><label>Figure 4</label><caption hwp:id="caption-4"><title hwp:id="title-13">BofA TMS2 is near the SpoIVFB active site.</title><p hwp:id="p-37">(<bold>A</bold>) Disulfide cross-linking of E44C at the cytTM-SpoIVFB active site to C46 in TMS2 of MBPÎ27BofA. pET Quartet plasmids were used to produce single-Cys E44C cytTM-SpoIVFB in combination with MBPÎ27BofA C46 (pSO91) or Cys-less MBPÎ27BofA C46S as a negative control (pSO110), and Cys-less variants of SpoIVFA and Pro-Ï<sup>K</sup>(1-127) in <italic toggle="yes">E. coli</italic>. Samples collected after 2 h of IPTG induction were treated for 60 min with Cu<sup>2+</sup>(phenanthroline)<sub>3</sub> (Cu +) to promote disulfide bond formation or with 2-phenanthroline (Cu â) as a negative control, then treated with TCA to precipitate proteins and resuspended in sample buffer with DTT (+) to reverse cross-links or without (â) to preserve cross-links, and finally subjected to immunoblot analysis with FLAG antibodies to visualize cytTM-SpoIVFB monomer, dimer, and complex with MBPÎ27BofA. (<bold>B</bold>) Disulfide cross-linking of V70C or P135C near the cytTM-SpoIVFB active site to C46 in TMS2 MBPÎ27BofA. pET Quartet plasmids were used to produce single- Cys V70C or P135C cytTM-SpoIVFB E44Q variants in combination with MBPÎ27BofA (pSO92, pSO93) or Cys-less MBPÎ27BofA C46S as a negative control (pSO111, pSO112), and Cys-less variants of SpoIVFA and Pro-Ï<sup>K</sup>(1-127) in <italic toggle="yes">E. coli</italic>. Samples collected after 2 h of IPTG induction were treated and subjected to immunoblot analysis as in (<bold>A</bold>). A representative result from at least two biological replicates is shown in (<bold>A</bold>) and (<bold>B</bold>).</p><p hwp:id="p-38"><bold>Figure 4-source data</bold></p><p hwp:id="p-39"><bold>Immunoblot images (raw and annotated).</bold></p></caption><graphic xlink:href="451828v4_fig4" position="float" orientation="portrait" hwp:id="graphic-4"/></fig><p hwp:id="p-40">In addition to E44 of SpoIVFB, V70 in a predicted membrane-reentrant loop and P135 in a predicted short loop interrupting TMS4 (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-13" hwp:rel-id="F1">Figure 1A</xref> and Figure 4-figure supplement 1A) were shown to be in proximity to the Proregion of Pro-Ï<sup>K</sup>(1â127) (<xref ref-type="bibr" rid="c55" hwp:id="xref-ref-55-5" hwp:rel-id="ref-55">55</xref>). Therefore, we tested whether MBPÎ27BofA C46 could be cross-linked to single-Cys V70C or P135C cytTM-SpoIVFB E44Q variants. We included the inactivating E44Q substitution since the V70C and P135C variants (unlike the E44C variant) could cleave Cys-less Pro-Ï<sup>K</sup>(1â127) (<xref ref-type="bibr" rid="c55" hwp:id="xref-ref-55-6" hwp:rel-id="ref-55">55</xref>), even though the inhibitory proteins were expected to almost completely inhibit cleavage (Figure 4-figure supplement 2).</p><p hwp:id="p-41">MBPÎ27BofA C46 formed a complex with the P135C variant, but not with the V70C variant (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-3" hwp:rel-id="F4">Figure 4B</xref>, lanes 2 &amp; 8). As expected, Cys-less MBPÎ27BofA C46S failed to form a complex with either variant (lanes 5 &amp; 11). Full-length BofA C46 (lacking MBP) also formed a complex of the expected (smaller) size with the E44C and P135C variants, but not with the V70C variant (Figure 4-figure supplement 4, lanes 2, 14, &amp; 8). As expected, Cys-less BofA C46S failed to form a complex with any of the variants (lanes 5, 11, &amp; 17). Our cross-linking results show that BofA TMS2 occupies the SpoIVFB active site cleft in the inhibition complex, placing BofA C46 in proximity to SpoIVFB E44 and P135, but not V70.</p><p hwp:id="p-42">Based on our initial cross-linking results, we modeled BofA TMS2 in the SpoIVFB active site cleft, and tested predictions of the model using additional disulfide cross-linking experiments (Figure 4-figure supplement 5 and Supplementary File 1). The results confirmed predictions of the initial model and suggested a preferred orientation of BofA TMS2 in the SpoIVFB active site cleft, which led to the refined model shown in Figure 4-figure supplement 1B.</p></sec><sec id="s2e" hwp:id="sec-7"><title hwp:id="title-14">BofA and SpoIVFA Do Not Prevent Pro-Ï<sup>K</sup>(1â127) from Interacting with SpoIVFB</title><p hwp:id="p-43">Since our cross-linking results show that BofA TMS2 occupies the SpoIVFB active site cleft, we tested whether BofA and SpoIVFA prevent Pro-Ï<sup>K</sup>(1â127) from interacting with SpoIVFB in <italic toggle="yes">E. coli</italic>. A catalytically-inactive E44C cytTM-SpoIVFB variant with a FLAG<sub>2</sub> epitope tag was co-produced with Pro-Ï<sup>K</sup>(1â127), SpoIVFA, and GFPÎ27BofA. Cell lysates were prepared and detergent- solubilized proteins were co-immunoprecipitated in pull-down assays with anti-FLAG antibody beads. All four proteins were seen in the bound sample (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-1" hwp:rel-id="F5">Figure 5A</xref>, lane 4), indicating that GFPÎ27BofA and SpoIVFA did not completely prevent Pro-Ï<sup>K</sup>(1â127) from interacting with the cytTM-SpoIVFB variant. However, only the cytTM-SpoIVFB variant was detected when the bound sample was diluted tenfold (lane 3) to match the input sample concentration (lane 1), and portions of the other three proteins were observed in the unbound sample (lane 2), indicating that co-purification was inefficient. A negative control with the cytTM-SpoIVFB variant lacking the FLAG<sub>2</sub> epitope tag showed no Pro-Ï<sup>K</sup>(1â127) in the bound sample, but small amounts of GFPÎ27BofA and SpoIVFA were detected (lane 8), indicative of weak, nonspecific binding to the beads.</p><fig id="fig5" position="float" orientation="portrait" fig-type="figure" hwp:id="F5" hwp:rev-id="xref-fig-5-1 xref-fig-5-2 xref-fig-5-3 xref-fig-5-4 xref-fig-5-5 xref-fig-5-6 xref-fig-5-7 xref-fig-5-8 xref-fig-5-9"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.07.09.451828v4/FIG5</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F5</object-id><object-id pub-id-type="publisher-id">fig5</object-id><label>Figure 5</label><caption hwp:id="caption-5"><title hwp:id="title-15">Inhibitory proteins do not prevent Pro-Ï<sup>K</sup>(1-127) from interacting with SpoIVFB.</title><p hwp:id="p-44">(<bold>A</bold>) Pro-Ï<sup>K</sup>(1-127), SpoIVFA, and GFPÎ27BofA co-purify with cytTM-SpoIVFB. pET Quartet plasmids were used to produce a catalytically-inactive E44C cytTM-SpoIVFB variant with a FLAG<sub>2</sub> tag (pSO73), or a variant lacking FLAG<sub>2</sub> as a negative control (pSO149), in combination with Pro-Ï<sup>K</sup>(1-127), SpoIVFA, and GFPÎ27BofA in <italic toggle="yes">E. coli</italic>. Samples collected after 2 h of IPTG induction were subjected to co-immunoprecipitation with anti-FLAG antibody beads. Input, unbound, 1/10 bound (diluted to match input), and (undiluted) bound samples were subjected to immunoblot analysis with FLAG, penta-His, SpoIVFA, and GFP antibodies. The single star (*) indicates cross-reacting proteins below SpoIVFA and the double star (**) indicates a cross-reacting protein or breakdown species of GFPÎ27BofA that fail to co-purify. A representative result from two biological replicates is shown. (<bold>B</bold>) A231C in the cytTM-SpoIVFB CBS domain forms disulfide cross-links with A97C in the C-terminal region of Pro-Ï<sup>K</sup>(1-127) in the absence or presence of inhibitory proteins. pET Duet plasmids were used to produce single- Cys A231C cytTM-SpoIVFB E44Q in combination with single-Cys A97C Pro-Ï<sup>K</sup>(1-127) (pSO130; squares and line with long dashes labeled âNo BofAâ, although SpoIVFA is also absent) or with Cys-less Pro-Ï<sup>K</sup>(1-127) as a negative control (pSO255; crosses and line labeled âCys-lessâ) in <italic toggle="yes">E. coli</italic>. pET Quartet plasmids were used to produce single-Cys A231C cytTM- SpoIVFB E44Q, single-Cys A97C Pro-Ï<sup>K</sup>(1-127), and Cys-less SpoIVFA in combination with Cys-less MBPÎ27BofA (pSO133; circles and line labeled âMBPÎ27BofAâ) or with Cys-less full-length BofA (pSO246; diamonds and line labeled âBofAâ) in <italic toggle="yes">E. coli</italic>. Samples collected after 2 h of IPTG induction were treated for 15, 30, 45, or 60 min with Cu<sup>2+</sup>(phenanthroline)<sub>3</sub> oxidant to promote disulfide bond formation and subjected to immunoblot analysis with FLAG antibodies to visualize the cytTM-SpoIVFB monomer, dimer, and complex with Pro-Ï<sup>K</sup>(1-127) (Figure 5-figure supplement 3C). Abundance of the complex was divided by the total amount of cytTM-SpoIVFB monomer, dimer, and complex. The ratio over time was plotted (n=2) with a best-fit trend line.</p><p hwp:id="p-45"><bold>Figure 5-source data 1</bold></p><p hwp:id="p-46"><bold>Immunoblot images (raw and annotated) (</bold><xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-2" hwp:rel-id="F5">Figure 5A</xref><bold>) and quantification of cross-linking (</bold><xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-3" hwp:rel-id="F5">Figure 5B</xref><bold>).</bold></p></caption><graphic xlink:href="451828v4_fig5" position="float" orientation="portrait" hwp:id="graphic-5"/></fig><p hwp:id="p-47">We also performed pull-down assays with cobalt resin, which binds to the His<sub>6</sub> tag on Pro-Ï<sup>K</sup>(1â127), and we performed both types of pull-down assays (i.e., anti-FLAG antibody beads and cobalt resin) when full-length BofA rather than GFPÎ27BofA was co-produced with the other three proteins (Figure 5-figure supplement 1 and Supplementary File 1). Neither BofA nor GFPÎ27BofA when co-produced with SpoIVFA prevented Pro-Ï<sup>K</sup>(1â127) from interacting with the cytTM-SpoIVFB variant. However, GFPÎ27BofA and SpoIVFA reduced co- purification of full-length Pro-Ï<sup>K</sup>-His<sub>6</sub> with the cytTM-SpoIVFB variant in both types of pull- down assays (Figure 5-figure supplement 2 and Supplementary File 1), as compared with Pro- Ï<sup>K</sup>(1â127) (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-4" hwp:rel-id="F5">Figure 5A</xref> and Figure 5-figure supplement 1), suggesting that the C-terminal half of Pro-Ï<sup>K</sup> affects complex formation (Supplementary File 2).</p><p hwp:id="p-48">To explain the presence of substrate in the pulled-down protein complexes, but the absence of substrate cleavage (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-14" hwp:rel-id="F1">Figure 1B</xref>), we hypothesized that inhibitory proteins block substrate access to the SpoIVFB active site cleft, but do not prevent substrate interaction with the soluble C-terminal CBS domain of SpoIVFB (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-15" hwp:rel-id="F1">Figure 1A</xref>). The model of catalytically-inactive SpoIVFB E44Q in complex with Pro-Ï<sup>K</sup>(1â127) predicts extensive interactions between the SpoIVFB CBS domain and the Pro-Ï<sup>K</sup>(1â127) C-terminal region (<xref ref-type="bibr" rid="c56" hwp:id="xref-ref-56-5" hwp:rel-id="ref-56">56</xref>). We used the model to guide testing of single-Cys variants of the two proteins for disulfide cross-link formation. We discovered that A231C in the cytTM-SpoIVFB CBS domain can be cross-linked to A97C in the Pro-Ï<sup>K</sup>(1â127) C-terminal region when <italic toggle="yes">E. coli</italic> co-producing the proteins are treated with oxidant (Figure 5-figure supplement 3A). We showed that the Cys substitutions do not impair cytTM- SpoIVFB activity or Pro-Ï<sup>K</sup>(1â127) susceptibility to cleavage (Figure 5-figure supplement 3B). Finally, we measured time-dependent cross-linking in the presence or absence of Cys-less inhibitory proteins. Co-production of inhibitory proteins had little or no effect on formation of cross-linked complex (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-5" hwp:rel-id="F5">Figure 5B</xref> and Figure 5-figure supplement 3C). These results suggest that neither full-length BofA nor MBPÎ27BofA, when co-produced with SpoIVFA, prevent Pro- Ï<sup>K</sup>(1â127) from interacting with the CBS domain of SpoIVFB in <italic toggle="yes">E. coli</italic>, consistent with the results of our pull-down assays (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-6" hwp:rel-id="F5">Figure 5A</xref> and Figure 5-figure supplement 1).</p></sec><sec id="s2f" hwp:id="sec-8"><title hwp:id="title-16">Inhibitory Proteins Block Access of the Substrate N-terminal Proregion to the SpoIVFB Active Site</title><p hwp:id="p-49">SpoIVFB cleaves Pro-Ï<sup>K</sup> (<xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-2" hwp:rel-id="ref-49">49</xref>) and Pro-Ï<sup>K</sup>(1â127) (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-7" hwp:rel-id="ref-37">37</xref>) between residues S21 and Y22. In disulfide cross-linking experiments, Cys substitutions for several residues near the cleavage site in otherwise Cys-less Pro-Ï<sup>K</sup>(1â127) formed a cross-linked complex with single- Cys (E44C, V70C, or P135C) cytTM-SpoIVFB variants (<xref ref-type="bibr" rid="c55" hwp:id="xref-ref-55-7" hwp:rel-id="ref-55">55</xref>). The complex was most abundant with the E44C and V70C variants, so we compared these interactions in the presence or absence of Cys-less inhibitory proteins.</p><p hwp:id="p-50">SpoIVFB E44 is presumed to activate a water molecule for substrate peptide bond hydrolysis at the enzyme active site (<xref ref-type="bibr" rid="c46" hwp:id="xref-ref-46-3" hwp:rel-id="ref-46">46</xref>, <xref ref-type="bibr" rid="c47" hwp:id="xref-ref-47-2" hwp:rel-id="ref-47">47</xref>). To test access of the substrate Proregion to the enzyme active site, we first measured time-dependent crosslinking between single-Cys E44C cytTM-SpoIVFB and single-Cys (F18C, V20C, S21C, K24C) Pro-Ï<sup>K</sup>(1â127) variants co- produced in the absence of inhibitory proteins in <italic toggle="yes">E. coli</italic>. The V20C and K24C Pro-Ï<sup>K</sup>(1â127) variants formed abundant complex that increased over time, but the F18C and S21C variants formed much less complex, only slightly more than the Cys-less Pro-Ï<sup>K</sup>(1â127) negative control (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-1" hwp:rel-id="F6">Figure 6A</xref> and Figure 6-figure supplement 1A). <xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-2" hwp:rel-id="F6">Figure 6B</xref> shows a representative immunoblot (60-min oxidant treatment). When Cys-less MBPÎ27BofA and SpoIVFA were co-produced, the V20C and K24C Pro-Ï<sup>K</sup>(1â127) variants formed much less complex and its abundance did not increase over time (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-3" hwp:rel-id="F6">Figure 6C</xref> and Figure 6-figure supplement 1B). <xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-4" hwp:rel-id="F6">Figure 6D</xref> shows a representative immunoblot (60-min oxidant treatment) for comparison with <xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-5" hwp:rel-id="F6">Figure 6B</xref>. When Cys-less full-length BofA and SpoIVFA were co-produced, similar decreases in abundance of the complex were observed (Figure 6-figure supplement 2). <xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-6" hwp:rel-id="F6">Figure 6</xref> E and F summarize the cross-linking time courses with and without inhibitory proteins for the V20C and K24C Pro- Ï<sup>K</sup>(1â127) variants. The effects of MBPÎ27BofA (lacking TMS1) and full-length BofA were indistinguishable. These results likely explain why BofA TMS1 is dispensable for most of the inhibitory function of BofA (<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-10" hwp:rel-id="ref-36">36</xref>, <xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-8" hwp:rel-id="ref-37">37</xref>) (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-16" hwp:rel-id="F1">Figure 1B</xref> and <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-11" hwp:rel-id="F3">3A</xref>). We conclude that inhibitory proteins block access of the substrate N-terminal Proregion to the SpoIVFB active site.</p><fig id="fig6" position="float" orientation="portrait" fig-type="figure" hwp:id="F6" hwp:rev-id="xref-fig-6-1 xref-fig-6-2 xref-fig-6-3 xref-fig-6-4 xref-fig-6-5 xref-fig-6-6 xref-fig-6-7 xref-fig-6-8 xref-fig-6-9 xref-fig-6-10 xref-fig-6-11 xref-fig-6-12 xref-fig-6-13 xref-fig-6-14 xref-fig-6-15 xref-fig-6-16 xref-fig-6-17"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.07.09.451828v4/FIG6</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F6</object-id><object-id pub-id-type="publisher-id">fig6</object-id><label>Figure 6</label><caption hwp:id="caption-6"><title hwp:id="title-17">Inhibitory proteins block access of the Pro-Ï<sup>K</sup>(1-127) N-terminal region to the SpoIVFB active site and hinder interaction with the SpoIVFB membrane-reentrant loop and interdomain linker.</title><p hwp:id="p-51">(<bold>A</bold>) E44C at the cytTM-SpoIVFB active site forms abundant disulfide cross-links with V20C or K24C in the N-terminal region of Pro-Ï<sup>K</sup>(1-127) in the absence of inhibitory proteins. pET Duet plasmids were used to produce single-Cys E44C cytTM-SpoIVFB in combination with single- Cys F18C (pSO167), V20C (pSO169), S21C (pSO170), or K24C (pSO128) Pro-Ï<sup>K</sup>(1-127), or with Cys-less Pro-Ï<sup>K</sup>(1-127) (pSO79) as a negative control, in <italic toggle="yes">E. coli</italic>. Samples collected after 2 h of IPTG induction were treated with Cu<sup>2+</sup>(phenanthroline)<sub>3</sub> oxidant for 15, 30, 45, or 60 min to promote disulfide bond formation and subjected to immunoblot analysis with FLAG antibodies to visualize the cytTM-SpoIVFB monomer, dimer, and complex with Pro-Ï<sup>K</sup>(1-127) (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-7" hwp:rel-id="F6">Figure 6</xref>- figure supplement 1A). Abundance of the complex was divided by the total amount of cytTM- SpoIVFB monomer, dimer, and complex. The ratio over time was plotted (n=2) with a best-fit trend line. (<bold>B</bold>) Representative immunoblots of 60-min samples from the experiment described in (<bold>A</bold>). (<bold>C</bold>) MBPÎ27BofA and SpoIVFA decrease cross-linking between E44C cytTM-SpoIVFB and V20C or K24C Pro-Ï<sup>K</sup>(1-127). pET Quartet plasmids were used to produce single-Cys E44C cytTM-SpoIVFB in combination with single-Cys F18C (pSO163), V20C (pSO165), S21C (pSO166), or K24C (pSO131) Pro-Ï<sup>K</sup>(1-127), or with Cys-less Pro-Ï<sup>K</sup>(1-127) (pSO110) as a negative control, and Cys-less variants of MBPÎ27BofA and SpoIVFA in <italic toggle="yes">E. coli</italic>. Samples collected after 2 h of IPTG induction were treated and subjected to immunoblot analysis as in (<bold>A</bold>) (Figure 6-figure supplement 1B). The complex/total ratio was plotted as in (<bold>A</bold>). (<bold>D</bold>) Representative immunoblots of 60-min samples from the experiment described in (<bold>C</bold>). (<bold>E</bold> and <bold>F</bold>) Summaries of the effects of inhibitory proteins on cross-linking between E44C cytTM-SpoIVFB and V20C or K24C Pro-Ï<sup>K</sup>(1-127). Data from (<bold>A</bold>) (labeled âNo BofAâ in (<bold>E</bold>), although SpoIVFA is also absent), (<bold>C</bold>) (labeled âMBPÎ27BofAâ in (<bold>E</bold>), although SpoIVFA is also present), and Figure 6-figure supplement 2 (labeled âBofAâ in (<bold>E</bold>), although SpoIVFA is also present) are plotted along with Cys-less Pro-Ï<sup>K</sup>(1-127) as a negative control. In (<bold>F</bold>), symbols and lines are as in (<bold>E</bold>). (<bold>G</bold> and <bold>H</bold>) Summaries of the effects of inhibitory proteins on cross-linking between V70C in the cytTM-SpoIVFB membrane-reentrant loop and F18C or K24C in the Pro- Ï<sup>K</sup>(1-127) N-terminal region. Data from Figure 6-figure supplement 3 are plotted using symbols and lines as in (<bold>E</bold>). (<bold>I</bold>) Summary of the effects of inhibitory proteins on cross-linking between Y214C in the cytTM-SpoIVFB interdomain linker and L41C in the Pro-Ï<sup>K</sup>(1-127) N-terminal region. Data from Figure 6-figure supplement 5 are plotted using symbols and lines as in (<bold>E</bold>).</p><p hwp:id="p-52"><bold>Figure 6-source data 1</bold></p><p hwp:id="p-53"><bold>Quantification of cross-linking (</bold><xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-8" hwp:rel-id="F6">Figure 6</xref> <bold>A, C, and E-I).</bold></p></caption><graphic xlink:href="451828v4_fig6" position="float" orientation="portrait" hwp:id="graphic-6"/></fig><p hwp:id="p-54">SpoIVFB V70 is located in a predicted membrane-reentrant loop (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-17" hwp:rel-id="F1">Figure 1A</xref>), which may bind to the Proregion and present it to the active site for cleavage (<xref ref-type="bibr" rid="c56" hwp:id="xref-ref-56-6" hwp:rel-id="ref-56">56</xref>) based on a study <italic toggle="yes">E. coli</italic> RseP (<xref ref-type="bibr" rid="c66" hwp:id="xref-ref-66-1" hwp:rel-id="ref-66">66</xref>). Single-Cys V70C cytTM-SpoIVFB E44Q formed abundant cross-linked complex with F18C and K24C Pro-Ï<sup>K</sup>(1â127) variants in the absence of inhibitory proteins (<xref ref-type="bibr" rid="c55" hwp:id="xref-ref-55-8" hwp:rel-id="ref-55">55</xref>) (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-9" hwp:rel-id="F6">Figure 6</xref> G and H; Figure 6-figure supplement 3 A and B). When Cys-less MBPÎ27BofA and SpoIVFA were co-produced, less complex formed (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-10" hwp:rel-id="F6">Figure 6</xref> G and H; Figure 6-figure supplement 3 C and D). Cys-less full-length BofA and SpoIVFA further decreased complex formation (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-11" hwp:rel-id="F6">Figure 6</xref> G and H; Figure 6-figure supplement 3 E and F) and caused four novel species to be observed, including with the Cys-less Pro-Ï<sup>K</sup>(1â127) negative control (Figure 6-figure supplement 3G), perhaps due to cross-linking of the V70C cytTM-SpoIVFB variant to <italic toggle="yes">E. coli</italic> proteins (i.e., BofA may cause the SpoIVFB membrane-reentrant loop to be exposed). Since full-length BofA hindered cross-linking more than MBPÎ27BofA (lacking TMS1) (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-12" hwp:rel-id="F6">Figure 6</xref> G and H), both TMSs of BofA appear to interfere with the normal interaction between the SpoIVFB membrane- reentrant loop and the substrate Proregion.</p><p hwp:id="p-55">Since full-length BofA also inhibited cleavage of Pro-Ï<sup>K</sup>(1â127) in <italic toggle="yes">E. coli</italic> (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-18" hwp:rel-id="F1">Figure 1B</xref>) and Pro-Ï<sup>K</sup> in <italic toggle="yes">B. subtilis</italic> (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-12" hwp:rel-id="F3">Figure 3A</xref>) slightly more than GFPÎ27BofA (lacking TMS1), we compared time-dependent cross-linking of C46 of BofA and MBPÎ27BofA to single-Cys E44C and P135C cytTM-SpoIVFB variants. The results suggest that full-length BofA forms slightly more complex over time, whereas complex abundance did not increase over time with MBPÎ27BofA (Figure 6-figure supplement 4). Hence, BofA TMS1 may slightly enhance TMS2 occupancy in the SpoIVFB active site cleft.</p><p hwp:id="p-56">To examine the extent to which inhibitory proteins hinder the interaction of the substrate with SpoIVFB, we identified a residue in the linker between the membrane and CBS domains of SpoIVFB (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-19" hwp:rel-id="F1">Figure 1A</xref>) that forms disulfide cross-linked complexes with Pro-Ï<sup>K</sup>(1â127). The model of catalytically-inactive SpoIVFB E44Q in complex with Pro-Ï<sup>K</sup>(1â127) (<xref ref-type="bibr" rid="c56" hwp:id="xref-ref-56-7" hwp:rel-id="ref-56">56</xref>) was used to guide testing for disulfide cross-link formation and we found that A214C in the cytTM-SpoIVFB linker can be cross-linked to A41C in Pro-Ï<sup>K</sup>(1â127) (Figure 6-figure supplement 5A). We showed that the Cys substitutions do not impair cytTM-SpoIVFB activity or Pro-Ï<sup>K</sup>(1â127) susceptibility to cleavage (Figure 5-figure supplement 3B). Finally, we measured time- dependent cross-linking in the presence or absence of Cys-less inhibitory proteins. Interestingly, formation of cross-linked complex was hindered more by full-length BofA than by MBPÎ27BofA, when co-produced with SpoIVFA (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-13" hwp:rel-id="F6">Figure 6I</xref> and Figure 6-figure supplement 5B), similar to cross-linking between V70C in the cytTM-SpoIVFB membrane-reentrant loop and F18C or K24C near the cleavage site in Pro-Ï<sup>K</sup>(1â127) (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-14" hwp:rel-id="F6">Figure 6</xref> G and H). The similar pattern suggests that in both cases BofA TMS2 partially interferes with the interaction and BofA TMS1 augments the interference.</p></sec><sec id="s2g" hwp:id="sec-9"><title hwp:id="title-18">A Model of SpoIVFB in Complex with BofA and Parts of SpoIVFA and Pro-Ï<sup>K</sup></title><p hwp:id="p-57">Computational models were generated using a similar protocol as described previously (<xref ref-type="bibr" rid="c56" hwp:id="xref-ref-56-8" hwp:rel-id="ref-56">56</xref>), but including additional constraints reflecting experimental cross-linking data reported herein, as well as newly predicted intra- and inter-chain contacts based on co-evolutionary couplings. Two final models were generated: 1) Full-length SpoIVFB modeled as a tetramer, with part of one Pro-Ï<sup>K</sup> molecule (residues 1-114), referred to as âfb.sigkâ; 2) Full-length SpoIVFB, again modeled as a tetramer, with one molecule each of full-length BofA and parts of Pro-Ï<sup>K</sup> (residues 38-114) and SpoIVFA (residues 65-111), referred to as âfb.sigk.bofa.faâ. The omitted residues of Pro-Ï<sup>K</sup> and SpoIVFA could not be placed with sufficient confidence. The first model is described in Figure 7-figure supplement 1 and Supplementary File 3.</p><p hwp:id="p-58">Relevant features of the second model are illustrated in <xref rid="fig7" ref-type="fig" hwp:id="xref-fig-7-1" hwp:rel-id="F7">Figure 7</xref> (only one molecule of SpoIVFB is shown). The first side view shows SpoIVFB with BofA TMS2 and the C-terminal part of Pro-Ï<sup>K</sup>(1â127) (<xref rid="fig7" ref-type="fig" hwp:id="xref-fig-7-2" hwp:rel-id="F7">Figure 7A</xref>). The membrane domain of SpoIVFB (green) interacts with BofA TMS2 (cyan) while the interdomain linker and CBS domain of SpoIVFB interact with the modeled portion of Pro-Ï<sup>K</sup>(1â127) (red). The enlarged view of the SpoIVFB active site cleft shows BofA TMS2 surrounded by SpoIVFB (TMSs labeled 1-6). The top view of the membrane domain emphasizes proximity between BofA TMS2, SpoIVFB TMSs 2-4, and the zinc ion (magenta) involved in catalysis. The second side view shows SpoIVFB with full-length BofA and the C-terminal part of Pro-Ï<sup>K</sup>(1â127) (<xref rid="fig7" ref-type="fig" hwp:id="xref-fig-7-3" hwp:rel-id="F7">Figure 7B</xref>). Our model predicts that BofA contains 2 TMSs and a membrane-embedded C-terminal region (labeled C near the C-terminus in the enlarged view of the SpoIVFB active site cleft) that forms two short Î±-helices connected by a turn. The enlarged and top views show that BofA interacts extensively with SpoIVFB and occupies its active site cleft, which would sterically hinder access of the Proregion of Pro-Ï<sup>K</sup>.</p><fig id="fig7" position="float" orientation="portrait" fig-type="figure" hwp:id="F7" hwp:rev-id="xref-fig-7-1 xref-fig-7-2 xref-fig-7-3 xref-fig-7-4 xref-fig-7-5 xref-fig-7-6 xref-fig-7-7 xref-fig-7-8 xref-fig-7-9 xref-fig-7-10"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.07.09.451828v4/FIG7</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F7</object-id><object-id pub-id-type="publisher-id">fig7</object-id><label>Figure 7</label><caption hwp:id="caption-7"><title hwp:id="title-19">Model of SpoIVFB monomer with BofA and parts of SpoIVFA and Pro-Ï<sup>K</sup>.</title><p hwp:id="p-59">(<bold>A</bold>) Model of SpoIVFB, BofA TMS2, and the C-terminal part of Pro-Ï<sup>K</sup>(1-127). At <italic toggle="yes">Left</italic>, a side view of the complex, showing the six TMSs of the SpoIVFB membrane domain with the active site zinc ion (magenta), the interdomain linker, and the CBS domain (green), BofA TMS2 (cyan), and Pro-Ï<sup>K</sup>(38â114) (red). In the enlarged view of the active site cleft (<italic toggle="yes">Center</italic>), TMSs 1â 6 of SpoIVFB and TMS2 of BofA are numbered. At <italic toggle="yes">Right</italic>, a top view is shown. (<bold>B</bold>) Model of SpoIVFB with full-length BofA and Pro-Ï<sup>K</sup>(38â114). Predicted TMSs 1 and 2 of BofA are numbered and its C-terminal region is labeled âCâ near the C-terminus in the views shown in the <italic toggle="yes">Center</italic> and at <italic toggle="yes">Right</italic>. (<bold>C</bold>) Model of SpoIVFB with full-length BofA, SpoIVFA(65â111) (purple, residue 111 is numbered), and Pro-Ï<sup>K</sup>(38â114).</p><p hwp:id="p-60"><bold>Figure 7-source data 1</bold></p><p hwp:id="p-61"><bold>PyMOL session file used to produce the images and PDB file of the model of a SpoIVFB tetramer with BofA and parts of SpoIVFA and Pro-Ï<sup>K</sup>.</bold></p></caption><graphic xlink:href="451828v4_fig7" position="float" orientation="portrait" hwp:id="graphic-7"/></fig><p hwp:id="p-62"><xref rid="fig7" ref-type="fig" hwp:id="xref-fig-7-4" hwp:rel-id="F7">Figure 7C</xref> shows the addition of the modeled portion of SpoIVFA (purple), which is predicted by co-evolutionary couplings to contact the BofA C-terminal region and SpoIVFB TMS4. Hence, the model predicts that SpoIVFA stabilizes the interaction of BofA with SpoIVFB. Since GFPÎ27BofA has the C-terminal region predicted to interact with SpoIVFA, the interaction of GFPÎ27BofA with SpoIVFB is likewise predicted to be stabilized by SpoIVFA, which may explain the dependence of SpoIVFB inhibition on both GFPÎ27BofA and SpoIVFA (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-20" hwp:rel-id="F1">Figure 1C</xref>), and why GFPÎ27BofA inhibits substrate cleavage (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-21" hwp:rel-id="F1">Figure 1B</xref> and <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-13" hwp:rel-id="F3">3A</xref>) and MBPÎ27BofA occupies the SpoIVFB active site cleft (Figure 6-figure supplement 4) nearly as well as full- length BofA.</p></sec></sec><sec id="s3" hwp:id="sec-10"><title hwp:id="title-20">Discussion</title><p hwp:id="p-63">Our results provide evidence that BofA TMS2 occupies the SpoIVFB active site cleft. Both inhibitory proteins block access of the substrate N-terminal Proregion to the SpoIVFB active site, but do not prevent interaction between the C-terminal region of Pro-Ï<sup>K</sup>(1â127) and the SpoIVFB CBS domain. The mechanism of SpoIVFB inhibition is novel in comparison with previously known mechanisms of IP regulation. Structural modeling predicts that three conserved BofA residues (N48, N61, and T64) interact to stabilize TMS2 and a membrane-embedded C-terminal region. SpoIVFA is predicted to contact the BofA C-terminal region and SpoIVFB TMS4, bridging the two proteins to stabilize the inhibition complex. The model has clear implications for relief of SpoIVFB and its orthologs from inhibition during sporulation, as well as for IP inhibitor design.</p><sec id="s3a" hwp:id="sec-11"><title hwp:id="title-21">A Novel Mechanism of Intramembrane Protease Regulation</title><p hwp:id="p-64">IPs were known to be regulated by three mechanisms â substrate localization, substrate extramembrane domain cleavage, and substrate interaction with an adapter protein. Substrate localization to a different organelle than its cognate IP is common in eukaryotic cells (<xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-3" hwp:rel-id="ref-3">3</xref>, <xref ref-type="bibr" rid="c51" hwp:id="xref-ref-51-2" hwp:rel-id="ref-51">51</xref>). An early example of this regulatory mechanism emerged from studies of S2P. SREBP substrates are retained in the endoplasmic reticulum by SCAP and Insig proteins, then transported to the Golgi when more cholesterol is needed (<xref ref-type="bibr" rid="c67" hwp:id="xref-ref-67-1" hwp:rel-id="ref-67">67</xref>) (<xref rid="fig8" ref-type="fig" hwp:id="xref-fig-8-1" hwp:rel-id="F8">Figure 8</xref>).</p><fig id="fig8" position="float" orientation="portrait" fig-type="figure" hwp:id="F8" hwp:rev-id="xref-fig-8-1 xref-fig-8-2 xref-fig-8-3 xref-fig-8-4 xref-fig-8-5"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.07.09.451828v4/FIG8</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F8</object-id><object-id pub-id-type="publisher-id">fig8</object-id><label>Figure 8</label><caption hwp:id="caption-8"><title hwp:id="title-22">Regulation of intramembrane proteolysis by SpoIVFB differs from that of S2P and RseP.</title><p hwp:id="p-65">(<bold>A</bold>) S2P regulation. Human S2P localizes to membranes of the Golgi apparatus and has eight predicted TMSs and a PDZ domain (<xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-1" hwp:rel-id="ref-20">20</xref>, <xref ref-type="bibr" rid="c92" hwp:id="xref-ref-92-1" hwp:rel-id="ref-92">92</xref>, <xref ref-type="bibr" rid="c93" hwp:id="xref-ref-93-1" hwp:rel-id="ref-93">93</xref>). SREBP substrates localize to endoplasmic reticulum (ER) membranes <italic toggle="yes">via</italic> interaction of their regulatory domain (Reg) with SCAP, which is bound by Insig proteins when the cholesterol level is high (<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-2" hwp:rel-id="ref-15">15</xref>). Cholesterol depletion releases SREBP-SCAP complexes from Insig and allows vesicular substrate transport to the Golgi membranes (<xref ref-type="bibr" rid="c94" hwp:id="xref-ref-94-1" hwp:rel-id="ref-94">94</xref>â<xref ref-type="bibr" rid="c96" hwp:id="xref-ref-96-1" hwp:rel-id="ref-96">96</xref>). Cleavage (lightning bolt) by S1P at site-1 in the luminal loop of SREBPs promotes separation of the TMSs and site-2 cleavage by S2P (<xref ref-type="bibr" rid="c97" hwp:id="xref-ref-97-1" hwp:rel-id="ref-97">97</xref>, <xref ref-type="bibr" rid="c98" hwp:id="xref-ref-98-1" hwp:rel-id="ref-98">98</xref>). S2P cleavage releases the basic helix-loop-helix (bHLH) domain of SREBP substrates into the cytosol, for subsequent entry into the nucleus and transcriptional activation of genes required for fatty acid and cholesterol synthesis and uptake (<xref ref-type="bibr" rid="c99" hwp:id="xref-ref-99-1" hwp:rel-id="ref-99">99</xref>). (<bold>B</bold>) RseP regulation. RseP localizes to the <italic toggle="yes">E. coli</italic> inner membrane (IM) and has four predicted TMSs and tandem PDZ domains (<xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-2" hwp:rel-id="ref-20">20</xref>, <xref ref-type="bibr" rid="c100" hwp:id="xref-ref-100-1" hwp:rel-id="ref-100">100</xref>, <xref ref-type="bibr" rid="c101" hwp:id="xref-ref-101-1" hwp:rel-id="ref-101">101</xref>). The substrate RseA also localizes to the inner membrane and sequesters Ï<sup>E</sup> in the absence of envelope stress (<xref ref-type="bibr" rid="c102" hwp:id="xref-ref-102-1" hwp:rel-id="ref-102">102</xref>). The PDZ domains of RseP block access of the RseA/Ï<sup>E</sup> complex to the RseP active site (<xref ref-type="bibr" rid="c69" hwp:id="xref-ref-69-1" hwp:rel-id="ref-69">69</xref>). Stress causes misfolding of outer membrane proteins and accumulation of lipopolysaccharide intermediates, which trigger site-1 cleavage by DegS in the RseA periplasmic domain (<xref ref-type="bibr" rid="c68" hwp:id="xref-ref-68-1" hwp:rel-id="ref-68">68</xref>, <xref ref-type="bibr" rid="c103" hwp:id="xref-ref-103-1" hwp:rel-id="ref-103">103</xref>). Removal of the RseA extramembrane domain permits entry into the RseP active site cleft for site-2 cleavage (<xref ref-type="bibr" rid="c104" hwp:id="xref-ref-104-1" hwp:rel-id="ref-104">104</xref>, <xref ref-type="bibr" rid="c105" hwp:id="xref-ref-105-1" hwp:rel-id="ref-105">105</xref>). Release of RseA/Ï<sup>E</sup> into the cytosol allows ClpXP protease to degrade RseA, liberating Ï<sup>E</sup> to direct transcription of stress-responsive genes (<xref ref-type="bibr" rid="c106" hwp:id="xref-ref-106-1" hwp:rel-id="ref-106">106</xref>, <xref ref-type="bibr" rid="c107" hwp:id="xref-ref-107-1" hwp:rel-id="ref-107">107</xref>). (<bold>C</bold>) SpoIVFB regulation. SpoIVFB localizes to the outer forespore membrane (OFM) during <italic toggle="yes">B. subtilis</italic> sporulation and has six predicted TMSs and a CBS domain (<xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-3" hwp:rel-id="ref-20">20</xref>, <xref ref-type="bibr" rid="c32" hwp:id="xref-ref-32-1" hwp:rel-id="ref-32">32</xref>, <xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-3" hwp:rel-id="ref-34">34</xref>, <xref ref-type="bibr" rid="c54" hwp:id="xref-ref-54-2" hwp:rel-id="ref-54">54</xref>). Our results support a novel regulatory mechanism in which the inhibitory proteins BofA and SpoIVFA occupy the SpoIVFB active site cleft and block access of the Pro-Ï<sup>K</sup> Proregion. The inhibitory proteins did not prevent interaction of Pro-Ï<sup>K</sup> with the SpoIVFB CBS domain in our <italic toggle="yes">E. coli</italic> system. Proteases SpoIVB and CtpB are secreted from the forespore into the intermembrane space and cleave the inhibitory proteins (<xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-2" hwp:rel-id="ref-41">41</xref>â<xref ref-type="bibr" rid="c43" hwp:id="xref-ref-43-3" hwp:rel-id="ref-43">43</xref>, <xref ref-type="bibr" rid="c45" hwp:id="xref-ref-45-4" hwp:rel-id="ref-45">45</xref>), allowing the Pro-Ï<sup>K</sup> Proregion to enter the SpoIVFB active site cleft for cleavage (<xref ref-type="bibr" rid="c46" hwp:id="xref-ref-46-4" hwp:rel-id="ref-46">46</xref>â<xref ref-type="bibr" rid="c48" hwp:id="xref-ref-48-3" hwp:rel-id="ref-48">48</xref>), which releases Ï<sup>K</sup> into the mother cell to direct transcription of sporulation genes (<xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-3" hwp:rel-id="ref-49">49</xref>, <xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-2" hwp:rel-id="ref-50">50</xref>).</p></caption><graphic xlink:href="451828v4_fig8" position="float" orientation="portrait" hwp:id="graphic-8"/></fig><p hwp:id="p-66">RIP of SREBPs also involves extramembrane loop cleavage, referred to as site-1 cleavage, prior to site-2 cleavage by S2P (<xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-3" hwp:rel-id="ref-1">1</xref>) (<xref rid="fig8" ref-type="fig" hwp:id="xref-fig-8-2" hwp:rel-id="F8">Figure 8</xref>). Substrates of bacterial metallo IPs (with the exception of SpoIVFB) typically also require initial regulated site-1 cleavage by another protease (<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-3" hwp:rel-id="ref-19">19</xref>). A well-studied example in <italic toggle="yes">E. coli</italic> involves envelope stress regulating site-1 cleavage of the RseA extramembrane domain by DegS, allowing site-2 cleavage by RseP (<xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-4" hwp:rel-id="ref-20">20</xref>, <xref ref-type="bibr" rid="c68" hwp:id="xref-ref-68-2" hwp:rel-id="ref-68">68</xref>) (<xref rid="fig8" ref-type="fig" hwp:id="xref-fig-8-3" hwp:rel-id="F8">Figure 8</xref>). Substrates of aspartyl IPs likewise require an initial cleavage by another protease, referred to as ectodomain shedding (<xref ref-type="bibr" rid="c52" hwp:id="xref-ref-52-2" hwp:rel-id="ref-52">52</xref>, <xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-2" hwp:rel-id="ref-53">53</xref>). Shedding and site-1 cleavage of RseA allow substrate entry to the IP active site cleft. Without the initial cleavage, the substrate extramembrane domain prevents entry, due to size exclusion by the IP. In RseP, tandem PDZ domains act as a size-exclusion filter (<xref ref-type="bibr" rid="c69" hwp:id="xref-ref-69-2" hwp:rel-id="ref-69">69</xref>) (<xref rid="fig8" ref-type="fig" hwp:id="xref-fig-8-4" hwp:rel-id="F8">Figure 8</xref>). The nicastrin subunit plays a similar role in the metazoan aspartyl IP Î³-secretase (<xref ref-type="bibr" rid="c70" hwp:id="xref-ref-70-1" hwp:rel-id="ref-70">70</xref>).</p><p hwp:id="p-67">Only two cases of IP regulation by substrate interaction with an adapter protein have been reported. In the bacterium <italic toggle="yes">Mycobacterium tuberculosis</italic>, the adapter protein Ppr1 bridges the metallo IP Rip1 to one of its substrates, but not to others (<xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-3" hwp:rel-id="ref-21">21</xref>). The Î³-secretase subunits nicastrin and PEN-2 also appear to interact with substrate before passage to the active site (<xref ref-type="bibr" rid="c71" hwp:id="xref-ref-71-1" hwp:rel-id="ref-71">71</xref>).</p><p hwp:id="p-68">Our results support a novel mechanism of IP regulation â inhibitory proteins block substrate access to the SpoIVFB active site (<xref rid="fig8" ref-type="fig" hwp:id="xref-fig-8-5" hwp:rel-id="F8">Figure 8</xref>). Many soluble proteases are regulated by inhibitory proteins, prodomains, or prosegments that sterically hinder substrate access to their active site (<xref ref-type="bibr" rid="c62" hwp:id="xref-ref-62-2" hwp:rel-id="ref-62">62</xref>), but analogous regulation of an IP has not been reported previously. In addition to steric hindrance, inhibition of soluble metalloproteases often involves a protein residue side chain coordinating the catalytic metal ion (<xref ref-type="bibr" rid="c62" hwp:id="xref-ref-62-3" hwp:rel-id="ref-62">62</xref>, <xref ref-type="bibr" rid="c63" hwp:id="xref-ref-63-2" hwp:rel-id="ref-63">63</xref>). We hypothesized that BofA N48 coordinates the predicted zinc ion at the SpoIVFB active site since Asn is highly conserved at the corresponding position in BofA orthologs (Figure 2-figure supplement 1) and BofA N48 is crucial for SpoIVFB inhibition (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-4" hwp:rel-id="F2">Figure 2</xref> and <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-14" hwp:rel-id="F3">3</xref>). Consistent with our hypothesis, BofA TMS2 with N48 near its center occupies the SpoIVFB active site cleft, based on disulfide cross-linking experiments (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-4" hwp:rel-id="F4">Figure 4</xref> and Figure 4-figure supplement 3-5). However, the N48 side chain points away from the zinc ion in our structural model, which instead predicts that the N48 side chain interacts with those of other conserved BofA residues shown to be important for SpoIVFB inhibition (Supplementary File 2). Therefore, we favor a simple steric hindrance mechanism of inhibition not involving a BofA residue acting as a zinc ligand.</p><p hwp:id="p-69">In addition to BofA TMS2 sterically hindering substrate access to the SpoIVFB active site, what are the roles of other parts of BofA in the novel inhibition mechanism? It was known that deletion of three residues from the C-terminal end of BofA caused a loss of function or stability in <italic toggle="yes">B. subtilis</italic> (<xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-4" hwp:rel-id="ref-33">33</xref>, <xref ref-type="bibr" rid="c60" hwp:id="xref-ref-60-3" hwp:rel-id="ref-60">60</xref>). We found that deleting the three residues or changing them to Ala in GFPÎ27BofA caused loss of SpoIVFB inhibition in our <italic toggle="yes">E. coli</italic> system (Figure 2-figure supplement 2A). Our structural model predicts that the three BofA residues interact with SpoIVFA and SpoIVFB (<xref rid="fig7" ref-type="fig" hwp:id="xref-fig-7-5" hwp:rel-id="F7">Figure 7C</xref>), which can be tested by cross-linking experiments.</p><p hwp:id="p-70">BofA TMS1 appears to sterically hinder some interactions between the Pro-Ï<sup>K</sup> N- terminal region and SpoIVFB, based on comparison between full-length BofA and MBPÎ27BofA (lacking TMS1) in cross-linking time courses. The interactions hindered more by full-length BofA included cross-links between the Pro-Ï<sup>K</sup> Proregion and the SpoIVFB membrane-reentrant loop (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-15" hwp:rel-id="F6">Figure 6G and H</xref>), which may bind to the Proregion and present it to the SpoIVFB active site for cleavage (<xref ref-type="bibr" rid="c56" hwp:id="xref-ref-56-9" hwp:rel-id="ref-56">56</xref>) based on a study of the homologous membrane- reentrant loop of <italic toggle="yes">E. coli</italic> RseP (<xref ref-type="bibr" rid="c66" hwp:id="xref-ref-66-2" hwp:rel-id="ref-66">66</xref>). Full-length BofA also hindered cross-links between Pro-Ï<sup>K</sup> L41C and the SpoIVFB interdomain linker (Y214C) more than MBPÎ27BofA (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-16" hwp:rel-id="F6">Figure 6I</xref>), suggesting that BofA TMS1 weakens the interaction between the interdomain linker and Pro-Ï<sup>K</sup>, which is crucial for cleavage (<xref ref-type="bibr" rid="c56" hwp:id="xref-ref-56-10" hwp:rel-id="ref-56">56</xref>, <xref ref-type="bibr" rid="c59" hwp:id="xref-ref-59-4" hwp:rel-id="ref-59">59</xref>). Our model predicts that both TMSs of BofA, as well as its C-terminal region, occupy the SpoIVFB active site cleft (<xref rid="fig7" ref-type="fig" hwp:id="xref-fig-7-6" hwp:rel-id="F7">Figure 7B</xref>), plausibly explaining the additional steric hindrance that BofA TMS1 appears to provide. Yet, TMS1 plays a minor role in SpoIVFB inhibition compared with BofA TMS2 and its C-terminal region, since full-length BofA inhibited cleavage of Pro-Ï<sup>K</sup>(1â127) in <italic toggle="yes">E. coli</italic> (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-22" hwp:rel-id="F1">Figure 1B</xref>) and Pro-Ï<sup>K</sup> in <italic toggle="yes">B. subtilis</italic> (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-15" hwp:rel-id="F3">Figure 3A</xref>) only slightly more than GFPÎ27BofA. Nevertheless, the minor role of BofA TMS1 may be important as premature Ï<sup>K</sup> production can reduce sporulation efficiency (<xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-3" hwp:rel-id="ref-31">31</xref>).</p></sec><sec id="s3b" hwp:id="sec-12"><title hwp:id="title-23">Implications for Activation of SpoIVFB and Its Orthologs in Other Endospore Formers</title><p hwp:id="p-71">Inhibition of SpoIVFB is relieved during <italic toggle="yes">B. subtilis</italic> sporulation when SpoIVB cleaves the C- terminal end of SpoIVFA (<xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-3" hwp:rel-id="ref-41">41</xref>â<xref ref-type="bibr" rid="c44" hwp:id="xref-ref-44-2" hwp:rel-id="ref-44">44</xref>) and CtpB cleaves the C-terminal ends of both SpoIVFA and BofA (<xref ref-type="bibr" rid="c42" hwp:id="xref-ref-42-3" hwp:rel-id="ref-42">42</xref>, <xref ref-type="bibr" rid="c43" hwp:id="xref-ref-43-4" hwp:rel-id="ref-43">43</xref>, <xref ref-type="bibr" rid="c45" hwp:id="xref-ref-45-5" hwp:rel-id="ref-45">45</xref>) (Figure 1-figure supplement 1). The levels of inhibitory proteins decrease coincident with increasing Pro-Ï<sup>K</sup> cleavage (<xref ref-type="bibr" rid="c38" hwp:id="xref-ref-38-2" hwp:rel-id="ref-38">38</xref>, <xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-4" hwp:rel-id="ref-41">41</xref>, <xref ref-type="bibr" rid="c42" hwp:id="xref-ref-42-4" hwp:rel-id="ref-42">42</xref>, <xref ref-type="bibr" rid="c45" hwp:id="xref-ref-45-6" hwp:rel-id="ref-45">45</xref>), suggesting that degradation of SpoIVFA and BofA permits SpoIVFB activity. Alternatively, a conformational change in the inhibition complex may suffice to trigger SpoIVFB activity, based on <italic toggle="yes">in vitro</italic> experiments indicating that SpoIVB cleavage of SpoIVFA alters susceptibility of the complex to general proteolysis but does not disrupt the complex (<xref ref-type="bibr" rid="c42" hwp:id="xref-ref-42-5" hwp:rel-id="ref-42">42</xref>).</p><p hwp:id="p-72">Our results imply that activation of SpoIVFB requires removal or substantial movement of inhibitory proteins to allow substrate access to the active site. Foremost, steric hindrance by BofA TMS2 must be relieved. Additionally, the critical roles of the BofA C-terminal region and SpoIVFA must be explained. Our structural model predicts that SpoIVFA bridges the BofA C- terminal region and SpoIVFB TMS4 to stabilize the inhibition complex (<xref rid="fig7" ref-type="fig" hwp:id="xref-fig-7-7" hwp:rel-id="F7">Figure 7C</xref>). We propose that cleavage of SpoIVFA by SpoIVB initiates destabilization of the inhibition complex. The initial cleavage, perhaps followed by further proteolysis of SpoIVFA, may destabilize the membrane-embedded BofA C-terminal region and expose it to cleavage by CtpB, which hastens SpoIVFB activation but is not essential (<xref ref-type="bibr" rid="c40" hwp:id="xref-ref-40-3" hwp:rel-id="ref-40">40</xref>, <xref ref-type="bibr" rid="c42" hwp:id="xref-ref-42-6" hwp:rel-id="ref-42">42</xref>, <xref ref-type="bibr" rid="c43" hwp:id="xref-ref-43-5" hwp:rel-id="ref-43">43</xref>, <xref ref-type="bibr" rid="c45" hwp:id="xref-ref-45-7" hwp:rel-id="ref-45">45</xref>). Finally, degradation of BofA or a conformational change would relieve steric hindrance by BofA TMS2 and allow substrate access to the SpoIVFB active site.</p><p hwp:id="p-73">The mechanisms of inhibition and activation of <italic toggle="yes">B. subtilis</italic> SpoIVFB likely apply to its orthologs in spore-forming bacilli since these bacteria encode BofA, SpoIVFA, SpoIVB, and CtpB (<xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-2" hwp:rel-id="ref-23">23</xref>, <xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-2" hwp:rel-id="ref-25">25</xref>). This group includes well-known human or plant pathogens such as <italic toggle="yes">Bacillus anthracis</italic>, <italic toggle="yes">Bacillus cereus</italic>, and <italic toggle="yes">Bacillus thuringiensis</italic>. In contrast, clostridia that form endospores do not have a recognizable gene for SpoIVFA (<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-3" hwp:rel-id="ref-22">22</xref>, <xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-3" hwp:rel-id="ref-23">23</xref>). In some clostridia, a non- orthologous gene has been proposed to code for a protein that performs the same function as SpoIVFA (<xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-4" hwp:rel-id="ref-23">23</xref>), so similar mechanisms of SpoIVFB regulation may apply. The <italic toggle="yes">E. coli</italic> system described herein will facilitate further testing of heterologous protein function. Many spore- forming clostridia also lack a recognizable gene for BofA (<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-3" hwp:rel-id="ref-25">25</xref>). Our results imply that SpoIVFB activity would be unregulated in these bacteria (i.e., coordination between forespore and mother cell gene expression would be lost). A precedence for less precise control of Ï<sup>K</sup>-dependent gene expression is known from studies of the human pathogen <italic toggle="yes">Clostridioides difficile</italic> (<xref ref-type="bibr" rid="c72" hwp:id="xref-ref-72-1" hwp:rel-id="ref-72">72</xref>, <xref ref-type="bibr" rid="c73" hwp:id="xref-ref-73-1" hwp:rel-id="ref-73">73</xref>), in which the gene for Ï<sup>K</sup> does not encode a Proregion and a gene for SpoIVFB is absent (<xref ref-type="bibr" rid="c74" hwp:id="xref-ref-74-1" hwp:rel-id="ref-74">74</xref>).</p><p hwp:id="p-74">Based on phylogenomic analysis, the precise control of Ï<sup>K</sup>-dependent gene expression observed in <italic toggle="yes">B. subtilis</italic> emerged early in evolution and has been maintained in bacilli which propagate primarily in aerobic environments, but has been modified or lost in many clostridia which are found mainly in anaerobic habitats (<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-4" hwp:rel-id="ref-25">25</xref>).</p></sec><sec id="s3c" hwp:id="sec-13"><title hwp:id="title-24">Design of IP Inhibitors</title><p hwp:id="p-75">Efforts toward development of therapeutic peptidyl inhibitors of serine IPs (rhomboids) are well-advanced (<xref ref-type="bibr" rid="c11" hwp:id="xref-ref-11-1" hwp:rel-id="ref-11">11</xref>, <xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-2" hwp:rel-id="ref-12">12</xref>, <xref ref-type="bibr" rid="c75" hwp:id="xref-ref-75-1" hwp:rel-id="ref-75">75</xref>). Translational work on aspartyl IPs has focused on Î³-secretase owing to its processing of the amyloid precursor protein (APP) associated with Alzheimerâs disease (<xref ref-type="bibr" rid="c76" hwp:id="xref-ref-76-1" hwp:rel-id="ref-76">76</xref>). Wide-spectrum inhibitors of Î³-secretase exhibit toxicity in clinical trials, mainly due to inhibition of signaling <italic toggle="yes">via</italic> Notch receptors, which are also substrates of Î³- secretase (<xref ref-type="bibr" rid="c77" hwp:id="xref-ref-77-1" hwp:rel-id="ref-77">77</xref>). The structures of Î³-secretase complexes with APP and Notch reveal differences in binding that may allow substrate-specific inhibitors to be developed as therapeutics (<xref ref-type="bibr" rid="c13" hwp:id="xref-ref-13-2" hwp:rel-id="ref-13">13</xref>, <xref ref-type="bibr" rid="c14" hwp:id="xref-ref-14-2" hwp:rel-id="ref-14">14</xref>). Stabilization of complexes in which Î³-secretase progressively cleaves APP is another promising approach toward development of drugs to treat Alzheimerâs disease (<xref ref-type="bibr" rid="c78" hwp:id="xref-ref-78-1" hwp:rel-id="ref-78">78</xref>).</p><p hwp:id="p-76">In comparison with rhomboids and Î³-secretase, translational work on metallo IP inhibitors is in its infancy. Recently, batimastat, a peptidic hydroxamate known to inhibit eukaryotic matrix metalloproteases (MMPs), was shown to selectively inhibit <italic toggle="yes">E. coli</italic> RseP <italic toggle="yes">in vivo</italic> (<xref ref-type="bibr" rid="c79" hwp:id="xref-ref-79-1" hwp:rel-id="ref-79">79</xref>). A lack of selectivity has been a problem in efforts toward using peptidic hydroxamates as MMP inhibitors for treatment of cancer, arthritis, and other diseases (<xref ref-type="bibr" rid="c80" hwp:id="xref-ref-80-1" hwp:rel-id="ref-80">80</xref>â<xref ref-type="bibr" rid="c82" hwp:id="xref-ref-82-1" hwp:rel-id="ref-82">82</xref>).</p><p hwp:id="p-77">The hydroxamate strongly coordinates the catalytic metal ion and the peptidic portions have not provided enough specificity to prevent off-target effects. Even so, the side effects may not preclude using peptidic hydroxamates to treat bacterial infections topically, and systemically if administered briefly. Other small-molecule MMP inhibitors that have already been developed (<xref ref-type="bibr" rid="c80" hwp:id="xref-ref-80-2" hwp:rel-id="ref-80">80</xref>) should be screened for activity against bacteria and fungi with metallo IPs known to be involved in pathogenesis (<xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-2" hwp:rel-id="ref-18">18</xref>â<xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-4" hwp:rel-id="ref-21">21</xref>).</p><p hwp:id="p-78">Our findings reveal concepts that may inform efforts to design selective inhibitors of IPs. BofA TMS2 appears to block the SpoIVFB active site (<xref rid="fig7" ref-type="fig" hwp:id="xref-fig-7-8" hwp:rel-id="F7">Figure 7A</xref>), similar to the prosegment of many latent proteases (<xref ref-type="bibr" rid="c62" hwp:id="xref-ref-62-4" hwp:rel-id="ref-62">62</xref>). Like BofA, some prosegments can act in <italic toggle="yes">trans</italic>, an observation that has led to the demonstration of prodomains as selective inhibitors of A Disintegrin And Metalloproteinase (ADAM) family enzymes (<xref ref-type="bibr" rid="c83" hwp:id="xref-ref-83-1" hwp:rel-id="ref-83">83</xref>, <xref ref-type="bibr" rid="c84" hwp:id="xref-ref-84-1" hwp:rel-id="ref-84">84</xref>). Selectivity relies on the extensive interaction surface between the prodomain and the enzyme, including features specific to the pair, which can boost efficacy and diminish off-target effects in therapeutic strategies (<xref ref-type="bibr" rid="c82" hwp:id="xref-ref-82-2" hwp:rel-id="ref-82">82</xref>). A peptide encompassing residues 48 to 64 of BofA may inhibit SpoIVFB, but our model also predicts extensive interactions between the BofA C-terminal region (residues 65 to 87) and SpoIVFB (<xref rid="fig7" ref-type="fig" hwp:id="xref-fig-7-9" hwp:rel-id="F7">Figure 7B</xref>), so a longer BofA peptide, perhaps flexibly linked to SpoIVFA residues 96 to 109, which are also predicted to interact with SpoIVFB (<xref rid="fig7" ref-type="fig" hwp:id="xref-fig-7-10" hwp:rel-id="F7">Figure 7C</xref>), may exhibit improved inhibition and selectivity. Since cleavage of Pro-Ï<sup>K</sup>(1â127) by cytTM-SpoIVFB has been reconstituted <italic toggle="yes">in vitro</italic> (<xref ref-type="bibr" rid="c48" hwp:id="xref-ref-48-4" hwp:rel-id="ref-48">48</xref>), it will be possible to test peptides for inhibition. Structure determination of SpoIVFB in complex with an inhibitory peptide, GFPÎ27BofA, or full-length BofA is an important goal to facilitate design of metallo IP inhibitors. In particular, it may inform efforts to design inhibitors of SpoIVFB orthologs in pathogenic bacilli and clostridia, which persist by forming endospores (<xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-2" hwp:rel-id="ref-27">27</xref>â<xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-2" hwp:rel-id="ref-29">29</xref>). Such efforts could lead to new strategies to control endosporulation.</p><p hwp:id="p-79">Our findings also suggest that BofA TMS1 interferes with interactions between the Pro- Ï<sup>K</sup> N-terminal region and SpoIVFB. Therefore, a cyclic peptide inhibitor may prove to be more effective than a linear one. The desirable characteristics of cyclic peptides as therapeutics, and new methods of producing and screening cyclic peptide libraries, make this an attractive possibility (<xref ref-type="bibr" rid="c85" hwp:id="xref-ref-85-1" hwp:rel-id="ref-85">85</xref>, <xref ref-type="bibr" rid="c86" hwp:id="xref-ref-86-1" hwp:rel-id="ref-86">86</xref>). Although we favor a simple steric hindrance mechanism of inhibition not involving a BofA residue acting as a zinc ligand (Supplementary File 2), it is possible that inclusion of such a residue in a BofA TMS2 peptide mimic would improve SpoIVFB inhibition. A similar strategy could be used to design inhibitors of other metallo IPs.</p></sec></sec><sec id="s4" hwp:id="sec-14"><title hwp:id="title-25">Materials and Methods</title><sec id="s4a" hwp:id="sec-15"><title hwp:id="title-26">Plasmids, Primers, and Strains</title><p hwp:id="p-80">Plasmids used in this study are described in Supplementary File 4, as are primers used in plasmid construction. Plasmids were cloned in <italic toggle="yes">E. coli</italic> strain DH5Î± (<xref ref-type="bibr" rid="c87" hwp:id="xref-ref-87-1" hwp:rel-id="ref-87">87</xref>). Relevant parts of plasmids were verified by DNA sequencing with primers listed in Supplementary File 4 and <italic toggle="yes">B. subtilis</italic> strains used in this study are also described therein.</p></sec><sec id="s4b" hwp:id="sec-16"><title hwp:id="title-27">Pro-Ï<sup>K</sup>(1â127) Cleavage in <italic toggle="yes">E. coli</italic></title><p hwp:id="p-81">Strain BL21(DE3) (Novagen) was used to produce proteins in <italic toggle="yes">E. coli</italic>. Two plasmids with different antibiotic resistance genes were cotransformed (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-9" hwp:rel-id="ref-37">37</xref>) or a single plasmid was transformed, with selection on Luria-Bertani (LB) agar supplemented with kanamycin sulfate (50 Î¼g/mL) and/or ampicillin (100 Î¼g/mL). Transformants (4-5 colonies) were grown in LB medium with 50 Î¼g/mL kanamycin sulfate and/or 200 Î¼g/mL ampicillin at 37Â°C with shaking (200 rpm). Typically, overnight culture (200 Î¼L) was transferred to 10 mL of</p><p hwp:id="p-82">LB medium with antibiotics, cultures were grown at 37Â°C with shaking (250 rpm) to an optical density of 60-80 Klett units, and isopropyl Î²-D-thiogalactopyranoside (IPTG) (0.5 mM) was added to induce protein production for 2 h. For transformants with either pET Quintet or full- length Pro-Ï<sup>K</sup>-His<sub>6</sub>, overnight growth was avoided. Transformants were transferred directly to 10 mL of LB medium with antibiotic, and cultures were grown and induced as described above. Equivalent amounts of cells (based on optical density in Klett units) were collected (12,000 Ã <italic toggle="yes">g</italic> for 1 min) and extracts were prepared (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-10" hwp:rel-id="ref-37">37</xref>), then subjected to immunoblot analysis (Supplementary File 3).</p></sec><sec id="s4c" hwp:id="sec-17"><title hwp:id="title-28">BofA Sequence Analysis</title><p hwp:id="p-83">Orthologs of <italic toggle="yes">B. subtilis bofA</italic>, which are present in the genomes of most endospore-forming bacteria (<xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-5" hwp:rel-id="ref-23">23</xref>), were collected from the NCBI and Uniprot databases. The protein sequences of BofA orthologs were aligned using the T-Coffee multiple sequence alignment package (<xref ref-type="bibr" rid="c88" hwp:id="xref-ref-88-1" hwp:rel-id="ref-88">88</xref>). Residues identical in at least 70% of the sequences were considered conserved.</p></sec><sec id="s4d" hwp:id="sec-18"><title hwp:id="title-29"><italic toggle="yes">B. subtilis</italic> Sporulation and GFPÎBofA Localization</title><p hwp:id="p-84">GFPÎ27BofA or its variants were expressed under control of the <italic toggle="yes">bofA</italic> promoter (P<italic toggle="yes"><sub>bofA</sub></italic>) after ectopic chromosomal integration. Plasmids bearing P<italic toggle="yes"><sub>bofA</sub></italic>-<italic toggle="yes">gfpÎ27bofA</italic> or its variant, bordered by regions of homology to <italic toggle="yes">B. subtilis amyE</italic>, were transformed into strain ZR264. Transformants with a gene replacement at <italic toggle="yes">amyE</italic> were selected on LB agar with spectinomycin sulfate (100 Î¼g/mL) and identified by loss of amylase activity (<xref ref-type="bibr" rid="c89" hwp:id="xref-ref-89-1" hwp:rel-id="ref-89">89</xref>). Sporulation was induced by growing cells in the absence of antibiotics followed by the resuspension of cells in SM medium (<xref ref-type="bibr" rid="c89" hwp:id="xref-ref-89-2" hwp:rel-id="ref-89">89</xref>). At indicated times PS, samples (50 Î¼L) were centrifuged (12,000 Ã <italic toggle="yes">g</italic> for 1 min), supernatants were removed, and cell pellets were stored at -80Â°C. Whole-cell extracts were prepared as described for <italic toggle="yes">E. coli</italic> (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-11" hwp:rel-id="ref-37">37</xref>), except samples were incubated at 50Â°C for 3 min instead of boiling for 3 min (<xref ref-type="bibr" rid="c56" hwp:id="xref-ref-56-11" hwp:rel-id="ref-56">56</xref>), and proteins were subjected to immunoblot analysis (Supplementary File 3).</p><p hwp:id="p-85">To image GFPÎ27BofA localization, samples collected at 3 h PS were examined by fluorescence microscopy using an Olympus FluoView FV-1000 filter-based confocal microscope. GFPÎ27BofA (ex/em â¼488/507 nm) was excited using a 458 nM argon laser and fluorescence was captured using a BA465-495 nm band pass filter. The lipophilic dye FM 4-64 (1 Î¼g/mL) (AAT Bioquest) was used to stain membranes. FM 4-64 (ex/em â¼515/640 nm) was excited using a 515 nm argon laser and fluorescence was captured using a BA560IF band pass filter (<xref ref-type="bibr" rid="c90" hwp:id="xref-ref-90-1" hwp:rel-id="ref-90">90</xref>).</p></sec><sec id="s4e" hwp:id="sec-19"><title hwp:id="title-30">Disulfide Cross-Linking</title><p hwp:id="p-86">A method described previously (<xref ref-type="bibr" rid="c91" hwp:id="xref-ref-91-1" hwp:rel-id="ref-91">91</xref>) was used with slight modifications (<xref ref-type="bibr" rid="c55" hwp:id="xref-ref-55-9" hwp:rel-id="ref-55">55</xref>). Briefly, as described above for Pro-Ï<sup>K</sup>(1â127) cleavage, <italic toggle="yes">E. coli</italic> BL21(DE3) was transformed with a plasmid, grown in LB (10 mL), induced with IPTG, and equivalent amounts of cells were collected. Cells were subjected to disulfide cross-linking, then lysed and proteins were precipitated by addition of trichloroacetic acid (5%), and proteins were subjected to immunoblot analysis (Supplementary File 3).</p></sec><sec id="s4f" hwp:id="sec-20"><title hwp:id="title-31">Co-Immunoprecipitation (FLAG<sub>2</sub> Pull-Down Assays)</title><p hwp:id="p-87"><italic toggle="yes">E. coli</italic> BL21(DE3) was transformed with a plasmid, grown in LB (1 L), and induced with IPTG as described above. The culture was split, cells were harvested, and cell pellets were stored at -80Â°C. Cell lysates were prepared as described (<xref ref-type="bibr" rid="c65" hwp:id="xref-ref-65-2" hwp:rel-id="ref-65">65</xref>), except that each cell pellet was resuspended in 20 mL of lysis buffer containing 50 mM Tris-HCl pH 7.1 rather than PBS. Cell lysates were centrifuged (15,000 Ã <italic toggle="yes">g</italic> for 15 min at 4 Â°C) to sediment cell debris and protein inclusion bodies. The supernatant was treated with 1% <italic toggle="yes">n</italic>-dodecyl-Î²-D-maltoside (DDM) (Anatrace) for 1 h at 4 Â°C to solubilize membrane proteins, then centrifuged at 150,000 Ã <italic toggle="yes">g</italic> for 1 h at 4 Â°C. The supernatant was designated the input sample and 1 mL was mixed with 50 uL anti-DYKDDDDK magnetic agarose (Pierce) that had been equilibrated with buffer (50 mM Tris-HCl pH 7.1, 0.1% DDM, 5 mM 2-mercaptoethanol, 10% glycerol) and the mixture was rotated for 1 h at 25Â°C. The magnetic agarose was removed with a DynaMag-2 magnet (Invitrogen) and the supernatant was saved (unbound sample). The magnetic agarose was washed three times by gently vortexing with 500 Î¼L wash buffer (50 mM Tris-HCl pH 7.1, 150 mM NaCl, 10% glycerol, 0.1% DDM), then washed once with 500 Î¼L water. The magnetic agarose was mixed with 50 Î¼L of 2Ã sample buffer (50 mM TrisÂ·HCl pH 6.8, 4% SDS, 20% glycerol, 200 mM DTT 0.03% bromophenol blue) and boiled for 3 min (bound sample). A portion of the bound sample was diluted tenfold (1/10 bound sample) with 1Ã sample buffer to match the concentration of the input sample. Samples were subjected to immunoblot analysis (Supplementary File 3).</p></sec><sec id="s4g" hwp:id="sec-21"><title hwp:id="title-32">Colbalt Affinity Purification (His<sub>6</sub> Pull-Down Assays)</title><p hwp:id="p-88">Input sample (15 mL) prepared as described above was mixed with imidazole (5 mM) and 0.5 mL of Talon superflow metal affinity resin (Clontech) that had been equilibrated with buffer (as above for magnetic agarose). The mixture was rotated for 1 h at 4Â°C. The cobalt resin was sedimented by centrifugation at 708 Ã <italic toggle="yes">g</italic> for 2 min at 4 Â°C and the supernatant was saved (unbound sample). The resin was washed three times with 5 mL wash buffer (as above plus 5 mM imidazole), each time rotating the mixture for 10 min at 4 Â°C and sedimenting resin as above. The resin was mixed with 0.5 mL 2Ã sample buffer and boiled for 3 min (bound sample). A portion of the bound sample was diluted fifteenfold (1/15 bound sample) with 1Ã sample buffer to match the concentration of the input sample. Samples were subjected to immunoblot analysis (Supplementary File 3).</p></sec><sec id="s4h" hwp:id="sec-22"><title hwp:id="title-33">Modeling of Complexes Containing SpoIVFB, BofA, and Parts of SpoIVFA and Pro-Ï<sup>K</sup></title><p hwp:id="p-89">The modeling proceeded through stages where initial monomeric models were assembled step- by-step into multimeric complexes guided primarily by the restraints from cross-linking experiments and predicted contacts from co-evolutionary coupling analysis. More specifically, a SpoIVFB monomer was first assembled from the membrane and CBS domains. Two monomers were combined into a dimer and the dimer was assembled into a plausible tetramer. Part of one molecule of Pro-Ï<sup>K</sup> (residues 1-114) was subsequently added, which resulted in âfb.sigkâ. The âfb.sigk.bofa.faâ model was developed by starting from âfb.sigkâ, truncating the Pro-Ï<sup>K</sup> N- terminus (residues 1-37), and subsequently adding first BofA and finally SpoIVFA (residues 65- 111). See Supplementary File 3 for additional description of the modeling.</p></sec></sec><sec sec-type="supplementary-material" hwp:id="sec-23"><title hwp:id="title-34">Supporting information</title><supplementary-material position="float" orientation="portrait" hwp:id="DC1"><object-id pub-id-type="other" hwp:sub-type="slug">DC1</object-id><label>Supplementary Results</label><media xlink:href="supplements/451828_file02.pdf" position="float" orientation="portrait" hwp:id="media-1"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC2"><object-id pub-id-type="other" hwp:sub-type="slug">DC2</object-id><label>Supplementary Discussion</label><media xlink:href="supplements/451828_file03.pdf" position="float" orientation="portrait" hwp:id="media-2"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC3"><object-id pub-id-type="other" hwp:sub-type="slug">DC3</object-id><label>Supplementary Materials and Methods</label><media xlink:href="supplements/451828_file04.pdf" position="float" orientation="portrait" hwp:id="media-3"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC4"><object-id pub-id-type="other" hwp:sub-type="slug">DC4</object-id><label>Figure Supplements</label><media xlink:href="supplements/451828_file05.pdf" position="float" orientation="portrait" hwp:id="media-4"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC5"><object-id pub-id-type="other" hwp:sub-type="slug">DC5</object-id><label>Supplementary Plasmids, Primers, and Strains</label><media xlink:href="supplements/451828_file06.pdf" position="float" orientation="portrait" hwp:id="media-5"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC6"><object-id pub-id-type="other" hwp:sub-type="slug">DC6</object-id><label>Supplementary File 5</label><media xlink:href="supplements/451828_file07.xlsx" position="float" orientation="portrait" hwp:id="media-6"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC7"><object-id pub-id-type="other" hwp:sub-type="slug">DC7</object-id><label>Supplementary File 6</label><media xlink:href="supplements/451828_file08.xlsx" position="float" orientation="portrait" hwp:id="media-7"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC8"><object-id pub-id-type="other" hwp:sub-type="slug">DC8</object-id><label>Supplementary File 7</label><media xlink:href="supplements/451828_file09.xlsx" position="float" orientation="portrait" hwp:id="media-8"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC9"><object-id pub-id-type="other" hwp:sub-type="slug">DC9</object-id><label>Supplementary File 8</label><media xlink:href="supplements/451828_file10.xlsx" position="float" orientation="portrait" hwp:id="media-9"/></supplementary-material></sec></body><back><ack hwp:id="ack-1"><title hwp:id="title-35">Acknowledgments</title><p hwp:id="p-90">We thank Daniel Parrell for assistance with fluorescence microscopy, Jon Kaguni for helpful comments on the manuscript, and David Rudner, Simon Cutting, Ruanbao Zhou, and Yang Zhang for plasmids. This research was supported by National Institutes of Health Grants R01 GM43585 (to L.K.) and R35 GM126948 (to M.F.), and by Michigan State University AgBioResearch.</p></ack><ref-list hwp:id="ref-list-1"><title hwp:id="title-36">References</title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1 xref-ref-1-2 xref-ref-1-3"><label>1.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Brown MS"><surname>Brown</surname> <given-names>MS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ye J"><surname>Ye</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rawson RB"><surname>Rawson</surname> <given-names>RB</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Goldstein JL"><surname>Goldstein</surname> <given-names>JL</given-names></string-name> (<year>2000</year>) <article-title hwp:id="article-title-2">Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans</article-title>. <source hwp:id="source-1">Cell</source> <volume>100</volume>(<issue>4</issue>):<fpage>391</fpage>â<lpage>398</lpage>.</citation></ref><ref id="c2" hwp:id="ref-2" hwp:rev-id="xref-ref-2-1 xref-ref-2-2 xref-ref-2-3"><label>2.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.2" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="Urban S"><surname>Urban</surname> <given-names>S</given-names></string-name> (<year>2013</year>) <article-title hwp:id="article-title-3">Mechanisms and cellular functions of intramembrane proteases</article-title>. <source hwp:id="source-2">Biochim. Biophys. Acta - Biomembr</source>. <volume>1828</volume>:<fpage>2797</fpage>â<lpage>2800</lpage>.</citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1 xref-ref-3-2 xref-ref-3-3"><label>3.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Kuhnle N"><surname>Kuhnle</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dederer V"><surname>Dederer</surname> <given-names>V</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Lemberg MK"><surname>Lemberg</surname> <given-names>MK</given-names></string-name> (<year>2019</year>) <article-title hwp:id="article-title-4">Intramembrane proteolysis at a glance: from signalling to protein degradation</article-title>. <source hwp:id="source-3">J. Cell Sci</source>. <volume>132</volume>(<fpage>16</fpage>):jcs217745.</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1 xref-ref-4-2"><label>4.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Manolaridis I"><surname>Manolaridis</surname> <given-names>I</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>) <article-title hwp:id="article-title-5">Mechanism of farnesylated CAAX protein processing by the intramembrane protease Rce1</article-title>. <source hwp:id="source-4">Nature</source> <volume>504</volume>(<issue>7479</issue>):<fpage>301</fpage>â<lpage>305</lpage>.</citation></ref><ref id="c5" hwp:id="ref-5"><label>5.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Hu J"><surname>Hu</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Xue Y"><surname>Xue</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lee S"><surname>Lee</surname> <given-names>S</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Ha Y"><surname>Ha</surname> <given-names>Y</given-names></string-name> (<year>2011</year>) <article-title hwp:id="article-title-6">The crystal structure of GXGD membrane protease FlaK</article-title>. <source hwp:id="source-5">Nature</source> <volume>475</volume>(<issue>7357</issue>):<fpage>528</fpage>â<lpage>531</lpage>.</citation></ref><ref id="c6" hwp:id="ref-6"><label>6.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Li X"><surname>Li</surname> <given-names>X</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>) <article-title hwp:id="article-title-7">Structure of a presenilin family intramembrane aspartate protease</article-title>. <source hwp:id="source-6">Nature</source> <volume>493</volume>(<issue>7430</issue>):<fpage>56</fpage>â<lpage>61</lpage>.</citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1"><label>7.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Feng L"><surname>Feng</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> (<year>2007</year>) <article-title hwp:id="article-title-8">Structure of a site-2 protease family intramembrane metalloprotease</article-title>. <source hwp:id="source-7">Science</source> <volume>318</volume>(<issue>5856</issue>):<fpage>1608</fpage>â<lpage>1612</lpage>.</citation></ref><ref id="c8" hwp:id="ref-8"><label>8.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.8" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Wang Y"><surname>Wang</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhang Y"><surname>Zhang</surname> <given-names>Y</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Ha Y"><surname>Ha</surname> <given-names>Y</given-names></string-name> (<year>2006</year>) <article-title hwp:id="article-title-9">Crystal structure of a rhomboid family intramembrane protease</article-title>. <source hwp:id="source-8">Nature</source> <volume>444</volume>(<issue>7116</issue>):<fpage>179</fpage>â<lpage>183</lpage>.</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1"><label>9.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Wu Z"><surname>Wu</surname> <given-names>Z</given-names></string-name>, <etal>et al.</etal> (<year>2006</year>) <article-title hwp:id="article-title-10">Structural analysis of a rhomboid family intramembrane protease reveals a gating mechanism for substrate entry</article-title>. <source hwp:id="source-9">Nat. Struct. Mol. Biol</source>. <volume>13</volume>(<issue>12</issue>):<fpage>1084</fpage>â<lpage>1091</lpage>.</citation></ref><ref id="c10" hwp:id="ref-10" hwp:rev-id="xref-ref-10-1"><label>10.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.10" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Cho S"><surname>Cho</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dickey SW"><surname>Dickey</surname> <given-names>SW</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Urban S"><surname>Urban</surname> <given-names>S</given-names></string-name> (<year>2016</year>) <article-title hwp:id="article-title-11">Crystal structures and inhibition kinetics reveal a two-stage catalytic mechanism with drug design implications for rhomboid proteolysis</article-title>. <source hwp:id="source-10">Mol. Cell</source> <volume>61</volume>(<issue>3</issue>):<fpage>329</fpage>â<lpage>340</lpage>.</citation></ref><ref id="c11" hwp:id="ref-11" hwp:rev-id="xref-ref-11-1"><label>11.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.11" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Cho S"><surname>Cho</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Baker RP"><surname>Baker</surname> <given-names>RP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ji M"><surname>Ji</surname> <given-names>M</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Urban S"><surname>Urban</surname> <given-names>S</given-names></string-name> (<year>2019</year>) <article-title hwp:id="article-title-12">Ten catalytic snapshots of rhomboid intramembrane proteolysis from gate opening to peptide release</article-title>. <source hwp:id="source-11">Nat. Struct. Mol. Biol</source>. <volume>26</volume>(<issue>10</issue>):<fpage>910</fpage>â<lpage>918</lpage>.</citation></ref><ref id="c12" hwp:id="ref-12" hwp:rev-id="xref-ref-12-1 xref-ref-12-2"><label>12.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Ticha A"><surname>Ticha</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> (<year>2017</year>) <article-title hwp:id="article-title-13">General and modular strategy for designing potent, selective, and pharmacologically compliant inhibitors of rhomboid proteases</article-title>. <source hwp:id="source-12">Cell Chem. Biol</source>. <volume>24</volume>(<issue>12</issue>):<fpage>1523</fpage>â<lpage>1536</lpage> e1524.</citation></ref><ref id="c13" hwp:id="ref-13" hwp:rev-id="xref-ref-13-1 xref-ref-13-2"><label>13.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Yang G"><surname>Yang</surname> <given-names>G</given-names></string-name>, <etal>et al.</etal> (<year>2019</year>) <article-title hwp:id="article-title-14">Structural basis of Notch recognition by human Î³-secretase</article-title>. <source hwp:id="source-13">Nature</source> <volume>565</volume>(<issue>7738</issue>):<fpage>192</fpage>â<lpage>197</lpage>.</citation></ref><ref id="c14" hwp:id="ref-14" hwp:rev-id="xref-ref-14-1 xref-ref-14-2"><label>14.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Zhou R"><surname>Zhou</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal> (<year>2019</year>) <article-title hwp:id="article-title-15">Recognition of the amyloid precursor protein by human Î³-secretase</article-title>. <source hwp:id="source-14">Science</source> <volume>363</volume>(<issue>6428</issue>):<fpage>eaaw0930</fpage>.</citation></ref><ref id="c15" hwp:id="ref-15" hwp:rev-id="xref-ref-15-1 xref-ref-15-2"><label>15.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Rawson RB"><surname>Rawson</surname> <given-names>RB</given-names></string-name> (<year>2013</year>) <article-title hwp:id="article-title-16">The site-2 protease</article-title>. <source hwp:id="source-15">Biochim. Biophys. Acta - Biomembr</source>. <volume>1828</volume>(<issue>12</issue>):<fpage>2801</fpage>â<lpage>2807</lpage>.</citation></ref><ref id="c16" hwp:id="ref-16" hwp:rev-id="xref-ref-16-1"><label>16.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Ye J"><surname>Ye</surname> <given-names>J</given-names></string-name> (<year>2013</year>) <article-title hwp:id="article-title-17">Roles of regulated intramembrane proteolysis in virus infection and antiviral immunity</article-title>. <source hwp:id="source-16">Biochim. Biophys. Acta - Biomembr</source>. <volume>1828</volume>(<issue>12</issue>):<fpage>2926</fpage>â<lpage>2932</lpage>.</citation></ref><ref id="c17" hwp:id="ref-17" hwp:rev-id="xref-ref-17-1"><label>17.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Adam Z"><surname>Adam</surname> <given-names>Z</given-names></string-name> (<year>2013</year>) <article-title hwp:id="article-title-18">Emerging roles for diverse intramembrane proteases in plant biology</article-title>. <source hwp:id="source-17">Biochim. Biophys. Acta - Biomembr</source>. <volume>1828</volume>(<issue>12</issue>):<fpage>2933</fpage>â<lpage>2936</lpage>.</citation></ref><ref id="c18" hwp:id="ref-18" hwp:rev-id="xref-ref-18-1 xref-ref-18-2"><label>18.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Chang YC"><surname>Chang</surname> <given-names>YC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bien CM"><surname>Bien</surname> <given-names>CM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lee H"><surname>Lee</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Espenshade PJ"><surname>Espenshade</surname> <given-names>PJ</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Kwon-Chung KJ"><surname>Kwon-Chung</surname> <given-names>KJ</given-names></string-name> (<year>2007</year>) <article-title hwp:id="article-title-19">Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for virulence in <italic toggle="yes">Cryptococcus neoformans</italic></article-title>. <source hwp:id="source-18">Mol. Microbiol</source>. <volume>64</volume>(<issue>3</issue>):<fpage>614</fpage>â<lpage>629</lpage>.</citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1 xref-ref-19-2 xref-ref-19-3"><label>19.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Urban S"><surname>Urban</surname> <given-names>S</given-names></string-name> (<year>2009</year>) <article-title hwp:id="article-title-20">Making the cut: central roles of intramembrane proteolysis in pathogenic microorganisms</article-title>. <source hwp:id="source-19">Nat. Rev. Microbiol</source>. <volume>7</volume>:<fpage>411</fpage>â<lpage>423</lpage>.</citation></ref><ref id="c20" hwp:id="ref-20" hwp:rev-id="xref-ref-20-1 xref-ref-20-2 xref-ref-20-3 xref-ref-20-4"><label>20.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Kroos L"><surname>Kroos</surname> <given-names>L</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Akiyama Y"><surname>Akiyama</surname> <given-names>Y</given-names></string-name> (<year>2013</year>) <article-title hwp:id="article-title-21">Biochemical and structural insights into intramembrane metalloprotease mechanisms</article-title>. <source hwp:id="source-20">Biochim. Biophys. Acta - Biomembr</source>. <volume>1828</volume>(<issue>12</issue>):<fpage>2873</fpage>â<lpage>2885</lpage>.</citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1 xref-ref-21-2 xref-ref-21-3 xref-ref-21-4"><label>21.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.21" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Schneider JS"><surname>Schneider</surname> <given-names>JS</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Glickman MS"><surname>Glickman</surname> <given-names>MS</given-names></string-name> (<year>2013</year>) <article-title hwp:id="article-title-22">Function of site-2 proteases in bacteria and bacterial pathogens</article-title>. <source hwp:id="source-21">Biochim. Biophys. Acta - Biomembr</source>. <volume>1828</volume>(<issue>12</issue>):<fpage>2808</fpage>â<lpage>2814</lpage>.</citation></ref><ref id="c22" hwp:id="ref-22" hwp:rev-id="xref-ref-22-1 xref-ref-22-2 xref-ref-22-3"><label>22.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="de Hoon MJ"><surname>de Hoon</surname> <given-names>MJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Eichenberger P"><surname>Eichenberger</surname> <given-names>P</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Vitkup D"><surname>Vitkup</surname> <given-names>D</given-names></string-name> (<year>2010</year>) <article-title hwp:id="article-title-23">Hierarchical evolution of the bacterial sporulation network</article-title>. <source hwp:id="source-22">Curr. Biol</source>. <volume>20</volume>(<issue>17</issue>):<fpage>R735</fpage>â<lpage>R745</lpage>.</citation></ref><ref id="c23" hwp:id="ref-23" hwp:rev-id="xref-ref-23-1 xref-ref-23-2 xref-ref-23-3 xref-ref-23-4 xref-ref-23-5"><label>23.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="Galperin MY"><surname>Galperin</surname> <given-names>MY</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>) <article-title hwp:id="article-title-24">Genomic determinants of sporulation in <italic toggle="yes">Bacilli</italic> and <italic toggle="yes">Clostridia</italic>: towards the minimal set of sporulation-specific genes</article-title>. <source hwp:id="source-23">Environ. Microbiol</source>. <volume>14</volume>(<issue>11</issue>):<fpage>2870</fpage>â<lpage>2890</lpage>.</citation></ref><ref id="c24" hwp:id="ref-24"><label>24.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Abecasis AB"><surname>Abecasis</surname> <given-names>AB</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>) <article-title hwp:id="article-title-25">A genomic signature and the identification of new sporulation genes</article-title>. <source hwp:id="source-24">J. Bacteriol</source>. <volume>195</volume>(<issue>9</issue>):<fpage>2101</fpage>â<lpage>2115</lpage>.</citation></ref><ref id="c25" hwp:id="ref-25" hwp:rev-id="xref-ref-25-1 xref-ref-25-2 xref-ref-25-3 xref-ref-25-4"><label>25.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Ramos-Silva P"><surname>Ramos-Silva</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Serrano M"><surname>Serrano</surname> <given-names>M</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Henriques AO"><surname>Henriques</surname> <given-names>AO</given-names></string-name> (<year>2019</year>) <article-title hwp:id="article-title-26">From root to tips: sporulation evolution and specialization in <italic toggle="yes">Bacillus subtilis</italic> and the intestinal pathogen <italic toggle="yes">Clostridioides difficile</italic></article-title>. <source hwp:id="source-25">Mol. Biol. Evol</source>. <volume>36</volume>(<issue>12</issue>):<fpage>2714</fpage>â<lpage>2736</lpage>.</citation></ref><ref id="c26" hwp:id="ref-26" hwp:rev-id="xref-ref-26-1"><label>26.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.26" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-26"><string-name name-style="western" hwp:sortable="McKenney PT"><surname>McKenney</surname> <given-names>PT</given-names></string-name>, <string-name name-style="western" hwp:sortable="Driks A"><surname>Driks</surname> <given-names>A</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Eichenberger P"><surname>Eichenberger</surname> <given-names>P</given-names></string-name> (<year>2013</year>) <article-title hwp:id="article-title-27">The <italic toggle="yes">Bacillus subtilis</italic> endospore: assembly and functions of the multilayered coat</article-title>. <source hwp:id="source-26">Nat. Rev. Microbiol</source>. <volume>11</volume>(<issue>1</issue>):<fpage>33</fpage>â<lpage>44</lpage>.</citation></ref><ref id="c27" hwp:id="ref-27" hwp:rev-id="xref-ref-27-1 xref-ref-27-2"><label>27.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.27" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-27"><string-name name-style="western" hwp:sortable="Al-Hinai MA"><surname>Al-Hinai</surname> <given-names>MA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jones SW"><surname>Jones</surname> <given-names>SW</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Papoutsakis ET"><surname>Papoutsakis</surname> <given-names>ET</given-names></string-name> (<year>2015</year>) <article-title hwp:id="article-title-28">The <italic toggle="yes">Clostridium</italic> sporulation programs: diversity and preservation of endospore differentiation</article-title>. <source hwp:id="source-27">Microbiol. Mol. Biol. Rev</source>. <volume>79</volume>(<issue>1</issue>):<fpage>19</fpage>â<lpage>37</lpage>.</citation></ref><ref id="c28" hwp:id="ref-28"><label>28.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.28" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-28"><string-name name-style="western" hwp:sortable="Checinska A"><surname>Checinska</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Paszczynski A"><surname>Paszczynski</surname> <given-names>A</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Burbank M"><surname>Burbank</surname> <given-names>M</given-names></string-name> (<year>2015</year>) <article-title hwp:id="article-title-29"><italic toggle="yes">Bacillus</italic> and other spore-forming genera: variations in responses and mechanisms for survival</article-title>. <source hwp:id="source-28">Annu. Rev. Food Sci. Technol</source>. <volume>6</volume>:<fpage>351</fpage>â<lpage>369</lpage>.</citation></ref><ref id="c29" hwp:id="ref-29" hwp:rev-id="xref-ref-29-1 xref-ref-29-2"><label>29.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.29" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-29"><string-name name-style="western" hwp:sortable="Browne HP"><surname>Browne</surname> <given-names>HP</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>) <article-title hwp:id="article-title-30">Culturing of âunculturableâ human microbiota reveals novel taxa and extensive sporulation</article-title>. <source hwp:id="source-29">Nature</source> <volume>533</volume>(<issue>7604</issue>):<fpage>543</fpage>â<lpage>546</lpage>.</citation></ref><ref id="c30" hwp:id="ref-30" hwp:rev-id="xref-ref-30-1"><label>30.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.30" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-30"><string-name name-style="western" hwp:sortable="Tan IS"><surname>Tan</surname> <given-names>IS</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Ramamurthi KS"><surname>Ramamurthi</surname> <given-names>KS</given-names></string-name> (<year>2014</year>) <article-title hwp:id="article-title-31">Spore formation in <italic toggle="yes">Bacillus subtilis</italic></article-title>. <source hwp:id="source-30">Environ. Microbiol. Rep</source>. <volume>6</volume>(<issue>3</issue>):<fpage>212</fpage>â<lpage>225</lpage>.</citation></ref><ref id="c31" hwp:id="ref-31" hwp:rev-id="xref-ref-31-1 xref-ref-31-2 xref-ref-31-3"><label>31.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.31" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-31"><string-name name-style="western" hwp:sortable="Cutting S"><surname>Cutting</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> (<year>1990</year>) <article-title hwp:id="article-title-32">A forespore checkpoint for mother-cell gene expression during development in <italic toggle="yes">Bacillus subtilis</italic></article-title>. <source hwp:id="source-31">Cell</source> <volume>62</volume>:<fpage>239</fpage>â<lpage>250</lpage>.</citation></ref><ref id="c32" hwp:id="ref-32" hwp:rev-id="xref-ref-32-1"><label>32.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.32" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-32"><string-name name-style="western" hwp:sortable="Cutting S"><surname>Cutting</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Roels S"><surname>Roels</surname> <given-names>S</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Losick R"><surname>Losick</surname> <given-names>R</given-names></string-name> (<year>1991</year>) <article-title hwp:id="article-title-33">Sporulation operon <italic toggle="yes">spoIVF</italic> and the characterization of mutations that uncouple mother-cell from forespore gene expression in <italic toggle="yes">Bacillus subtilis</italic></article-title>. <source hwp:id="source-32">J. Mol. Biol</source>. <volume>221</volume>:<fpage>1237</fpage>â<lpage>1256</lpage>.</citation></ref><ref id="c33" hwp:id="ref-33" hwp:rev-id="xref-ref-33-1 xref-ref-33-2 xref-ref-33-3 xref-ref-33-4"><label>33.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.33" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-33"><string-name name-style="western" hwp:sortable="Ricca E"><surname>Ricca</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cutting S"><surname>Cutting</surname> <given-names>S</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Losick R"><surname>Losick</surname> <given-names>R</given-names></string-name> (<year>1992</year>) <article-title hwp:id="article-title-34">Characterization of <italic toggle="yes">bofA</italic>, a gene involved in intercompartmental regulation of pro-Ï<sup>K</sup> processing during sporulation in <italic toggle="yes">Bacillus subtilis</italic></article-title>. <source hwp:id="source-33">J. Bacteriol</source>. <volume>174</volume>:<fpage>3177</fpage>â<lpage>3184</lpage>.</citation></ref><ref id="c34" hwp:id="ref-34" hwp:rev-id="xref-ref-34-1 xref-ref-34-2 xref-ref-34-3"><label>34.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.34" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-34"><string-name name-style="western" hwp:sortable="Resnekov O"><surname>Resnekov</surname> <given-names>O</given-names></string-name>, <string-name name-style="western" hwp:sortable="Alper S"><surname>Alper</surname> <given-names>S</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Losick R"><surname>Losick</surname> <given-names>R</given-names></string-name> (<year>1996</year>) <article-title hwp:id="article-title-35">Subcellular localization of proteins governing the proteolytic activation of a developmental transcription factor in <italic toggle="yes">Bacillus subtilis</italic></article-title>. <source hwp:id="source-34">Genes Cells</source> <volume>1</volume>(<issue>6</issue>):<fpage>529</fpage>â<lpage>542</lpage>.</citation></ref><ref id="c35" hwp:id="ref-35"><label>35.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.35" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-35"><string-name name-style="western" hwp:sortable="Rudner DZ"><surname>Rudner</surname> <given-names>DZ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pan Q"><surname>Pan</surname> <given-names>Q</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Losick RM"><surname>Losick</surname> <given-names>RM</given-names></string-name> (<year>2002</year>) <article-title hwp:id="article-title-36">Evidence that subcellular localization of a bacterial membrane protein is achieved by diffusion and capture</article-title>. <source hwp:id="source-35">Proc. Natl. Acad. Sci. USA</source> <volume>99</volume>(<issue>13</issue>):<fpage>8701</fpage>â<lpage>8706</lpage>.</citation></ref><ref id="c36" hwp:id="ref-36" hwp:rev-id="xref-ref-36-1 xref-ref-36-2 xref-ref-36-3 xref-ref-36-4 xref-ref-36-5 xref-ref-36-6 xref-ref-36-7 xref-ref-36-8 xref-ref-36-9 xref-ref-36-10"><label>36.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.36" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-36"><string-name name-style="western" hwp:sortable="Rudner DZ"><surname>Rudner</surname> <given-names>DZ</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Losick R"><surname>Losick</surname> <given-names>R</given-names></string-name> (<year>2002</year>) <article-title hwp:id="article-title-37">A sporulation membrane protein tethers the pro-Ï<sup>K</sup> processing enzyme to its inhibitor and dictates its subcellular localization</article-title>. <source hwp:id="source-36">Genes Dev</source>. <volume>16</volume>(<issue>8</issue>):<fpage>1007</fpage>â<lpage>1018</lpage>.</citation></ref><ref id="c37" hwp:id="ref-37" hwp:rev-id="xref-ref-37-1 xref-ref-37-2 xref-ref-37-3 xref-ref-37-4 xref-ref-37-5 xref-ref-37-6 xref-ref-37-7 xref-ref-37-8 xref-ref-37-9 xref-ref-37-10 xref-ref-37-11"><label>37.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.37" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-37"><string-name name-style="western" hwp:sortable="Zhou R"><surname>Zhou</surname> <given-names>R</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Kroos L"><surname>Kroos</surname> <given-names>L</given-names></string-name> (<year>2004</year>) <article-title hwp:id="article-title-38">BofA protein inhibits intramembrane proteolysis of pro-Ï<sup>K</sup> in an intercompartmental signaling pathway during <italic toggle="yes">Bacillus subtilis</italic> sporulation</article-title>. <source hwp:id="source-37">Proc. Natl. Acad. Sci. USA</source> <volume>101</volume>(<issue>17</issue>):<fpage>6385</fpage>â<lpage>6390</lpage>.</citation></ref><ref id="c38" hwp:id="ref-38" hwp:rev-id="xref-ref-38-1 xref-ref-38-2"><label>38.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.38" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-38"><string-name name-style="western" hwp:sortable="Kroos L"><surname>Kroos</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yu YT"><surname>Yu</surname> <given-names>YT</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mills D"><surname>Mills</surname> <given-names>D</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Ferguson-Miller S"><surname>Ferguson-Miller</surname> <given-names>S</given-names></string-name> (<year>2002</year>) <article-title hwp:id="article-title-39">Forespore signaling is necessary for pro-Ï<sup>K</sup> processing during <italic toggle="yes">Bacillus subtilis</italic> sporulation despite the loss of SpoIVFA upon translational arrest</article-title>. <source hwp:id="source-38">J. Bacteriol</source>. <volume>184</volume>(<issue>19</issue>):<fpage>5393</fpage>â<lpage>5401</lpage>.</citation></ref><ref id="c39" hwp:id="ref-39" hwp:rev-id="xref-ref-39-1"><label>39.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.39" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-39"><string-name name-style="western" hwp:sortable="Cutting S"><surname>Cutting</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Driks A"><surname>Driks</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schmidt R"><surname>Schmidt</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kunkel B"><surname>Kunkel</surname> <given-names>B</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Losick R"><surname>Losick</surname> <given-names>R</given-names></string-name> (<year>1991</year>) <article-title hwp:id="article-title-40">Forespore-specific transcription of a gene in the signal transduction pathway that governs pro-Ï<sup>K</sup> processing in <italic toggle="yes">Bacillus subtilis</italic></article-title>. <source hwp:id="source-39">Genes Dev</source>. <volume>5</volume>:<fpage>456</fpage>â<lpage>466</lpage>.</citation></ref><ref id="c40" hwp:id="ref-40" hwp:rev-id="xref-ref-40-1 xref-ref-40-2 xref-ref-40-3"><label>40.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.40" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-40"><string-name name-style="western" hwp:sortable="Pan Q"><surname>Pan</surname> <given-names>Q</given-names></string-name>, <string-name name-style="western" hwp:sortable="Losick R"><surname>Losick</surname> <given-names>R</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Rudner DZ"><surname>Rudner</surname> <given-names>DZ</given-names></string-name> (<year>2003</year>) <article-title hwp:id="article-title-41">A second PDZ-containing serine protease contributes to activation of the sporulation transcription factor Ï<sup>K</sup> in <italic toggle="yes">Bacillus subtilis</italic></article-title>. <source hwp:id="source-40">J. Bacteriol</source>. <volume>185</volume>(<issue>20</issue>):<fpage>6051</fpage>â<lpage>6056</lpage>.</citation></ref><ref id="c41" hwp:id="ref-41" hwp:rev-id="xref-ref-41-1 xref-ref-41-2 xref-ref-41-3 xref-ref-41-4"><label>41.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.41" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-41"><string-name name-style="western" hwp:sortable="Dong TC"><surname>Dong</surname> <given-names>TC</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Cutting SM"><surname>Cutting</surname> <given-names>SM</given-names></string-name> (<year>2003</year>) <article-title hwp:id="article-title-42">SpoIVB-mediated cleavage of SpoIVFA could provide the intercellular signal to activate processing of Pro-Ï<sup>K</sup> in <italic toggle="yes">Bacillus subtilis</italic></article-title>. <source hwp:id="source-41">Mol. Microbiol</source>. <volume>49</volume>(<issue>5</issue>):<fpage>1425</fpage>â<lpage>1434</lpage>.</citation></ref><ref id="c42" hwp:id="ref-42" hwp:rev-id="xref-ref-42-1 xref-ref-42-2 xref-ref-42-3 xref-ref-42-4 xref-ref-42-5 xref-ref-42-6"><label>42.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.42" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-42"><string-name name-style="western" hwp:sortable="Campo N"><surname>Campo</surname> <given-names>N</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Rudner DZ"><surname>Rudner</surname> <given-names>DZ</given-names></string-name> (<year>2006</year>) <article-title hwp:id="article-title-43">A branched pathway governing the activation of a developmental transcription factor by regulated intramembrane proteolysis</article-title>. <source hwp:id="source-42">Mol. Cell</source> <volume>23</volume>(<issue>1</issue>):<fpage>25</fpage>â<lpage>35</lpage>.</citation></ref><ref id="c43" hwp:id="ref-43" hwp:rev-id="xref-ref-43-1 xref-ref-43-2 xref-ref-43-3 xref-ref-43-4 xref-ref-43-5"><label>43.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.43" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-43"><string-name name-style="western" hwp:sortable="Campo N"><surname>Campo</surname> <given-names>N</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Rudner DZ"><surname>Rudner</surname> <given-names>DZ</given-names></string-name> (<year>2007</year>) <article-title hwp:id="article-title-44">SpoIVB and CtpB are both forespore signals in the activation of the sporulation transcription factor Ï<sup>K</sup> in <italic toggle="yes">Bacillus subtilis</italic></article-title>. <source hwp:id="source-43">J. Bacteriol</source>. <volume>189</volume>(<issue>16</issue>):<fpage>6021</fpage>â<lpage>6027</lpage>.</citation></ref><ref id="c44" hwp:id="ref-44" hwp:rev-id="xref-ref-44-1 xref-ref-44-2"><label>44.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.44" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-44"><string-name name-style="western" hwp:sortable="Mastny M"><surname>Mastny</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>) <article-title hwp:id="article-title-45">CtpB assembles a gated protease tunnel regulating cell-cell signaling during spore formation in <italic toggle="yes">Bacillus subtilis</italic></article-title>. <source hwp:id="source-44">Cell</source> <volume>155</volume>(<issue>3</issue>):<fpage>647</fpage>â<lpage>658</lpage>.</citation></ref><ref id="c45" hwp:id="ref-45" hwp:rev-id="xref-ref-45-1 xref-ref-45-2 xref-ref-45-3 xref-ref-45-4 xref-ref-45-5 xref-ref-45-6 xref-ref-45-7"><label>45.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.45" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-45"><string-name name-style="western" hwp:sortable="Zhou R"><surname>Zhou</surname> <given-names>R</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Kroos L"><surname>Kroos</surname> <given-names>L</given-names></string-name> (<year>2005</year>) <article-title hwp:id="article-title-46">Serine proteases from two cell types target different components of a complex that governs regulated intramembrane proteolysis of pro-Ï<sup>K</sup> during <italic toggle="yes">Bacillus subtilis</italic> development</article-title>. <source hwp:id="source-45">Mol. Microbiol</source>. <volume>58</volume>(<issue>3</issue>):<fpage>835</fpage>â<lpage>846</lpage>.</citation></ref><ref id="c46" hwp:id="ref-46" hwp:rev-id="xref-ref-46-1 xref-ref-46-2 xref-ref-46-3 xref-ref-46-4"><label>46.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.46" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-46"><string-name name-style="western" hwp:sortable="Rudner D"><surname>Rudner</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fawcett P"><surname>Fawcett</surname> <given-names>P</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Losick R"><surname>Losick</surname> <given-names>R</given-names></string-name> (<year>1999</year>) <article-title hwp:id="article-title-47">A family of membrane-embedded metalloproteases involved in regulated proteolysis of membrane-associated transcription factors</article-title>. <source hwp:id="source-46">Proc. Natl. Acad. Sci. USA</source> <volume>96</volume>:<fpage>14765</fpage>â<lpage>14770</lpage>.</citation></ref><ref id="c47" hwp:id="ref-47" hwp:rev-id="xref-ref-47-1 xref-ref-47-2"><label>47.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.47" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-47"><string-name name-style="western" hwp:sortable="Yu Y-TN"><surname>Yu</surname> <given-names>Y-TN</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Kroos L"><surname>Kroos</surname> <given-names>L</given-names></string-name> (<year>2000</year>) <article-title hwp:id="article-title-48">Evidence that SpoIVFB is a novel type of membrane metalloprotease governing intercompartmental communication during <italic toggle="yes">Bacillus subtilis</italic> sporulation</article-title>. <source hwp:id="source-47">J. Bacteriol</source>. <volume>182</volume>:<fpage>3305</fpage>â<lpage>3309</lpage>.</citation></ref><ref id="c48" hwp:id="ref-48" hwp:rev-id="xref-ref-48-1 xref-ref-48-2 xref-ref-48-3 xref-ref-48-4"><label>48.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.48" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-48"><string-name name-style="western" hwp:sortable="Zhou R"><surname>Zhou</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cusumano C"><surname>Cusumano</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sui D"><surname>Sui</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Garavito RM"><surname>Garavito</surname> <given-names>RM</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Kroos L"><surname>Kroos</surname> <given-names>L</given-names></string-name> (<year>2009</year>) <article-title hwp:id="article-title-49">Intramembrane proteolytic cleavage of a membrane-tethered transcription factor by a metalloprotease depends on ATP</article-title>. <source hwp:id="source-48">Proc. Natl. Acad. Sci. USA</source> <volume>106</volume>:<fpage>16174</fpage>â<lpage>16179</lpage>.</citation></ref><ref id="c49" hwp:id="ref-49" hwp:rev-id="xref-ref-49-1 xref-ref-49-2 xref-ref-49-3"><label>49.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.49" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-49"><string-name name-style="western" hwp:sortable="Kroos L"><surname>Kroos</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kunkel B"><surname>Kunkel</surname> <given-names>B</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Losick R"><surname>Losick</surname> <given-names>R</given-names></string-name> (<year>1989</year>) <article-title hwp:id="article-title-50">Switch protein alters specificity of RNA polymerase containing a compartment-specific sigma factor</article-title>. <source hwp:id="source-49">Science</source> <volume>243</volume>:<fpage>526</fpage>â<lpage>529</lpage>.</citation></ref><ref id="c50" hwp:id="ref-50" hwp:rev-id="xref-ref-50-1 xref-ref-50-2"><label>50.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.50" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-50"><string-name name-style="western" hwp:sortable="Eichenberger P"><surname>Eichenberger</surname> <given-names>P</given-names></string-name>, <etal>et al.</etal> (<year>2004</year>) <article-title hwp:id="article-title-51">The program of gene transcription for a single differentiating cell type during sporulation in <italic toggle="yes">Bacillus subtilis</italic></article-title>. <source hwp:id="source-50">PLoS Biol</source>. <volume>2</volume>(<issue>10</issue>):<fpage>e328</fpage>.</citation></ref><ref id="c51" hwp:id="ref-51" hwp:rev-id="xref-ref-51-1 xref-ref-51-2"><label>51.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.51" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-51"><string-name name-style="western" hwp:sortable="Morohashi Y"><surname>Morohashi</surname> <given-names>Y</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Tomita T"><surname>Tomita</surname> <given-names>T</given-names></string-name> (<year>2013</year>) <article-title hwp:id="article-title-52">Protein trafficking and maturation regulate intramembrane proteolysis</article-title>. <source hwp:id="source-51">Biochim. Biophys. Acta</source> <volume>1828</volume>(<issue>12</issue>):<fpage>2855</fpage>â<lpage>2861</lpage>.</citation></ref><ref id="c52" hwp:id="ref-52" hwp:rev-id="xref-ref-52-1 xref-ref-52-2"><label>52.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.52" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-52"><string-name name-style="western" hwp:sortable="Lichtenthaler SF"><surname>Lichtenthaler</surname> <given-names>SF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lemberg MK"><surname>Lemberg</surname> <given-names>MK</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Fluhrer R"><surname>Fluhrer</surname> <given-names>R</given-names></string-name> (<year>2018</year>) <article-title hwp:id="article-title-53">Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments</article-title>. <source hwp:id="source-52">EMBO J</source>. <volume>37</volume>(<issue>15</issue>):<fpage>e99456</fpage>.</citation></ref><ref id="c53" hwp:id="ref-53" hwp:rev-id="xref-ref-53-1 xref-ref-53-2"><label>53.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.53" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-53"><string-name name-style="western" hwp:sortable="Beard HA"><surname>Beard</surname> <given-names>HA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Barniol-Xicota M"><surname>Barniol-Xicota</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yang J"><surname>Yang</surname> <given-names>J</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Verhelst SHL"><surname>Verhelst</surname> <given-names>SHL</given-names></string-name> (<year>2019</year>) <article-title hwp:id="article-title-54">Discovery of cellular roles of intramembrane proteases</article-title>. <source hwp:id="source-53">ACS Chem. Biol</source>. <volume>14</volume>(<issue>11</issue>):<fpage>2372</fpage>â<lpage>2388</lpage>.</citation></ref><ref id="c54" hwp:id="ref-54" hwp:rev-id="xref-ref-54-1 xref-ref-54-2"><label>54.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.54" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-54"><string-name name-style="western" hwp:sortable="Kinch LN"><surname>Kinch</surname> <given-names>LN</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ginalski K"><surname>Ginalski</surname> <given-names>K</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Grishin NV"><surname>Grishin</surname> <given-names>NV</given-names></string-name> (<year>2006</year>) <article-title hwp:id="article-title-55">Site-2 protease regulated intramembrane proteolysis: sequence homologs suggest an ancient signaling cascade</article-title>. <source hwp:id="source-54">Protein Sci</source>. <volume>15</volume>(<issue>1</issue>):<fpage>84</fpage>â<lpage>93</lpage>.</citation></ref><ref id="c55" hwp:id="ref-55" hwp:rev-id="xref-ref-55-1 xref-ref-55-2 xref-ref-55-3 xref-ref-55-4 xref-ref-55-5 xref-ref-55-6 xref-ref-55-7 xref-ref-55-8 xref-ref-55-9"><label>55.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.55" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-55"><string-name name-style="western" hwp:sortable="Zhang Y"><surname>Zhang</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Luethy PM"><surname>Luethy</surname> <given-names>PM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhou R"><surname>Zhou</surname> <given-names>R</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Kroos L"><surname>Kroos</surname> <given-names>L</given-names></string-name> (<year>2013</year>) <article-title hwp:id="article-title-56">Residues in conserved loops of intramembrane metalloprotease SpoIVFB interact with residues near the cleavage site in Pro-Ï<sup>K</sup></article-title>. <source hwp:id="source-55">J. Bacteriol</source>. <volume>195</volume>(<issue>21</issue>):<fpage>4936</fpage>â<lpage>4946</lpage>.</citation></ref><ref id="c56" hwp:id="ref-56" hwp:rev-id="xref-ref-56-1 xref-ref-56-2 xref-ref-56-3 xref-ref-56-4 xref-ref-56-5 xref-ref-56-6 xref-ref-56-7 xref-ref-56-8 xref-ref-56-9 xref-ref-56-10 xref-ref-56-11"><label>56.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.56" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-56"><string-name name-style="western" hwp:sortable="Halder S"><surname>Halder</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Parrell D"><surname>Parrell</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Whitten D"><surname>Whitten</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Feig M"><surname>Feig</surname> <given-names>M</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Kroos L"><surname>Kroos</surname> <given-names>L</given-names></string-name> (<year>2017</year>) <article-title hwp:id="article-title-57">Interaction of intramembrane metalloprotease SpoIVFB with substrate Pro-Ï<sup>K</sup></article-title>. <source hwp:id="source-56">Proc. Natl. Acad. Sci. USA</source> <volume>114</volume>:<fpage>E10677</fpage>â<lpage>E10686</lpage>.</citation></ref><ref id="c57" hwp:id="ref-57" hwp:rev-id="xref-ref-57-1"><label>57.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.57" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-57"><string-name name-style="western" hwp:sortable="Saribas AS"><surname>Saribas</surname> <given-names>AS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gruenke L"><surname>Gruenke</surname> <given-names>L</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Waskell L"><surname>Waskell</surname> <given-names>L</given-names></string-name> (<year>2001</year>) <article-title hwp:id="article-title-58">Overexpression and purification of the membrane-bound cytochrome P450 2B4</article-title>. <source hwp:id="source-57">Protein Expr. Purif</source>. <volume>21</volume>(<issue>2</issue>):<fpage>303</fpage>â<lpage>309</lpage>.</citation></ref><ref id="c58" hwp:id="ref-58" hwp:rev-id="xref-ref-58-1"><label>58.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.58" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-58"><string-name name-style="western" hwp:sortable="Prince H"><surname>Prince</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhou R"><surname>Zhou</surname> <given-names>R</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Kroos L"><surname>Kroos</surname> <given-names>L</given-names></string-name> (<year>2005</year>) <article-title hwp:id="article-title-59">Substrate requirements for regulated intramembrane proteolysis of <italic toggle="yes">Bacillus subtilis</italic> pro-Ï<sup>K</sup></article-title>. <source hwp:id="source-58">J. Bacteriol</source>. <volume>187</volume>:<fpage>961</fpage>â<lpage>971</lpage>.</citation></ref><ref id="c59" hwp:id="ref-59" hwp:rev-id="xref-ref-59-1 xref-ref-59-2 xref-ref-59-3 xref-ref-59-4"><label>59.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.59" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-59"><string-name name-style="western" hwp:sortable="Ramirez-Guadiana FH"><surname>Ramirez-Guadiana</surname> <given-names>FH</given-names></string-name>, <etal>et al.</etal> (<year>2018</year>) <article-title hwp:id="article-title-60">Evidence that regulation of intramembrane proteolysis is mediated by substrate gating during sporulation in <italic toggle="yes">Bacillus subtilis</italic></article-title>. <source hwp:id="source-59">PLoS Genet</source>. <volume>14</volume>(<issue>11</issue>):<fpage>e1007753</fpage>.</citation></ref><ref id="c60" hwp:id="ref-60" hwp:rev-id="xref-ref-60-1 xref-ref-60-2 xref-ref-60-3"><label>60.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.60" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-60"><string-name name-style="western" hwp:sortable="Varcamonti M"><surname>Varcamonti</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Marasco R"><surname>Marasco</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="De Felice M"><surname>De Felice</surname> <given-names>M</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Sacco M"><surname>Sacco</surname> <given-names>M</given-names></string-name> (<year>1997</year>) <article-title hwp:id="article-title-61">Membrane topology analysis of the <italic toggle="yes">Bacillus subtilis</italic> BofA protein involved in pro-Ï<sup>K</sup> processing</article-title>. <source hwp:id="source-60">Microbiol</source>. <volume>143</volume>(<issue>Pt 4</issue>):<fpage>1053</fpage>â<lpage>1058</lpage>.</citation></ref><ref id="c61" hwp:id="ref-61" hwp:rev-id="xref-ref-61-1"><label>61.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.61" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-61"><string-name name-style="western" hwp:sortable="Resnekov O"><surname>Resnekov</surname> <given-names>O</given-names></string-name> (<year>1999</year>) <article-title hwp:id="article-title-62">Role of the sporulation protein BofA in regulating activation of the <italic toggle="yes">Bacillus subtilis</italic> developmental transcription factor Ï<sup>K</sup></article-title>. <source hwp:id="source-61">J. Bacteriol</source>. <volume>181</volume>:<fpage>5384</fpage>â<lpage>5388</lpage>.</citation></ref><ref id="c62" hwp:id="ref-62" hwp:rev-id="xref-ref-62-1 xref-ref-62-2 xref-ref-62-3 xref-ref-62-4"><label>62.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.62" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-62"><string-name name-style="western" hwp:sortable="Arolas JL"><surname>Arolas</surname> <given-names>JL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Goulas T"><surname>Goulas</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cuppari A"><surname>Cuppari</surname> <given-names>A</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Gomis-Ruth FX"><surname>Gomis-Ruth</surname> <given-names>FX</given-names></string-name> (<year>2018</year>) <article-title hwp:id="article-title-63">Multiple architectures and mechanisms of latency in metallopeptidase zymogens</article-title>. <source hwp:id="source-62">Chem. Rev</source>. <volume>118</volume>(<issue>11</issue>):<fpage>5581</fpage>â<lpage>5597</lpage>.</citation></ref><ref id="c63" hwp:id="ref-63" hwp:rev-id="xref-ref-63-1 xref-ref-63-2"><label>63.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.63" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-63"><string-name name-style="western" hwp:sortable="Van Wart HE"><surname>Van Wart</surname> <given-names>HE</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Birkedal-Hansen H"><surname>Birkedal-Hansen</surname> <given-names>H</given-names></string-name> (<year>1990</year>) <article-title hwp:id="article-title-64">The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family</article-title>. <source hwp:id="source-63">Proc. Natl. Acad. Sci. USA</source> <volume>87</volume>(<issue>14</issue>):<fpage>5578</fpage>â<lpage>5582</lpage>.</citation></ref><ref id="c64" hwp:id="ref-64" hwp:rev-id="xref-ref-64-1"><label>64.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.64" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-64"><string-name name-style="western" hwp:sortable="Odintsov SG"><surname>Odintsov</surname> <given-names>SG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sabala I"><surname>Sabala</surname> <given-names>I</given-names></string-name>, <string-name name-style="western" hwp:sortable="Marcyjaniak M"><surname>Marcyjaniak</surname> <given-names>M</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Bochtler M"><surname>Bochtler</surname> <given-names>M</given-names></string-name> (<year>2004</year>) <article-title hwp:id="article-title-65">Latent LytM at 1.3 Ã resolution</article-title>. <source hwp:id="source-64">J. Mol. Biol</source>. <volume>335</volume>(<issue>3</issue>):<fpage>775</fpage>â<lpage>785</lpage>.</citation></ref><ref id="c65" hwp:id="ref-65" hwp:rev-id="xref-ref-65-1 xref-ref-65-2"><label>65.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.65" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-65"><string-name name-style="western" hwp:sortable="Zhang Y"><surname>Zhang</surname> <given-names>Y</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>) <article-title hwp:id="article-title-66">Complex formed between intramembrane metalloprotease SpoIVFB and its substrate, Pro-Ï<sup>K</sup></article-title>. <source hwp:id="source-65">J. Biol. Chem.</source> <volume>291</volume>:<fpage>10347</fpage>â<lpage>10362</lpage>.</citation></ref><ref id="c66" hwp:id="ref-66" hwp:rev-id="xref-ref-66-1 xref-ref-66-2"><label>66.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.66" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-66"><string-name name-style="western" hwp:sortable="Akiyama K"><surname>Akiyama</surname> <given-names>K</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>) <article-title hwp:id="article-title-67">Roles of the membrane-reentrant Î²-hairpin-like loop of RseP protease in selective substrate cleavage</article-title>. <source hwp:id="source-66">eLife</source> <volume>4</volume>:<fpage>e08928</fpage></citation></ref><ref id="c67" hwp:id="ref-67" hwp:rev-id="xref-ref-67-1"><label>67.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.67" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-67"><string-name name-style="western" hwp:sortable="Rawson RB"><surname>Rawson</surname> <given-names>RB</given-names></string-name> (<year>2003</year>) <article-title hwp:id="article-title-68">The SREBP pathway--insights from Insigs and insects</article-title>. <source hwp:id="source-67">Nat. Rev. Mol. Cell Biol</source>. <volume>4</volume>(<issue>8</issue>):<fpage>631</fpage>â<lpage>640</lpage>.</citation></ref><ref id="c68" hwp:id="ref-68" hwp:rev-id="xref-ref-68-1 xref-ref-68-2"><label>68.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.68" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-68"><string-name name-style="western" hwp:sortable="Lima S"><surname>Lima</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Guo MS"><surname>Guo</surname> <given-names>MS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chaba R"><surname>Chaba</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gross CA"><surname>Gross</surname> <given-names>CA</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Sauer RT"><surname>Sauer</surname> <given-names>RT</given-names></string-name> (<year>2013</year>) <article-title hwp:id="article-title-69">Dual molecular signals mediate the bacterial response to outer-membrane stress</article-title>. <source hwp:id="source-68">Science</source> <volume>340</volume>(<issue>6134</issue>):<fpage>837</fpage>â<lpage>841</lpage>.</citation></ref><ref id="c69" hwp:id="ref-69" hwp:rev-id="xref-ref-69-1 xref-ref-69-2"><label>69.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.69" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-69"><string-name name-style="western" hwp:sortable="Hizukuri Y"><surname>Hizukuri</surname> <given-names>Y</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>) <article-title hwp:id="article-title-70">A structure-based model of substrate discrimination by a noncanonical PDZ tandem in the intramembrane-cleaving protease RseP</article-title>. <source hwp:id="source-69">Structure</source> <volume>22</volume>(<issue>2</issue>):<fpage>326</fpage>â<lpage>336</lpage>.</citation></ref><ref id="c70" hwp:id="ref-70" hwp:rev-id="xref-ref-70-1"><label>70.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.70" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-70"><string-name name-style="western" hwp:sortable="Bolduc DM"><surname>Bolduc</surname> <given-names>DM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Montagna DR"><surname>Montagna</surname> <given-names>DR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gu YL"><surname>Gu</surname> <given-names>YL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Selkoe DJ"><surname>Selkoe</surname> <given-names>DJ</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Wolfe MS"><surname>Wolfe</surname> <given-names>MS</given-names></string-name> (<year>2016</year>) <article-title hwp:id="article-title-71">Nicastrin functions to sterically hinder Î³-secretase-substrate interactions driven by substrate transmembrane domain</article-title>. <source hwp:id="source-70">Proc. Natl. Acad. Sci. USA</source> <volume>113</volume>(<issue>5</issue>):<fpage>E509</fpage>â<lpage>E518</lpage>.</citation></ref><ref id="c71" hwp:id="ref-71" hwp:rev-id="xref-ref-71-1"><label>71.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.71" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-71"><string-name name-style="western" hwp:sortable="Fukumori A"><surname>Fukumori</surname> <given-names>A</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Steiner H"><surname>Steiner</surname> <given-names>H</given-names></string-name> (<year>2016</year>) <article-title hwp:id="article-title-72">Substrate recruitment of Î³-secretase and mechanism of clinical presenilin mutations revealed by photoaffinity mapping</article-title>. <source hwp:id="source-71">EMBO J</source>. <volume>35</volume>(<issue>15</issue>):<fpage>1628</fpage>â<lpage>1643</lpage>.</citation></ref><ref id="c72" hwp:id="ref-72" hwp:rev-id="xref-ref-72-1"><label>72.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.72" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-72"><string-name name-style="western" hwp:sortable="Pereira FC"><surname>Pereira</surname> <given-names>FC</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>) <article-title hwp:id="article-title-73">The spore differentiation pathway in the enteric pathogen <italic toggle="yes">Clostridium difficile</italic></article-title>. <source hwp:id="source-72">PLoS Genet</source>. <volume>9</volume>(<issue>10</issue>):<fpage>e1003782</fpage>.</citation></ref><ref id="c73" hwp:id="ref-73" hwp:rev-id="xref-ref-73-1"><label>73.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.73" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-73"><string-name name-style="western" hwp:sortable="Saujet L"><surname>Saujet</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>) <article-title hwp:id="article-title-74">Genome-wide analysis of cell type-specific gene transcription during spore formation in <italic toggle="yes">Clostridium difficile</italic></article-title>. <source hwp:id="source-73">PLoS Genet</source>. <volume>9</volume>(<issue>10</issue>):<fpage>e1003756</fpage>.</citation></ref><ref id="c74" hwp:id="ref-74" hwp:rev-id="xref-ref-74-1"><label>74.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.74" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-74"><string-name name-style="western" hwp:sortable="Haraldsen JD"><surname>Haraldsen</surname> <given-names>JD</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Sonenshein AL"><surname>Sonenshein</surname> <given-names>AL</given-names></string-name> (<year>2003</year>) <article-title hwp:id="article-title-75">Efficient sporulation in <italic toggle="yes">Clostridium difficile</italic> requires disruption of the Ï<sup>K</sup> gene</article-title>. <source hwp:id="source-74">Mol. Microbiol</source>. <volume>48</volume>(<issue>3</issue>):<fpage>811</fpage>â<lpage>821</lpage>.</citation></ref><ref id="c75" hwp:id="ref-75" hwp:rev-id="xref-ref-75-1"><label>75.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.75" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-75"><string-name name-style="western" hwp:sortable="Ticha A"><surname>Ticha</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Collis B"><surname>Collis</surname> <given-names>B</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Strisovsky K"><surname>Strisovsky</surname> <given-names>K</given-names></string-name> (<year>2018</year>) <article-title hwp:id="article-title-76">The rhomboid superfamily: structural mechanisms and chemical biology opportunities</article-title>. <source hwp:id="source-75">Trends Biochem. Sci</source>. <volume>43</volume>(<issue>9</issue>):<fpage>726</fpage>â<lpage>739</lpage>.</citation></ref><ref id="c76" hwp:id="ref-76" hwp:rev-id="xref-ref-76-1"><label>76.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.76" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-76"><string-name name-style="western" hwp:sortable="Wolfe MS"><surname>Wolfe</surname> <given-names>MS</given-names></string-name> (<year>2019</year>) <article-title hwp:id="article-title-77">Dysfunctional Î³-secretase in familial Alzheimerâs disease</article-title>. <source hwp:id="source-76">Neurochem Res</source> <volume>44</volume>(<issue>1</issue>):<fpage>5</fpage>â<lpage>11</lpage>.</citation></ref><ref id="c77" hwp:id="ref-77" hwp:rev-id="xref-ref-77-1"><label>77.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.77" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-77"><string-name name-style="western" hwp:sortable="De Strooper B"><surname>De Strooper</surname> <given-names>B</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Chavez Gutierrez L"><surname>Chavez Gutierrez</surname> <given-names>L</given-names></string-name> (<year>2015</year>) <article-title hwp:id="article-title-78">Learning by failing: ideas and concepts to tackle Î³-secretases in Alzheimerâs disease and beyond</article-title>. <source hwp:id="source-77">Annu. Rev. Pharmacol. Toxicol</source>. <volume>55</volume>:<fpage>419</fpage>â<lpage>437</lpage>.</citation></ref><ref id="c78" hwp:id="ref-78" hwp:rev-id="xref-ref-78-1"><label>78.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.78" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-78"><string-name name-style="western" hwp:sortable="Szaruga M"><surname>Szaruga</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> (<year>2017</year>) <article-title hwp:id="article-title-79">Alzheimerâs-causing mutations shift AÎ² length by destabilizing Î³- secretase-AÎ²n interactions</article-title>. <source hwp:id="source-78">Cell</source> <volume>170</volume>(<issue>3</issue>):<fpage>443</fpage>â<lpage>456</lpage> e414.</citation></ref><ref id="c79" hwp:id="ref-79" hwp:rev-id="xref-ref-79-1"><label>79.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.79" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-79"><string-name name-style="western" hwp:sortable="Konovalova A"><surname>Konovalova</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> (<year>2018</year>) <article-title hwp:id="article-title-80">Inhibitor of intramembrane protease RseP blocks the Ï<sup>E</sup> response causing lethal accumulation of unfolded outer membrane proteins</article-title>. <source hwp:id="source-79">Proc. Natl. Acad. Sci. USA</source> <volume>115</volume>(<issue>28</issue>):<fpage>E6614</fpage>â<lpage>E6621</lpage>.</citation></ref><ref id="c80" hwp:id="ref-80" hwp:rev-id="xref-ref-80-1 xref-ref-80-2"><label>80.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.80" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-80"><string-name name-style="western" hwp:sortable="Jacobsen JA"><surname>Jacobsen</surname> <given-names>JA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Major Jourden JL"><surname>Major Jourden</surname> <given-names>JL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Miller MT"><surname>Miller</surname> <given-names>MT</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Cohen SM"><surname>Cohen</surname> <given-names>SM</given-names></string-name> (<year>2010</year>) <article-title hwp:id="article-title-81">To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibition</article-title>. <source hwp:id="source-80">Biochim. Biophys. Acta</source> <volume>1803</volume>(<issue>1</issue>):<fpage>72</fpage>â<lpage>94</lpage>.</citation></ref><ref id="c81" hwp:id="ref-81"><label>81.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.81" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-81"><string-name name-style="western" hwp:sortable="Fields GB"><surname>Fields</surname> <given-names>GB</given-names></string-name> (<year>2015</year>) <article-title hwp:id="article-title-82">New strategies for targeting matrix metalloproteinases</article-title>. <source hwp:id="source-81">Matrix Biol</source>. <volume>44- 46</volume>:<fpage>239</fpage>â<lpage>246</lpage>.</citation></ref><ref id="c82" hwp:id="ref-82" hwp:rev-id="xref-ref-82-1 xref-ref-82-2"><label>82.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.82" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-82"><string-name name-style="western" hwp:sortable="Gomis-Ruth FX"><surname>Gomis-Ruth</surname> <given-names>FX</given-names></string-name> (<year>2017</year>) <article-title hwp:id="article-title-83">Third time lucky? Getting a grip on matrix metalloproteinases</article-title>. <source hwp:id="source-82">J. Biol. Chem</source>. <volume>292</volume>(<issue>43</issue>):<fpage>17975</fpage>â<lpage>17976</lpage>.</citation></ref><ref id="c83" hwp:id="ref-83" hwp:rev-id="xref-ref-83-1"><label>83.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.83" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-83"><string-name name-style="western" hwp:sortable="Moss ML"><surname>Moss</surname> <given-names>ML</given-names></string-name>, <etal>et al.</etal> (<year>2007</year>) <article-title hwp:id="article-title-84">The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events</article-title>. <source hwp:id="source-83">J. Biol. Chem</source>. <volume>282</volume>(<issue>49</issue>):<fpage>35712</fpage>â<lpage>35721</lpage>.</citation></ref><ref id="c84" hwp:id="ref-84" hwp:rev-id="xref-ref-84-1"><label>84.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.84" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-84"><string-name name-style="western" hwp:sortable="Wong E"><surname>Wong</surname> <given-names>E</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>) <article-title hwp:id="article-title-85">Harnessing the natural inhibitory domain to control TNFÎ± Converting Enzyme (TACE) activity <italic toggle="yes">in vivo</italic></article-title>. <source hwp:id="source-84">Sci. Rep</source>. <volume>6</volume>:<fpage>35598</fpage>.</citation></ref><ref id="c85" hwp:id="ref-85" hwp:rev-id="xref-ref-85-1"><label>85.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.85" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-85"><string-name name-style="western" hwp:sortable="Zorzi A"><surname>Zorzi</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Deyle K"><surname>Deyle</surname> <given-names>K</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Heinis C"><surname>Heinis</surname> <given-names>C</given-names></string-name> (<year>2017</year>) <article-title hwp:id="article-title-86">Cyclic peptide therapeutics: past, present and future</article-title>. <source hwp:id="source-85">Curr. Opin. Chem. Biol</source>. <volume>38</volume>:<fpage>24</fpage>â<lpage>29</lpage>.</citation></ref><ref id="c86" hwp:id="ref-86" hwp:rev-id="xref-ref-86-1"><label>86.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.86" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-86"><string-name name-style="western" hwp:sortable="Sohrabi C"><surname>Sohrabi</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Foster A"><surname>Foster</surname> <given-names>A</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Tavassoli A"><surname>Tavassoli</surname> <given-names>A</given-names></string-name> (<year>2020</year>) <article-title hwp:id="article-title-87">Methods for generating and screening libraries of genetically encoded cyclic peptides in drug discovery</article-title>. <source hwp:id="source-86">Nat. Rev. Chem</source>. <volume>4</volume>(<issue>2</issue>):<fpage>90</fpage>â<lpage>101</lpage>.</citation></ref><ref id="c87" hwp:id="ref-87" hwp:rev-id="xref-ref-87-1"><label>87.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.87" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-87"><string-name name-style="western" hwp:sortable="Hanahan D"><surname>Hanahan</surname> <given-names>D</given-names></string-name> (<year>1983</year>) <article-title hwp:id="article-title-88">Studies on transformation of <italic toggle="yes">Escherichia coli</italic> with plasmids</article-title>. <source hwp:id="source-87">J. Mol. Biol</source>. <volume>166</volume>:<fpage>557</fpage>â<lpage>580</lpage>.</citation></ref><ref id="c88" hwp:id="ref-88" hwp:rev-id="xref-ref-88-1"><label>88.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.88" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-88"><string-name name-style="western" hwp:sortable="Notredame C"><surname>Notredame</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Higgins DG"><surname>Higgins</surname> <given-names>DG</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Heringa J"><surname>Heringa</surname> <given-names>J</given-names></string-name> (<year>2000</year>) <article-title hwp:id="article-title-89">T-Coffee: A novel method for fast and accurate multiple sequence alignment</article-title>. <source hwp:id="source-88">J. Mol. Biol</source>. <volume>302</volume>(<issue>1</issue>):<fpage>205</fpage>â<lpage>217</lpage>.</citation></ref><ref id="c89" hwp:id="ref-89" hwp:rev-id="xref-ref-89-1 xref-ref-89-2"><label>89.</label><citation publication-type="book" citation-type="book" ref:id="2021.07.09.451828v4.89" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-89"><string-name name-style="western" hwp:sortable="Harwood CR"><surname>Harwood</surname> <given-names>CR</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Cutting SM"><surname>Cutting</surname> <given-names>SM</given-names></string-name> (<year>1990</year>) <source hwp:id="source-89">Molecular Biological Methods for Bacillus</source> (<publisher-name>John Wiley &amp; Sons</publisher-name>, <publisher-loc>Chichester, England</publisher-loc>) p <fpage>581</fpage>.</citation></ref><ref id="c90" hwp:id="ref-90" hwp:rev-id="xref-ref-90-1"><label>90.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.90" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-90"><string-name name-style="western" hwp:sortable="Parrell D"><surname>Parrell</surname> <given-names>D</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Kroos L"><surname>Kroos</surname> <given-names>L</given-names></string-name> (<year>2020</year>) <article-title hwp:id="article-title-90">Channels modestly impact compartment-specific ATP levels during <italic toggle="yes">Bacillus subtilis</italic> sporulation and a rise in the mother cell ATP level is not necessary for Pro-Ï<sup>K</sup> cleavage</article-title>. <source hwp:id="source-90">Mol. Microbiol</source>. <volume>114</volume>:<fpage>563</fpage>â<lpage>581</lpage>.</citation></ref><ref id="c91" hwp:id="ref-91" hwp:rev-id="xref-ref-91-1"><label>91.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.91" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-91"><string-name name-style="western" hwp:sortable="Koide K"><surname>Koide</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ito K"><surname>Ito</surname> <given-names>K</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Akiyama Y"><surname>Akiyama</surname> <given-names>Y</given-names></string-name> (<year>2008</year>) <article-title hwp:id="article-title-91">Substrate recognition and binding by RseP, an <italic toggle="yes">Escherichia coli</italic> intramembrane protease</article-title>. <source hwp:id="source-91">J. Biol. Chem</source>. <volume>283</volume>(<issue>15</issue>):<fpage>9562</fpage>â<lpage>9570</lpage>.</citation></ref><ref id="c92" hwp:id="ref-92" hwp:rev-id="xref-ref-92-1"><label>92.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.92" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-92"><string-name name-style="western" hwp:sortable="Ha Y"><surname>Ha</surname> <given-names>Y</given-names></string-name> (<year>2009</year>) <article-title hwp:id="article-title-92">Structure and mechanism of intramembrane protease</article-title>. <source hwp:id="source-92">Semin. Cell Dev. Biol</source>. <volume>20</volume>(<issue>2</issue>):<fpage>240</fpage>â<lpage>250</lpage>.</citation></ref><ref id="c93" hwp:id="ref-93" hwp:rev-id="xref-ref-93-1"><label>93.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.93" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-93"><string-name name-style="western" hwp:sortable="Zelenski N"><surname>Zelenski</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rawson R"><surname>Rawson</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Brown M"><surname>Brown</surname> <given-names>M</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Goldstein J"><surname>Goldstein</surname> <given-names>J</given-names></string-name> (<year>1999</year>) <article-title hwp:id="article-title-93">Membrane topology of S2P, a protein required for intramembranous cleavage of sterol regulatory element-binding proteins</article-title>. <source hwp:id="source-93">J. Biol. Chem</source>. <volume>274</volume>:<fpage>21973</fpage>â<lpage>21980</lpage>.</citation></ref><ref id="c94" hwp:id="ref-94" hwp:rev-id="xref-ref-94-1"><label>94.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.94" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-94"><string-name name-style="western" hwp:sortable="Nohturfft A"><surname>Nohturfft</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="DeBose-Boyd RA"><surname>DeBose-Boyd</surname> <given-names>RA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Scheek S"><surname>Scheek</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Goldstein JL"><surname>Goldstein</surname> <given-names>JL</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Brown MS"><surname>Brown</surname> <given-names>MS</given-names></string-name> (<year>1999</year>) <article-title hwp:id="article-title-94">Sterols regulate cycling of SREBP cleavage-activating protein (SCAP) between endoplasmic reticulum and Golgi</article-title>. <source hwp:id="source-94">Proc. Natl. Acad. Sci. USA</source> <volume>96</volume>(<issue>20</issue>):<fpage>11235</fpage>â<lpage>11240</lpage>.</citation></ref><ref id="c95" hwp:id="ref-95"><label>95.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.95" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-95"><string-name name-style="western" hwp:sortable="DeBose-Boyd RA"><surname>DeBose-Boyd</surname> <given-names>RA</given-names></string-name>, <etal>et al.</etal> (<year>1999</year>) <article-title hwp:id="article-title-95">Transport-dependent proteolysis of SREBP: relocation of site-1 protease from Golgi to ER obviates the need for SREBP transport to Golgi</article-title>. <source hwp:id="source-95">Cell</source> <volume>99</volume>(<issue>7</issue>):<fpage>703</fpage>â<lpage>712</lpage>.</citation></ref><ref id="c96" hwp:id="ref-96" hwp:rev-id="xref-ref-96-1"><label>96.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.96" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-96"><string-name name-style="western" hwp:sortable="Chen G"><surname>Chen</surname> <given-names>G</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Zhang X"><surname>Zhang</surname> <given-names>X</given-names></string-name> (<year>2010</year>) <article-title hwp:id="article-title-96">New insights into S2P signaling cascades: regulation, variation, and conservation</article-title>. <source hwp:id="source-96">Protein Sci</source>. <volume>19</volume>(<issue>11</issue>):<fpage>2015</fpage>â<lpage>2030</lpage>.</citation></ref><ref id="c97" hwp:id="ref-97" hwp:rev-id="xref-ref-97-1"><label>97.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.97" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-97"><string-name name-style="western" hwp:sortable="Sakai J"><surname>Sakai</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> (<year>1996</year>) <article-title hwp:id="article-title-97">Sterol-regulated release of SREBP-2 from cell membrane requires two sequential cleavages, one within a transmembrane domain</article-title>. <source hwp:id="source-97">Cell</source> <volume>85</volume>:<fpage>1037</fpage>â<lpage>1048</lpage>.</citation></ref><ref id="c98" hwp:id="ref-98" hwp:rev-id="xref-ref-98-1"><label>98.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.98" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-98"><string-name name-style="western" hwp:sortable="Sakai J"><surname>Sakai</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> (<year>1997</year>) <article-title hwp:id="article-title-98">Identification of complexes between the COOH-terminal domains of sterol regulatory element-binding proteins (SREBPs) and SREBP cleavage-activating protein</article-title>. <source hwp:id="source-98">J. Biol. Chem</source>. <volume>272</volume>(<issue>32</issue>):<fpage>20213</fpage>â<lpage>20221</lpage>.</citation></ref><ref id="c99" hwp:id="ref-99" hwp:rev-id="xref-ref-99-1"><label>99.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.99" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-99"><string-name name-style="western" hwp:sortable="Horton JD"><surname>Horton</surname> <given-names>JD</given-names></string-name>, <etal>et al.</etal> (<year>2003</year>) <article-title hwp:id="article-title-99">Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes</article-title>. <source hwp:id="source-99">Proc. Natl. Acad. Sci. USA</source> <volume>100</volume>(<issue>21</issue>):<fpage>12027</fpage>â<lpage>12032</lpage>.</citation></ref><ref id="c100" hwp:id="ref-100" hwp:rev-id="xref-ref-100-1"><label>100.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.100" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-100"><string-name name-style="western" hwp:sortable="Kanehara K"><surname>Kanehara</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Akiyama Y"><surname>Akiyama</surname> <given-names>Y</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Ito K"><surname>Ito</surname> <given-names>K</given-names></string-name> (<year>2001</year>) <article-title hwp:id="article-title-100">Characterization of the <italic toggle="yes">yaeL</italic> gene product and its S2P-protease motifs in <italic toggle="yes">Escherichia coli</italic></article-title>. <source hwp:id="source-100">Gene</source> <volume>281</volume>(<issue>1-2</issue>):<fpage>71</fpage>â<lpage>79</lpage>.</citation></ref><ref id="c101" hwp:id="ref-101" hwp:rev-id="xref-ref-101-1"><label>101.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.101" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-101"><string-name name-style="western" hwp:sortable="Drew D"><surname>Drew</surname> <given-names>D</given-names></string-name>, <etal>et al.</etal> (<year>2002</year>) <article-title hwp:id="article-title-101">Rapid topology mapping of <italic toggle="yes">Escherichia coli</italic> inner-membrane proteins by prediction and PhoA/GFP fusion analysis</article-title>. <source hwp:id="source-101">Proc. Natl. Acad. Sci. USA</source> <volume>99</volume>(<issue>5</issue>):<fpage>2690</fpage>â<lpage>2695</lpage>.</citation></ref><ref id="c102" hwp:id="ref-102" hwp:rev-id="xref-ref-102-1"><label>102.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.102" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-102"><string-name name-style="western" hwp:sortable="Ades SE"><surname>Ades</surname> <given-names>SE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Connolly LE"><surname>Connolly</surname> <given-names>LE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Alba BM"><surname>Alba</surname> <given-names>BM</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Gross CA"><surname>Gross</surname> <given-names>CA</given-names></string-name> (<year>1999</year>) <article-title hwp:id="article-title-102">The <italic toggle="yes">Escherichia coli</italic> Ï<sup>E</sup>-dependent extracytoplasmic stress response is controlled by the regulated proteolysis of an anti-Ï factor</article-title>. <source hwp:id="source-102">Genes Dev</source>. <volume>13</volume>(<issue>18</issue>):<fpage>2449</fpage>â<lpage>2461</lpage>.</citation></ref><ref id="c103" hwp:id="ref-103" hwp:rev-id="xref-ref-103-1"><label>103.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.103" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-103"><string-name name-style="western" hwp:sortable="Walsh NP"><surname>Walsh</surname> <given-names>NP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Alba BM"><surname>Alba</surname> <given-names>BM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bose B"><surname>Bose</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gross CA"><surname>Gross</surname> <given-names>CA</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Sauer RT"><surname>Sauer</surname> <given-names>RT</given-names></string-name> (<year>2003</year>) <article-title hwp:id="article-title-103">OMP peptide signals initiate the envelope-stress response by activating DegS protease via relief of inhibition mediated by its PDZ domain</article-title>. <source hwp:id="source-103">Cell</source> <volume>113</volume>(<issue>1</issue>):<fpage>61</fpage>â<lpage>71</lpage>.</citation></ref><ref id="c104" hwp:id="ref-104" hwp:rev-id="xref-ref-104-1"><label>104.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.104" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-104"><string-name name-style="western" hwp:sortable="Kanehara K"><surname>Kanehara</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ito K"><surname>Ito</surname> <given-names>K</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Akiyama Y"><surname>Akiyama</surname> <given-names>Y</given-names></string-name> (<year>2002</year>) <article-title hwp:id="article-title-104">YaeL (EcfE) activates the Ï<sup>E</sup> pathway of stress response through a site-2 cleavage of anti-Ï<sup>E</sup>, RseA</article-title>. <source hwp:id="source-104">Genes Dev</source>. <volume>16</volume>(<issue>16</issue>):<fpage>2147</fpage>â<lpage>2155</lpage>.</citation></ref><ref id="c105" hwp:id="ref-105" hwp:rev-id="xref-ref-105-1"><label>105.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.105" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-105"><string-name name-style="western" hwp:sortable="Alba BM"><surname>Alba</surname> <given-names>BM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Leeds JA"><surname>Leeds</surname> <given-names>JA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Onufryk C"><surname>Onufryk</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lu CZ"><surname>Lu</surname> <given-names>CZ</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Gross CA"><surname>Gross</surname> <given-names>CA</given-names></string-name> (<year>2002</year>) <article-title hwp:id="article-title-105">DegS and YaeL participate sequentially in the cleavage of RseA to activate the Ï<sup>E</sup>-dependent extracytoplasmic stress response</article-title>. <source hwp:id="source-105">Genes Dev</source>. <volume>16</volume>(<issue>16</issue>):<fpage>2156</fpage>â<lpage>2168</lpage>.</citation></ref><ref id="c106" hwp:id="ref-106" hwp:rev-id="xref-ref-106-1"><label>106.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.106" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-106"><string-name name-style="western" hwp:sortable="Flynn JM"><surname>Flynn</surname> <given-names>JM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Neher SB"><surname>Neher</surname> <given-names>SB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kim YI"><surname>Kim</surname> <given-names>YI</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sauer RT"><surname>Sauer</surname> <given-names>RT</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Baker TA"><surname>Baker</surname> <given-names>TA</given-names></string-name> (<year>2003</year>) <article-title hwp:id="article-title-106">Proteomic discovery of cellular substrates of the ClpXP protease reveals five classes of ClpX-recognition signals</article-title>. <source hwp:id="source-106">Mol. Cell</source> <volume>11</volume>(<issue>3</issue>):<fpage>671</fpage>â<lpage>683</lpage>.</citation></ref><ref id="c107" hwp:id="ref-107" hwp:rev-id="xref-ref-107-1"><label>107.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.07.09.451828v4.107" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-107"><string-name name-style="western" hwp:sortable="Chaba R"><surname>Chaba</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Grigorova IL"><surname>Grigorova</surname> <given-names>IL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Flynn JM"><surname>Flynn</surname> <given-names>JM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Baker TA"><surname>Baker</surname> <given-names>TA</given-names></string-name>, &amp; <string-name name-style="western" hwp:sortable="Gross CA"><surname>Gross</surname> <given-names>CA</given-names></string-name> (<year>2007</year>) <article-title hwp:id="article-title-107">Design principles of the proteolytic cascade governing the Ï<sup>E</sup>-mediated envelope stress response in <italic toggle="yes">Escherichia coli</italic>: keys to graded, buffered, and rapid signal transduction</article-title>. <source hwp:id="source-107">Genes Dev</source>. <volume>21</volume>(<issue>1</issue>):<fpage>124</fpage>â<lpage>136</lpage>.</citation></ref></ref-list><sec id="s5" hwp:id="sec-24"><title hwp:id="title-37">Figure Supplements</title><p hwp:id="p-91"><bold>Figure 1-figure supplement 1</bold></p><p hwp:id="p-92"><bold>Morphological changes during endosporulation and regulated intramembrane proteolysis of Pro-Ï<sup>K</sup> in <italic toggle="yes">B. subtilis</italic>.</bold></p><p hwp:id="p-93"><bold>Figure 1-figure supplement 2</bold></p><p hwp:id="p-94"><bold>Full-length BofA alone fails to inhibit Pro-Ï<sup>K</sup>(</bold>1-127<bold>) cleavage in <italic toggle="yes">E. coli</italic> and full-length Pro- Ï<sup>K</sup> is similar to Pro-Ï<sup>K</sup>(</bold>1-127<bold>) in terms of requirements for cleavage inhibition.</bold></p><p hwp:id="p-95"><bold>Figure 1-figure supplement 3</bold></p><p hwp:id="p-96"><bold>Cleavage assays examining the effects of SpoIVB production on BofA and SpoIVFA inhibition of SpoIVFB in <italic toggle="yes">E. coli</italic>.</bold></p><p hwp:id="p-97"><bold>Figure 1-figure supplement 4</bold></p><p hwp:id="p-98"><bold>An F66A substitution in cytTM-SpoIVFB partially overcomes inhibition by GFPÎ27BofA and SpoIVFA in <italic toggle="yes">E. coli</italic>.</bold></p><p hwp:id="p-99"><bold>Figure 2-figure supplement 1</bold></p><p hwp:id="p-100"><bold>Sequence alignments of BofA orthologs to determine conserved residues.</bold></p><p hwp:id="p-101"><bold>Figure 2-figure supplement 2</bold></p><p hwp:id="p-102"><bold>Effects of BofA C-terminal residues and residues preceding predicted TMS2 on SpoIVFB inhibition in <italic toggle="yes">E. coli</italic>.</bold></p><p hwp:id="p-103"><bold>Figure 3-figure supplement 1</bold></p><p hwp:id="p-104"><bold>GFPÎ27BofA variants are intact during <italic toggle="yes">B. subtilis</italic> sporulation.</bold></p><p hwp:id="p-105"><bold>Figure 4-figure supplement 1</bold></p><p hwp:id="p-106"><bold>Models of SpoIVFB and BofA TMS2.</bold></p><p hwp:id="p-107"><bold>Figure 4-figure supplement 2</bold></p><p hwp:id="p-108"><bold>Cys-less variants of SpoIVFA and MBPÎ27BofA inhibit cleavage of Pro-Ï<sup>K</sup>(</bold>1-127<bold>) by cytTM-SpoIVFB in <italic toggle="yes">E. coli</italic>.</bold></p><p hwp:id="p-109"><bold>Figure 4-figure supplement 3</bold></p><p hwp:id="p-110"><bold>BofA TMS2 is in proximity to the active site of SpoIVFB.</bold></p><p hwp:id="p-111"><bold>Figure 4-figure supplement 4</bold></p><p hwp:id="p-112"><bold>Full-length BofA is in proximity to the active site of SpoIVFB.</bold></p><p hwp:id="p-113"><bold>Figure 4-figure supplement 5</bold></p><p hwp:id="p-114"><bold>BofA TMS2 has a preferred orientation in the active site cleft of SpoIVFB.</bold></p><p hwp:id="p-115"><bold>Figure 5-figure supplement 1</bold></p><p hwp:id="p-116"><bold>Neither GFPÎ27BofA nor full-length BofA when co-produced with SpoIVFA prevent Pro- Ï<sup>K</sup>(</bold>1-127<bold>) from interacting with SpoIVFB.</bold></p><p hwp:id="p-117"><bold>Figure 5-figure supplement 2</bold></p><p hwp:id="p-118"><bold>GFPÎ27BofA and SpoIVFA do not prevent full-length Pro-Ï<sup>K</sup> from interacting with SpoIVFB.</bold></p><p hwp:id="p-119"><bold>Figure 5-figure supplement 3</bold></p><p hwp:id="p-120"><bold>Disulfide cross-linking between the cytTM-SpoIVFB CBS domain and the Pro-Ï<sup>K</sup>(</bold>1-127<bold>) C-terminal region.</bold></p><p hwp:id="p-121"><bold>Figure 6-figure supplement 1</bold></p><p hwp:id="p-122"><bold>Disulfide cross-linking between E44C at the active site of cytTM-SpoIVFB and the Proregion of Pro-Ï<sup>K</sup>(</bold>1-127<bold>) in the absence of inhibitory proteins or in the presence of MBPÎ27BofA and SpoIVFA.</bold></p><p hwp:id="p-123"><bold>Figure 6-figure supplement 2</bold></p><p hwp:id="p-124"><bold>Full-length BofA and SpoIVFA decrease cross-linking between E44C cytTM-SpoIVFB and V20C or K24C Pro-Ï<sup>K</sup>(</bold>1-127<bold>).</bold></p><p hwp:id="p-125"><bold>Figure 6-figure supplement 3</bold></p><p hwp:id="p-126"><bold>Disulfide cross-linking between V70C in the cytTM-SpoIVFB membrane-reentrant loop and F18C or K24C in the Pro-Ï<sup>K</sup>(</bold>1-127<bold>) N-terminal region is decreased more by full-length BofA than by MBPÎ27BofA (lacking TMS1).</bold></p><p hwp:id="p-127"><bold>Figure 6-figure supplement 4</bold></p><p hwp:id="p-128"><bold>Comparison of disulfide cross-linking between C46 in TMS2 of full-length BofA or MBPÎ27BofA (lacking TMS1) and E44C at or P135C near the active site of cytTM- SpoIVFB.</bold></p><p hwp:id="p-129"><bold>Figure 6-figure supplement 5</bold></p><p hwp:id="p-130"><bold>Disulfide cross-linking between Y214C in the cytTM-SpoIVFB interdomain linker and L41C in the Pro-Ï<sup>K</sup>(</bold>1-127<bold>) N-terminal region is decreased more by full-length BofA than by MBPÎ27BofA (lacking TMS1).</bold></p><p hwp:id="p-131"><bold>Figure 7-figure supplement 1</bold></p><p hwp:id="p-132"><bold>Model of SpoIVFB tetramer with part of one Pro-Ï<sup>K</sup> molecule.</bold></p></sec><sec id="s6" hwp:id="sec-25"><title hwp:id="title-38">Source Data Files</title><p hwp:id="p-133"><bold>Figure 1-source data 1</bold></p><p hwp:id="p-134"><bold>Immunoblot images (raw and annotated) and quantification of cleavage assays (</bold><xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-23" hwp:rel-id="F1"><bold>Figure 1</bold></xref> <bold>B and C).</bold></p><p hwp:id="p-135"><bold>Figure 1-figure supplement 2-source data 1</bold></p><p hwp:id="p-136"><bold>Immunoblot images (raw and annotated) and quantification of cleavage assays.</bold></p><p hwp:id="p-137"><bold>Figure 1-figure supplement 3-source data 1</bold></p><p hwp:id="p-138"><bold>Immunoblot images (raw and annotated) and quantification of cleavage assays.</bold></p><p hwp:id="p-139"><bold>Figure 1-figure supplement 4-source data 1</bold></p><p hwp:id="p-140"><bold>Immunoblot images (raw and annotated) and quantification of cleavage assays.</bold></p><p hwp:id="p-141"><bold>Figure 2-source data 1</bold></p><p hwp:id="p-142"><bold>Immunoblot images (raw and annotated) and quantification of cleavage assays.</bold></p><p hwp:id="p-143"><bold>Figure 2-figure supplement 2-source data 1</bold></p><p hwp:id="p-144"><bold>Immunoblot images (raw and annotated) and quantification of cleavage assays.</bold></p><p hwp:id="p-145"><bold>Figure 3-source data 1</bold></p><p hwp:id="p-146"><bold>Immunoblot images (annotated) and quantification of cleavage assays (</bold><xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-16" hwp:rel-id="F3"><bold>Figure 3A</bold></xref><bold>), and confocal microscopy images (see the readme file) and a table of the numbers of sporangia in which FS localization of GFPÎ27BofA and the three variants was counted (</bold><xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-17" hwp:rel-id="F3"><bold>Figure 3B</bold></xref><bold>).</bold></p><p hwp:id="p-147"><bold>Figure 3-source data 2</bold></p><p hwp:id="p-148"><bold>Immunoblot images (raw) (</bold><xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-18" hwp:rel-id="F3"><bold>Figure 3A</bold></xref><bold>).</bold></p><p hwp:id="p-149"><bold>Figure 3-figure supplement 1-source data 1 Immunoblot images (raw and annotated).</bold></p><p hwp:id="p-150"><bold>Figure 4-source data 1</bold></p><p hwp:id="p-151"><bold>Immunoblot images (raw and annotated).</bold></p><p hwp:id="p-152"><bold>Figure 4-figure supplement 1-source data 1 PyMOL session file used to produce the images.</bold></p><p hwp:id="p-153"><bold>Figure 4-figure supplement 2-source data 1</bold></p><p hwp:id="p-154"><bold>Immunoblot images (raw and annotated) and quantification of cleavage assays.</bold></p><p hwp:id="p-155"><bold>Figure 4-figure supplement 4-source data 1 Immunoblot images (raw and annotated).</bold></p><p hwp:id="p-156"><bold>Figure 4-figure supplement 5-source data 1</bold></p><p hwp:id="p-157"><bold>Immunoblot images (raw and annotated) (Figure 4-figure supplement 5 B and C) and quantification of cleavage assays (Figure 4-figure supplement 5B).</bold></p><p hwp:id="p-158"><bold>Figure 5-source data 1</bold></p><p hwp:id="p-159"><bold>Immunoblot images (raw and annotated) (</bold><xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-7" hwp:rel-id="F5"><bold>Figure 5A</bold></xref><bold>) and quantification of cross-linking (</bold><xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-8" hwp:rel-id="F5"><bold>Figure 5B</bold></xref><bold>).</bold></p><p hwp:id="p-160"><bold>Figure 5-figure supplement 1-source data 1 Immunoblot images (raw and annotated).</bold></p><p hwp:id="p-161"><bold>Figure 5-figure supplement 2-source data 1 Immunoblot images (raw and annotated).</bold></p><p hwp:id="p-162"><bold>Figure 5-figure supplement 3-source data 1</bold></p><p hwp:id="p-163"><bold>Immunoblot images (raw and annotated) and quantification of cleavage assays (</bold><xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-9" hwp:rel-id="F5"><bold>Figure 5</bold></xref><bold>- figure supplement 3B).</bold></p><p hwp:id="p-164"><bold>Figure 6-source data 1</bold></p><p hwp:id="p-165"><bold>Quantification of cross-linking (</bold><xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-17" hwp:rel-id="F6"><bold>Figure 6</bold></xref> <bold>A, C, and E-I).</bold></p><p hwp:id="p-166"><bold>Figure 6-figure supplement 1-source data 1</bold></p><p hwp:id="p-167"><bold>Immunoblot images (raw and annotated) (Figure 6-figure supplement 1A).</bold></p><p hwp:id="p-168"><bold>Figure 6-figure supplement 1-source data 2</bold></p><p hwp:id="p-169"><bold>Immunoblot images (raw and annotated) (Figure 6-figure supplement 1B).</bold></p><p hwp:id="p-170"><bold>Figure 6-figure supplement 2-source data 1</bold></p><p hwp:id="p-171"><bold>Immunoblot images (raw and annotated) (Figure 6-figure supplement 2A) and quantification of cross-linking (Figure 6-figure supplement 2B).</bold></p><p hwp:id="p-172"><bold>Figure 6-figure supplement 3-source data 1</bold></p><p hwp:id="p-173"><bold>Immunoblot images (raw and annotated) (Figure 6-figure supplement 3 A, C, E, and G) and quantification of cross-linking (Figure 6-figure supplement 3 B, D, and F).</bold></p><p hwp:id="p-174"><bold>Figure 6-figure supplement 4-source data 1</bold></p><p hwp:id="p-175"><bold>Immunoblot images (raw and annotated) (Figure 6-figure supplement 4 A, B, D, and E) and quantification of cross-linking (Figure 6-figure supplement 4 C and F).</bold></p><p hwp:id="p-176"><bold>Figure 6-figure supplement 5-source data 1 Immunoblot images (raw and annotated).</bold></p><p hwp:id="p-177"><bold>Figure 7-source data 1</bold></p><p hwp:id="p-178"><bold>PyMOL session file used to produce the images and PDB file of the model of a SpoIVFB tetramer with BofA and parts of SpoIVFA and Pro-Ï<sup>K</sup>.</bold></p><p hwp:id="p-179"><bold>Figure 7-figure supplement 1-source data 1</bold></p><p hwp:id="p-180"><bold>PyMOL session file used to produce the images and PDB file of the model of a SpoIVFB tetramer with part of one molecule of Pro-Ï<sup>K</sup>.</bold></p></sec><sec id="s7" hwp:id="sec-26"><title hwp:id="title-39">Supplementary Files</title><p hwp:id="p-181"><bold>Supplementary File 1</bold></p><p hwp:id="p-182"><bold>Supplementary Results.</bold></p><p hwp:id="p-183"><bold>Supplementary File 2</bold></p><p hwp:id="p-184"><bold>Supplementary Discussion.</bold></p><p hwp:id="p-185"><bold>Supplementary File 3</bold></p><p hwp:id="p-186"><bold>Supplementary Materials and Methods.</bold></p><p hwp:id="p-187"><bold>Supplementary File 4</bold></p><p hwp:id="p-188"><bold>Plasmids, primers, and <italic toggle="yes">B. subtilis</italic> strains used in this study.</bold></p><p hwp:id="p-189"><bold>Supplementary File 5</bold></p><p hwp:id="p-190"><bold>Applied restraints from cross-linking, and distance evaluation, for the model of SpoIVFB in complex with part of Pro-Ï<sup>K</sup>.</bold></p><p hwp:id="p-191"><bold>Supplementary File 6</bold></p><p hwp:id="p-192"><bold>Applied restraints from co-evolutionary coupling analysis, and distance evaluation, for the model of SpoIVFB in complex with part of Pro-Ï<sup>K</sup>.</bold></p><p hwp:id="p-193"><bold>Supplementary File 7</bold></p><p hwp:id="p-194"><bold>Applied restraints from cross-linking, and distance evaluation, for the model of SpoIVFB in complex with BofA and parts of SpoIVFA and Pro-Ï<sup>K</sup>.</bold></p><p hwp:id="p-195"><bold>Supplementary File 8</bold></p><p hwp:id="p-196"><bold>Applied restraints from co-evolutionary coupling analysis, and distance evaluation, for the model of SpoIVFB in complex with BofA and parts of SpoIVFA and Pro-Ï<sup>K</sup>.</bold></p></sec></back></article>
